Datasets:
nmixx-fin
/
opensource_english_finance_datasets

Dataset card Data Studio Files Community
1
source
stringclasses
6 values
text
stringlengths
2
343k
category
stringclasses
1 value
token_count
int64
1
77.7k
Zihan1004/FNSPID
June 2021 Options Now Available For Advanced Micro Devices (AMD) Investors in Advanced Micro Devices Inc (Symbol: AMD) saw new options begin trading today, for the June 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 532 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMD options chain for the new June 2021 contracts and identified one put and one call contract of particular interest. The put contract at the $45.00 strike price has a current bid of $7.85. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $45.00, but will also collect the premium, putting the cost basis of the shares at $37.15 (before broker commissions). To an investor already interested in purchasing shares of AMD, that could represent an attractive alternative to paying $48.19/share today. Because the $45.00 strike represents an approximate 7% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 67%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 17.44% return on the cash commitment, or 11.97% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Advanced Micro Devices Inc, and highlighting in green where the $45.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $50.00 strike price has a current bid of $9.95. If an investor was to purchase shares of AMD stock at the current price level of $48.19/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $50.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 24.40% if the stock gets called away at the June 2021 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if AMD shares really soar, which is why looking at the trailing twelve month trading history for Advanced Micro Devices Inc, as well as studying the business fundamentals becomes important. Below is a chart showing AMD's trailing twelve month trading history, with the $50.00 strike highlighted in red: Considering the fact that the $50.00 strike represents an approximate 4% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 38%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 20.65% boost of extra return to the investor, or 14.17% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 55%, while the implied volatility in the call contract example is 57%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $48.19) to be 51%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the Nasdaq 100 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
982
Zihan1004/FNSPID
Noteworthy Friday Option Activity: MGM, TEAM, BBBY Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in MGM Resorts International (Symbol: MGM), where a total volume of 18,731 contracts has been traded thus far today, a contract volume which is representative of approximately 1.9 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 53.4% of MGM's average daily trading volume over the past month, of 3.5 million shares. Particularly high volume was seen for the $33 strike put option expiring January 17, 2020, with 5,469 contracts trading so far today, representing approximately 546,900 underlying shares of MGM. Below is a chart showing MGM's trailing twelve month trading history, with the $33 strike highlighted in orange: Atlassian Corp PLC (Symbol: TEAM) options are showing a volume of 5,974 contracts thus far today. That number of contracts represents approximately 597,400 underlying shares, working out to a sizeable 52% of TEAM's average daily trading volume over the past month, of 1.1 million shares. Especially high volume was seen for the $122 strike put option expiring January 17, 2020, with 1,753 contracts trading so far today, representing approximately 175,300 underlying shares of TEAM. Below is a chart showing TEAM's trailing twelve month trading history, with the $122 strike highlighted in orange: And Bed, Bath & Beyond, Inc. (Symbol: BBBY) options are showing a volume of 31,552 contracts thus far today. That number of contracts represents approximately 3.2 million underlying shares, working out to a sizeable 51.9% of BBBY's average daily trading volume over the past month, of 6.1 million shares. Particularly high volume was seen for the $16.50 strike call option expiring January 03, 2020, with 4,121 contracts trading so far today, representing approximately 412,100 underlying shares of BBBY. Below is a chart showing BBBY's trailing twelve month trading history, with the $16.50 strike highlighted in orange: For the various different available expirations for MGM options, TEAM options, or BBBY options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
589
Zihan1004/FNSPID
Jeff Clark’s Market Minute: These Stocks Will Carry the Market in 2020 2019 was a great year for the stock market – one of the strongest years ever. Source: Shutterstock And typically, following that sort of performance, the next year is great too. So, while nothing is ever guaranteed when it comes to the market… the odds are pretty good 2020 will be another bullish year. But – and this is important to understand – we likely won’t see that great performance in the exact same sectors… Semiconductor stocks were the top performers in 2019. Advanced Micro Devices (NASDAQ:) gained 152%. Lam Research (NASDAQ:) popped 116% higher. Applied Materials (NASDAQ:AMAT) jumped 88%. But, it probably won’t be the big winners of 2019 that lead the market higher this year. Instead, traders should look for the laggards to play catch-up. No doubt, 2019 was a momentum-driven market. Strong stocks got stronger throughout the year. Weak stocks got weaker. And, that trend accelerated in December as institutions and money managers engaged in the art of “window dressing.” They bought more of the market’s best-performing stocks so when they published their holdings at the end of the year, they could show investors they owned the markets best performers. And, they sold off the worst-performing stocks so they could show investors their limited exposure to bad performers. That action has created one of the widest valuation discrepancies between growth stocks and value stocks since 2000. You see, on a relative basis, growth stocks are historically expensive today… and value stocks are historically cheap. AMD, for example, trades at 44 times 2020 earnings estimates. That’s quite richly valued compared to the S&P 500, which trades for about 18 times 2020 earnings estimates. Meanwhile, value stocks like Teva Pharmaceuticals (NYSE:), which trades at less than 4 times 2020 earnings estimates, are historically cheap. Granted… TEVA has its issues, and the outlook is cloudy. And, AMD is firing on all cylinders and the future is shining bright. But gosh… is AMD really worth ten times the earnings multiple of TEVA – or any other company that actually has earnings? My point is… the valuation gap between growth and value has expanded to a historically wide level. Growth stocks are trading for historically high valuations. Value stocks are historically cheap. If the broad stock market is going to continue higher in 2020, then it’s going to be fueled by a “catch-up” rally in the value stocks. Traders should be looking for the undervalued and underappreciated names of 2019 to lead the market higher this year. Best regards and good trading, Jeff Clark P.S. If you ask my friend and colleague Teeka Tiwari, there’s another sector that should do very well in 2020… But, it’s not in the stock market. Teeka says that by , you could potentially pay for your whole retirement after one specific day this year. If you’re interested, just . But don’t wait too long… This opportunity closes for good before the end of January. Reader Mailbag Today a new subscriber thanks Jeff for his frequent communication… Jeff, though I’m fairly new to your services and have hardly placed any trades – the amount of communication you have is awesome. The transparency of your thoughts, daily, about where you see potential trades going is bold. No one gets everything right all the time, but you actually put yourself out there consistently. I think it’ll make me a better trader by just reading your thoughts you share consistently. – Mark And another subscriber shares his recent gains using Jeff’s Breakout Alert strategy… Thank you for one of your most recent Breakout Alert trade recommendations… I was able to close it with over 70% gains! On top of another recent trade that brought me 30% gains, this makes the Breakout Alert my favorite subscription, next to Delta Direct and Delta Report. I stopped using all my other subscriptions. I like the way you explain the trades, how you follow up with the trades, and your approach to the trades. The Jeff Clark Mobile app is practical, and I use it every day. I look forward to reading your report every morning as well as updates throughout the day. – German And one more reports on their experience using the new Jeff Clark Mobile app… Jeff, this latest app is working simply awesome for me. I used to use the text alerts for notifications then log on and look what was just posted. This latest revision of your app requires only my fingerprint without having to fumble passwords. PLUS, it gives the latest of each subscription, so at first glance I only get what I haven’t seen. I’m so excited because I get a better jump on your recommended trade at each post. If I want to look at something that’s aging in a portfolio, I can always use the web browser for that. Thanks, Jeff, for your relentless improvements! – Paul If you haven’t already, make sure to download the Jeff Clark Trader mobile app ( for iPhone and here for Android). And if you like what you see… or even think it could use some work… consider leaving a review on either app store. As always, thank you for your thoughtful emails. We look forward to reading them every day. Keep them coming to . In Case You Missed It… “The biggest 5G growth phase is set to begin soon. Up to $12.3 trillion will be unleashed, and dozens of tiny stocks could soar. Join me as I reveal my script for finding the best 5G plays before they go parabolic.” – 5G expert Jeff Brown More From InvestorPlace The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,612
Zihan1004/FNSPID
Friday's ETF with Unusual Volume: FTC The First Trust Large Cap Growth AlphaDEX Fund ETF (FTC) is seeing unusually high volume in afternoon trading Friday, with over 355,000 shares traded versus three month average volume of about 49,000. Shares of FTC were up about 0.2% on the day. Components of that ETF with the highest volume on Friday were Sirius XM Holdings (SIRI), trading off about 0.5% with over 13.2 million shares changing hands so far this session, and Snap (SNAP), up about 0.9% on volume of over 12.9 million shares. Lamb Weston Holdings (LW) is the component faring the best Friday, up by about 11.8% on the day, while Twitter (TWTR) is lagging other components of the First Trust Large Cap Growth AlphaDEX Fund ETF, trading lower by about 2.7%. VIDEO: Friday's ETF with Unusual Volume: FTC The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
244
Zihan1004/FNSPID
Stock Alert: Shares Of TransUnion (TRU) Hit 52-Week High (RTTNews) - Shares of TransUnion (TRU), risk and information solutions provider, touched a 52-week high of $87.82 on Jan. 2, 2020, and closed Thursday's trading session at $87.81, up $2.20 or 2.57%. Q3 Results The company's Q3 net income was $92 million or $0.48 per share versus $46 million or $0.24 per share last year. Adjusted net income was $146 million or $0.76 per share versus $125 million or $0.65 per share in the prior year period. Total revenue was $689 million, an increase of 14% compared with the third quarter of 2018. Chris Cartwright, President and CEO, said, "The results reflect the high-performance culture of the TransUnion team as well as our array of advantaged data assets, capabilities and technology infrastructure. We continue to aggressively invest in all of these areas to maintain our leadership position in the industry." Also, the company prepaid another $165 million of debt, bringing its total prepayments to $265 million for the year, and $325 million over the past twelve months. For the full year of 2019... The company raised its adjusted revenue, adjusted EBITDA and adjusted earnings per share guidance. Adjusted revenue is now expected to be between $2.644 billion and $2.649 billion, an increase of 13% compared with 2018. Adjusted EBITDA is now expected to be between $1.048 billion and $1.052 billion, an increase of 14% - 15%. Adjusted EPS is now projected to range between $2.74 and $2.76, an increase of 10%. For the fourth quarter of 2019... Adjusted revenue is expected to be between $667 million and $672 million, up 7% - 8% over last year. Adjusted EBITDA is expected to be $264 million - $268 million, and adjusted EPS between $0.69 and $0.71. TransUnion is slated to release its Q4 financial results on Tuesday, February 18, 2020. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
563
Zihan1004/FNSPID
3 Top Drug Stocks to Own In 2020 Broadly speaking, drug stocks have been some of the strongest performing names in the latter part of 2019. Since October 2019, the iShares NASDAQ Biotechnology ETF (NASDAQ:) has rallied from a low of $96 to nearly $124. The SPDR S&P Biotech ETF (NYSE: exploded from $75 to a high of $98.79. Even ProShares Ultra NASDAQ Biotechnology (NASDAQ:) popped from a low of $41 to a high of nearly $65. All despite concerns over potential changes to drug pricing policies with elections ahead. “While we get the sense that biotech investors are cautious into 2020 with the election and broader macro concerns, we believe that macro issues are unlikely to have material fundamental impact,” says . Wedbush , “The fundamentals of the sector look strong. Biotech surged in the third quarter, approvals from the Food & Drug Administration are coming through above the average annual rate, the valuation of large-cap biotechs are attractive, and there have been significant mergers and acquisitions in past years.” Plus, one of the biggest catalysts for future growth are the millions of retiring baby boomers. We’re also seeing new, innovative treatments for a myriad of issues. In addition, such stocks are recession-proof because folks will always require medical attention. Here are three of the top biotech stocks to watch in the New Year. Top Drug Stocks: Fate Therapeutics (FATE) After struggling out the gate, Fate Therapeutics (NASDAQ:) exploded from a low of $14 to $20 a share after posting positive trial results from its natural kill (NK) cell product candidate. With regards to data from its natural killer (NK) , “Current patient- and donor-specific CAR T-cell immunotherapies recognize only one antigen and fail to address the significant risk of relapse due to antigen escape. FT596 is ground-breaking in that it is designed to be available off-the-shelf for timely patient access and to promote deeper and more durable responses by targeting multiple tumor-associated antigens,” said Bob Valamehr, Ph.D., Chief Development Officer of Fate Therapeutics. The company’s other natural cell killer was also found to in a patient with acute myeloid leukemia (AML). Wells Fargo recently upgraded the FATE stock to an overweight rating with a target of $24. Axsome Therapeutics (AXSM) Axsome Therapeutics (NASDAQ:) had an explosive year. Since January 2019, AXSM stock exploded from a low of $2.64 to a recent high of $105.55. All after a series of major announcements, throughout the year. In January, for example, AXSM noted that its lead drug candidate, AXS-05 met its primary endpoint in a Phase II trial for major depressive disorder. Two months later, AXSM won FDA Breakthrough Therapy for the drug. By April, the drug also achieved its primary endpoint for smoking cessation. By December, its AXS-12 drug met its primary endpoint in a Phase II trial targeting narcolepsy. Then just two weeks ago, the AXSM stock ramped higher on news of positive late-state results for AXS-05, as a treatment of major depressive disorder. “Given the documented medical need for more potent MDD therapies, and the fact that a whopping 17 million American adults suffer from this condition every year, according to the National Institutes of Health, this experimental depression med has a clear path toward blockbuster status,” noted . Pfizer (PFE) Last year wasn’t kind to Pfizer (NYSE:) or its shareholders. In late July, PFE plunged 21% on company plans to combine its blockbuster drug-selling unit with Mylan (NYSE:), and announced it was cutting its sales and adjusted earnings forecast. However, with a strong drug portfolio, acquisitions, and an undervalued stock, PFE is attracting interest once again. The company also just raised its dividend by 5.6%, which brings the new quarterly dividend to 38 cents from 36 cents payable March 6, 2020 to shareholders as of Jan. 31. Plus, “the valuation on new Pfizer looks appealing, given management’s expectation of 6% annualized sales growth through 2025, which could produce 10%-plus yearly gains in earnings per share. New Pfizer has important patent-protected drugs like Ibrance for breast cancer and the pneumonia vaccine Prevnar, plus a strong pipeline,” . As of this writing, Ian Cooper did not hold a position in any of the aforementioned securities. The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,052
Zihan1004/FNSPID
Is Pot Stock Canopy Growth a Buy in 2020? Last year was supposed to when the marijuana industry proved skeptics wrong and demonstrated that it could be a profitable industry. For the most part, this vision fell flat on its face. In Canada, supply issues remained persistent throughout the year, keeping legal product off dispensary shelves and fueling an already resilient black market. Meanwhile, in the U.S., high tax rates in select states (looking at you, California) made it virtually impossible for legal growers to compete with illicit production. The end result was weaker-than-expected legal weed sales throughout much of North America and steep declines in market valuation for most marijuana stocks. The thing is, with cannabis stocks losing so much in 2019, some investors are genuinely wondering whether 2020 is the time to buy pot stocks. One name that's certain to come to mind is Canopy Growth (NYSE: CGC), the largest marijuana stock by market cap. In 2019, Canopy Growth lost about 27% of its value and shed around $10 billion in market cap from its closing high for the year. But is Canopy Growth a pot stock you should be buying in 2020? The answer is probably going to disappoint you. Image source: Getty Images. Canopy Growth looks like a buy -- on paper On one hand, Canopy Growth does seem to offer a number of advantages -- on paper. It has 10 cultivation facilities that are fully capable of more than 500,000 kilos, combined, of peak annual output. This substantive production is a big reason the company wound up securing more than 70,000 kilos of supply agreements in total with all of Canada's provinces. And Canopy Growth's Tweed is arguably the most recognized cannabis brand in Canada. The company has also done a seemingly bang-up job of pushing into overseas markets. Including Canada, it has an export, production, research, or partnership presence in 17 countries. If and when dried flower becomes oversupplied, these foreign countries could provide invaluable sales channels to offload excess product. But the real envy surrounds Canopy Growth's cash position. In November 2018, Canopy closed a $4 billion equity investment from Modelo and Corona beer-maker Constellation Brands (NYSE: STZ). The investment gave Constellation a 37% stake in Canopy and further diversified its future revenue channels within the vice space. For Canopy, it gave the company ample cash to make acquisitions, hire, and expand the company's existing operations. Top-tier production, international expansion, and plenty of cash on hand -- sounds like a buy, right? Unfortunately, that's not the case. Image source: Getty Images. A fundamental disaster that should be avoided in 2020 Canopy Growth may be a well-known and popular pot stock, but popularity isn't going to do a darn thing for the financial mess this company has gotten itself into. For one, regulatory issues have done Canopy (and the entire industry) no favors. Although the company hasn't had any issues getting cultivation and sales licenses for its facilities, it's been walloped by licensing issues in certain provinces. Ontario, for example, is Canada's largest province by population, yet it only had 24 open dispensaries as of the one-year anniversary of the commencement of recreational weed sales. That's only one store open per 604,000 people, and it's created a massive supply bottleneck in the region. Though Ontario is (thankfully) abandoning its lottery system for retail licenses in 2020, it's going to be some time before the cannabis supply chain improves. This is also a company that's been losing a staggering amount of money. In just the fiscal second quarter alone, Canopy's loss from operations totaled $265.8 million Canadian, with CA$388.9 million in losses through the first six months of fiscal 2020. While hiring a boatload of new employees has pushed costs higher, the real kick in the pants has been skyrocketing share-based compensation. Now-former co-CEO Bruce Linton believed that giving long-term vesting stock to employees was the best way to motivate them and keep them loyal. However, it's ballooned Canopy's costs so much that share-based compensation was higher than the company's net sales in Q2 2020. This makes profitability a distant hope for the company at the moment. Furthermore, Canopy's balance sheet isn't as pristine as its CA$2.7 billion in cash, cash equivalents, and marketable securities would imply. That's because, in addition to whittling away at its cash pile due to ongoing operating losses, it also seems to have grossly overpaid for its acquisitions. The company's CA$1.91 billion in goodwill represents 23% of total assets and is climbing. This looks to be a writedown just waiting to happen. Lastly, Canopy is welcoming a new CEO in January. While I have no doubt David Klein, Constellation Brands' soon-to-be former chief financial officer and new Canopy CEO, will handle some serious belt-tightening, he ultimately has no experience in the cannabis industry and puts the company's previous long-term strategy into doubt. Image source: Getty Images. What needs to happen for Canopy Growth to be worth buying? Just because this company has been an absolute mess of late doesn't mean you can't add it to your watch list for future evaluation. As noted, it has a number of positives on paper but would need a lot to go right before becoming a buy for investors. First, there would need to be some serious improvement of Canopy's income statement. This starts with serious cost-cutting, as well as supply-chain resolutions. Ontario should be able to open roughly 250 new dispensaries this year, which is a good start to pressuring the black market and giving consumers access to legal-channel product. Canopy doesn't have to be profitable on a recurring basis to be taken seriously as an investment, but it can't be on track for close to CA$800 million in operating losses, either. Secondly, the company would probably have to clean up its balance sheet a bit. On top of reducing its net-cash outflow, Canopy would likely have to admit that it overpaid for a number of its acquisitions and take a writedown to clean the slate, so to speak. Make no mistake about it: A writedown would not be well-received but a smart move for the long run. Lastly, Canopy will need a much better showing in international markets. The company should begin to realize hemp-processing revenue from its New York processing plant later this calendar year, and will hopefully see an uptick in European medical marijuana sales as more EU countries establish medical pot regulations and commence imports. It's not an impossible hill to climb for Canopy Growth, but it's not a stock you'll want to own in 2020. Here's The Marijuana Stock You've Been Waiting For A little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom. And make no mistake – it is coming. Cannabis legalization is sweeping over North America – 11 states plus Washington, D.C., have all legalized recreational marijuana over the last few years, and full legalization came to Canada in October 2018. And one under-the-radar Canadian company is poised to explode from this coming marijuana revolution. Because a game-changing deal just went down between the Ontario government and this powerhouse company...and you need to hear this story today if you have even considered investing in pot stocks. Simply click here to get the full story now. Learn more Sean Williams has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,676
Zihan1004/FNSPID
Ex-Div Reminder for Progressive (PGR) Looking at the universe of stocks we cover at Dividend Channel, on 1/7/20, Progressive Corp. (Symbol: PGR) will trade ex-dividend, for its quarterly dividend of $0.10, payable on 1/15/20. As a percentage of PGR's recent stock price of $73.66, this dividend works out to approximately 0.14%. In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from PGR is likely to continue, and whether the current estimated yield of 0.54% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of PGR shares, versus its 200 day moving average: Looking at the chart above, PGR's low point in its 52 week range is $58.82 per share, with $84.96 as the 52 week high point — that compares with a last trade of $73.53. In Friday trading, Progressive Corp. shares are currently down about 0.9% on the day. Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
310
Zihan1004/FNSPID
ManpowerGroup Reaches Analyst Target Price In recent trading, shares of ManpowerGroup Inc (Symbol: MAN) have crossed above the average analyst 12-month target price of $97.62, changing hands for $97.96/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. Analyst reaction may also depend on the fundamental business developments that may be responsible for driving the stock price higher — if things are looking up for the company, perhaps it is time for that target price to be raised. There are 8 different analyst targets contributing to that average for ManpowerGroup Inc, but the average is just that — a mathematical average. There are analysts with lower targets than the average, including one looking for a price of $88.00. And then on the other side of the spectrum one analyst has a target as high as $110.00. The standard deviation is $7.836. But the whole reason to look at the average MAN price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes. And so with MAN crossing above that average target price of $97.62/share, investors in MAN have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $97.62 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? Below is a table showing the current thinking of the analysts that cover ManpowerGroup Inc: RECENT MAN ANALYST RATINGS BREAKDOWN » Current 1 Month Ago 2 Month Ago 3 Month Ago Strong buy ratings: 1 1 1 2 Buy ratings: 2 2 1 1 Hold ratings: 7 7 6 6 Sell ratings: 0 0 0 0 Strong sell ratings: 0 0 0 0 Average rating: 2.6 2.6 2.63 2.44 The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. This article used data provided by Zacks Investment Research via Quandl.com. Get the latest Zacks research report on MAN — FREE. The Top 25 Broker Analyst Picks of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
590
Zihan1004/FNSPID
Friday Sector Leaders: Utilities, Energy In afternoon trading on Friday, Utilities stocks are the best performing sector, up 0.2%. Within that group, CMS Energy Corp (Symbol: CMS) and NextEra Energy Inc (Symbol: NEE) are two of the day's stand-outs, showing a gain of 1.3% and 0.9%, respectively. Among utilities ETFs, one ETF following the sector is the Utilities Select Sector SPDR ETF (Symbol: XLU), which is up 0.3% on the day, and down 0.97% year-to-date. CMS Energy Corp, meanwhile, is down 0.54% year-to-date, and NextEra Energy Inc, is down 0.57% year-to-date. Combined, CMS and NEE make up approximately 14.9% of the underlying holdings of XLU. The next best performing sector is the Energy sector, not showing much of a loss. Among large Energy stocks, Hess Corp (Symbol: HES) and Concho Resources Inc (Symbol: CXO) are the most notable, showing a gain of 3.2% and 2.6%, respectively. One ETF closely tracking Energy stocks is the Energy Select Sector SPDR ETF (XLE), which is down 0.3% in midday trading, and up 0.57% on a year-to-date basis. Hess Corp, meanwhile, is up 4.57% year-to-date, and Concho Resources Inc is up 1.86% year-to-date. Combined, HES and CXO make up approximately 3.3% of the underlying holdings of XLE. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Friday. As you can see, one sector is up on the day, while seven sectors are down. SECTOR % CHANGE Utilities +0.2% Energy 0.0% Consumer Products -0.4% Services -0.5% Financial -0.5% Industrial -0.9% Healthcare -1.0% Technology & Communications -1.0% Materials -1.3% 25 Dividend Giants Widely Held By ETFs » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
542
Zihan1004/FNSPID
These 3 Healthcare Stocks Are Dashing Towards a Brighter Future, Says Analyst Out of all the kinds of stocks you might invest in, healthcare stocks have been the second-best performing class of stocks over the past 50 years. And yet, in 2019, healthcare stocks lagged market averages, actually underperforming the broader S&P 500 by nearly 10 full percentage points. Will 2020 be the year healthcare bounces back, and resumes trumping the market? Maybe yes, maybe no. Given the durability of healthcare's outperformance -- a half century of beating the market -- it would appear healthcare has a built-in advantage over other kinds of stocks. In search of specific healthcare picks that could outperform in the new year, we've consulted TipRanks' Stock Screener and come up with a trio of picks that Evercore ISI analyst Vijay Kumar believes will outperform in 2020. Baxter International (BAX) Deerfield, Illinois-based Baxter International had a pretty good year in 2019, ending the year with its shares up 30%. Its numbers would have been even better, however, had Baxter not had to announce, in its Q3 report, that it was starting an internal investigation into its accounting for foreign exchange gains -- which revelation subtracted 12.5% from its market cap in a matter of weeks. The plus side of this news for new investors, of course, is that Baxter's share price pullback has created "a nice entry point" into the stock, says Kumar. Baxter's audit, says Kumar, "will be resolved in the very near term, and will not have an operational impact" on the company, which the analyst sees growing its earnings 11% this year. And after the audit is over, Kumar sees Baxter growing its revenues in the 5% to 6% range from 2021 through 2025 at least, with "EPS upside." As a result, Kumar upgrades Baxter stock from "in line" (i.e. "hold") to "outperform" rating alongside a $94 price target, which implies nearly 9% upside from today's prices. (To watch Kumar's track record, click here) And incidentally, this is the conservative position. Across Wall Street, buy ratings have outweighed hold ratings 3-to-1 over the past month (with no sells), and on average, Street analysts are forecasting a price target of $95.29 per share -- 11% above current prices. (See Baxter stock analysis on TipRanks) PerkinElmer (PKI) Next up is PerkinElmer, a diagnostics and life sciences company based out of Waltham, Massachusetts. Priced at more than 47 times trailing earnings already, PerkinElmer isn't as much of a favorite on the Street, where most analysts see the stock not rising, but falling 2% or 3% over the next 12 months (consensus target: $96.33 per share). Regardless, this one is another of Kumar's favorite picks, winning an outperform rating and a $114 price target that sits 15% above today's prices. Why does Kumar like it? "We think PKI is massively underappreciated by the Street," comments Kumar, who thinks PerkinElmer is being unfairly punished for announcing a revenue guidance cut last year, even as it grew its operating profit margin by triple digits. Placing a bet on President Trump's New Year's Eve announcement of a truce in the China trade war, Kumar sees upside to Chinese sales in 2020, and introducing new products that will create "potential upside to EPS" in the new year. Specifically, Kumar predicts that this year investors will see profits more than double at PerkinElmer, to perhaps $4.74 per share. Growth will then moderate into the 12% range (EPS: $5.33) in 2021 -- still better than average growth on the S&P 500. And given that this is the second straight buy rating that PerkinElmer stock has received in the past month, it could be that other analysts are also starting to come around to this point of view. (See PerkinElmer stock analysis on TipRanks) Varian Medical Systems (VAR) Last but not least is Varian Medical Systems, a stock that with one notable exception (RBC Capital) has received nothing but "buy" ratings from Wall Street over the entirety of last year. Surprise, surprise, Kumar likes this one as well. Upgrading Varian to "outperform" with a $164 price target (nearly $20 above what the stock costs today, and about 10% higher than the Street consensus price target of $148.80), Kumar argues that Varian, which sells both medical devices and software products for cancer treatment, is entering a series of new product cycles that will drive 8% to 11% organic earnings growth, and potential total earnings growth in the "teens." Here, as with PerkinElmer, Kumar sees China as a catalyst, combined with new products and "bundling" of products and services to drive sales. Based on these assumptions, the analyst is forecasting 12.5% sales growth for Varian in 2020, to $3.6 billion, followed by 8% growth to $3.9 billion in 2021. As if that weren't good enough already, the analyst is further forecasting that earnings per share will surge as much as 70% to $5.40 per share this year, and a still respectable 15% (to $6.21 per share) next year. With numbers like these, Kumar considers Varian a "best in class" business and a "top pick" in the healthcare sector. To find good ideas for healthcare stocks trading at fair value or better, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,317
Zihan1004/FNSPID
Physicians Realty Trust Named Top Dividend Stock With Insider Buying and 5.04% Yield (DOC) In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So when stocks turn up that see insider buying, and are also top ranked, investors are wise to take notice. One such company is Physicians Realty Trust (Symbol: DOC), which saw buying by EVP of Asset/Investments Mark D. Theine. Back on December 10, Theine invested $50,429.50 into 2,650 shares of DOC, for a cost per share of $19.03. In trading on Friday, bargain hunters could buy shares of Physicians Realty Trust (Symbol: DOC) and achieve a cost basis 4.4% cheaper than Theine, with shares changing hands as low as $18.20 per share. It should be noted that Theine has collected $0.23/share in dividends since the time of their purchase, so they are currently down 3.2% on their purchase from a total return basis. Physicians Realty Trust shares are currently trading +1.81% on the day. The chart below shows the one year performance of DOC shares, versus its 200 day moving average: Looking at the chart above, DOC's low point in its 52 week range is $15.58 per share, with $19.34 as the 52 week high point — that compares with a last trade of $18.57. By comparison, below is a table showing the prices at which insider buying was recorded over the last six months: PURCHASED INSIDER TITLE SHARES PRICE/SHARE VALUE 09/06/2019 Bradley D. Page Senior VP & General Counsel 4,330 $17.27 $74,779.10 11/08/2019 Laurie P. Becker SVP-Controller 553 $18.09 $10,003.77 11/08/2019 John W. Lucey Chief Acctg. & Admin Officer 2,900 $17.96 $52,075.60 11/11/2019 Jeffrey Theiler Executive Vice President & CFO 4,150 $18.19 $75,488.50 12/10/2019 Mark D. Theine EVP of Asset/Investments 2,650 $19.03 $50,429.50 The DividendRank report noted that among the coverage universe, DOC shares displayed both attractive valuation metrics and strong profitability metrics. For example, the recent DOC share price of $18.25 represents a price-to-book ratio of 1.4 and an annual dividend yield of 5.04% — by comparison, the average company in Dividend Channel's coverage universe yields 4.1% and trades at a price-to-book ratio of 2.2. The report also cited the strong quarterly dividend history at Physicians Realty Trust, and favorable long-term multi-year growth rates in key fundamental data points. The report stated, ''Dividend investors approaching investing from a value standpoint are generally most interested in researching the strongest most profitable companies, that also happen to be trading at an attractive valuation. That's what we aim to find using our proprietary DividendRank formula, which ranks the coverage universe based upon our various criteria for both profitability and valuation, to generate a list of the top most 'interesting' stocks, meant for investors as a source of ideas that merit further research.'' The annualized dividend paid by Physicians Realty Trust is $0.92/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 01/02/2020. Below is a long-term dividend history chart for DOC, which the report stressed as being of key importance. Indeed, studying a company's past dividend history can be of good help in judging whether the most recent dividend is likely to continue. The Top DividendRank'ed Stocks With Insider Buying » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,021
Zihan1004/FNSPID
What Hexo Stock Needs Is Some Old-Fashioned Reaganomics “I’m from the government and I’m here to help.” These were the mocking words that former President Ronald Reagan used to describe government incompetence and inefficiency. In many ways, they perfectly describe the plight of Canadian cannabis firm Hexo (NYSE:) and other, more esteemed players like Cronos Group (NASDAQ:) and Canopy Growth (NYSE:). Indeed, government incompetence may be the biggest factor for why the Hexo stock price tanked in 2019. Source: Shutterstock One of the commonly cited explanations for the hemorrhaging in the Canadian cannabis market was the lack of fiscal credibility. Undoubtedly, all weed competitors enjoyed a compelling and overriding narrative: the transition of a black market into a viable (as in taxable) market. Generally, recreational cannabis is a personal, victimless endeavor. Thus, the rational thinking goes, both corporations like HEXO and the underlying government should benefit from it. However, investors aren’t in the business of talking about their feelings at their local book of the month club. Rather, they may enjoy a good story but only to the extent that it brings about profitability. Unfortunately, most cannabis firms are far from being in the black. Instead, weed players eschewed profitability for growth. Wall Street accepted this for a while, driving up the Hexo stock price and similar investments. But patience grew thin. As cannabis companies delivered disappointing earnings results, many stakeholders saw the writing on the wall. Making matters worse, many organizations, including HEXO, sought dilutive measures to continue their growth strategies. That was the last straw for the remaining believers, cratering the Hexo stock price. What turned a market which held so much promise into a veritable embarrassment? The answer: government inefficiency. Canada Doing No Favors for Hexo Stock Source: Chart by Josh Enomoto Now, I’m not breaking new ground when I mention the Canadian government’s role in hurting HEXO. Many analysts have cited the administrative backlog that has unnecessarily stymied the burgeoning weed market. However, performing a deeper dive into the subject reveals shocking inefficiencies that deserve consideration. For starters, the Canadian cannabis market is quite robust. In the first calendar quarter of 2018, 4.18 million Canadians ages 15 and older used cannabis. By Q3 2019, that figure grew to nearly 5.2 million. By itself, this is good news for Hexo stock. However, the year-over-year growth rate in the trailing three quarters slipped from 27% to 14%. This slowdown in growth suggests that external factors are weighing on cannabis usage. In my opinion, the biggest such factor is the irrational distribution of marijuana licenses across Canada’s provinces. If you look at the market share of cannabis usage by province in the , you’ll see that Ontario makes up the lion’s share of pot users. Between Q1 2018 through Q3 2019, Ontario took an average of nearly 41% market share. No other province comes close. Yet as of October 2019, Ontario had that were approved and open for business (or scheduled for such). However, Ontario also has over two million cannabis users. Thus, each store serves a whopping 26,972 users. To put this into perspective, that’s well more than the average per-game attendance of U.S. professional soccer. Now consider British Columbia. It has 830,000 cannabis users but to serve them. That’s just under 8,000 users per store. Surprisingly, the city of Calgary now has 200 stores, but only 1.34 million residents. If we assume 17% of them are cannabis users, that translates to 1,139 stores per user. Something is very wrong here! Risky but Compelling Before you jump into Hexo stock with reckless abandon, let’s note the obvious: cannabis stocks remain a mess. Furthermore, all the criticisms that have been leveled at the sector at least have a ring of truth to them. Finally, the fiscal stability of most sector players hardly offers a reason for confidence. Again, narratives are great, but they have a time limit. Right now, Wall Street is in no mood to hear more stories. However, the case for Hexo stock is a compelling one because of the unnecessary government-level headwind. In all likelihood, if the country’s regulatory agency had focused more time on approving applications from high-volume markets like Ontario, HEXO and others may look a lot different today. From another angle, the Canadian market has a hidden catalyst that is going untapped. Should the government apply the hard lessons learned, Hexo stock could make a comeback. If you have the stomach to endure choppiness and volatility, this is a name to watch for 2020. As of this writing, Josh Enomoto is long Hexo stock. The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,160
Zihan1004/FNSPID
Technology Sector Update for 01/03/2020: SNAP,INPX,AXE,WCC,BKI Top Tech Stocks MSFT -0.83% AAPL -0.61% IBM -0.64% CSCO -1.54% GOOG -0.21% Technology stocks were drifting back near their earlier session lows, with the shares of tech stocks in the S&P 500 Friday falling over 0.8% while the Philadelphia Semiconductor Index was sliding nearly 1.6%. Among technology stocks moving on news: (+) Snap (SNAP) was fractionally higher Friday afternoon, overcoming an early decline, after the photo-sharing website confirmed to Variety it acquired the company behind its new Cameo feature that allows users to insert a selfie of themselves into short videos. Snap paid about $166 million for AI Factory - which was co-founded by Victor Shaburov, who help launch another Snap acquisition, Looksery - according to AIN.ua, the Ukrainian tech publication that first reported the deal. In other sector news: (+) Inpixon (INPX) surged 37% on Friday. A new regulatory filing showed hedge fund Sabby Management increased its equity stake in the big data analytics company to more than 1.14 million shares, or about 1.73% of its outstanding stock. (+) Anixter International (AXE) rose 1% after Wesco International (WCC) raised its buyout offer for the networking equipment company to $97 per share in cash and stock, one day after private-equity investors Clayton, Dubilier & Rice matched Wesco's most recent $93.50-per-share bid. (+) Black Knight (BKI) was about 1% higher late Friday. The software firm Friday said it has expanded its collaboration with privately held location technologies company Digital Map Products to also include risk and valuation analysis of commercial real estate transactions. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
438
Zihan1004/FNSPID
Here's Why Shares of Southern Copper Climbed 12% in December What happened Extending the 20% rise they'd been on from the beginning of September through the end of November, shares of Southern Copper (NYSE: SCCO) an industry leader in copper production, climbed 12% last month, according to data from S&P Global Market Intelligence. Besides the ongoing reaction to a late-October news report regarding a long-delayed project, investors responded to the prices of commodities as well as the ebbing of tension in the trade dispute between the U.S. and China. Image source: Getty Images. So what Investors last month continued to be motivated by Southern Copper's announcement from the end of October announcing the Peruvian government's granting of a construction permit for the Tia Maria project. Estimated to have a development budge of $1.4 billion, Tia Maria has potential annual copper production of 120,000 tons, according to Southern Copper's management. The government's decision is notable, considering the development of the controversial project had been delayed in 2011 and 2015 over opposition from locals concerned about the adverse environmental impact of the mine. The greater catalyst, however, for the stock's movement was simply the rise in the price of copper. Since there's a high correlation between the price of commodities and mining companies that deal in them, the increased buying of Southern Copper's stock is unsurprising, since the average price of copper in December was $2.77 -- its highest level since April, when its monthly average was $2.92. Besides copper, the 6.9% rise in the price of silver through the month also figured prominently in shareholders' thoughts as they remembered management's 2019 forecast from the Q3 conference call. Estimating silver production of 19.7 million ounces, Southern Copper believes it will achieve a 14% increase in silver production compared with 2018, so the rise in the price of the metal is certainly of interest to shareholders. Lastly, the seeming cooling of tensions regarding the trade dispute between the U.S. and China excited shareholders -- especially since many analysts project that a resolution to the dispute will result in higher copper prices. Between the mid-December announcement that there was agreement regarding phase one of the trade deal and the apparent confidence that progress was being made toward phase two, investors felt inspired to pick up shares of Southern Copper. Now what While there seems to be some momentum growing toward the construction of Tia Maria, the project is likely to face continued opposition from local communities, possibly portending further delays in its development. Therefore, investors shouldn't interpret the Peruvian government's decision as a guarantee that the mine's development will proceed smoothly. In regard to the rise in copper and silver prices, savvy investors recognize the cyclical nature of commodity prices, and they know that this, in and of itself, is a poor foundation to base an investment. Nonetheless, investors with a long-term perspective -- our favorite type of investors -- would be well served to consider Southern Copper, as it represents one of the more compelling options among copper stocks. 10 stocks we like better than Southern Copper When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Southern Copper wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 Scott Levine has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
840
Zihan1004/FNSPID
Friday Sector Laggards: Materials, Healthcare The worst performing sector as of midday Friday is the Materials sector, showing a 1.3% loss. Within the sector, Mohawk Industries, Inc. (Symbol: MHK) and Eastman Chemical Co (Symbol: EMN) are two large stocks that are lagging, showing a loss of 3.5% and 3.2%, respectively. Among the high volume ETFs, one ETF closely following materials stocks is the Materials Select Sector SPDR ETF (Symbol: XLB), which is down 1.4% on the day, and down 2.51% year-to-date. Mohawk Industries, Inc., meanwhile, is down 4.60% year-to-date, and Eastman Chemical Co, is down 3.97% year-to-date. EMN makes up approximately 1.5% of the underlying holdings of XLB. The next worst performing sector is the Healthcare sector, showing a 1.0% loss. Among large Healthcare stocks, Incyte Corporation (Symbol: INCY) and Perrigo Company plc (Symbol: PRGO) are the most notable, showing a loss of 10.3% and 2.4%, respectively. One ETF closely tracking Healthcare stocks is the Health Care Select Sector SPDR ETF (XLV), which is down 0.8% in midday trading, and down 0.53% on a year-to-date basis. Incyte Corporation, meanwhile, is down 11.72% year-to-date, and Perrigo Company plc, is down 3.14% year-to-date. Combined, INCY and PRGO make up approximately 0.5% of the underlying holdings of XLV. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Friday. As you can see, one sector is up on the day, while seven sectors are down. SECTOR % CHANGE Utilities +0.2% Energy 0.0% Consumer Products -0.4% Services -0.5% Financial -0.5% Industrial -0.9% Healthcare -1.0% Technology & Communications -1.0% Materials -1.3% 25 Dividend Giants Widely Held By ETFs » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
557
Zihan1004/FNSPID
Equillium (EQ) Well Equipped For 2020... (RTTNews) - After a disappointing performance in 2019, shares of Equillium Inc. (EQ) seem to have started the year on a right note - gaining over 20% on Thursday - the first day of trading in 2020. Equillium is a clinical-stage biotechnology company developing products to treat severe autoimmune and inflammatory disorders with high unmet medical need. The Company's lead product candidate is Itolizumab (EQ001). Equillium acquired exclusive rights to Itolizumab for the U.S. & Canada from Biocon. Itolizumab is the first antibody targeting the novel CD6/ALCAM pathway for the treatment of severe immuno-inflammatory disorders. The ongoing trials with Itolizumab include: -- A phase Ib uncontrolled trial in moderate to severe asthma patients, dubbed EQUIP, initiated in June 2019, with initial data expected in the second half of this year. -- A phase 1b/2 trial in Acute Graft Versus Host Disease, known as EQUATE, initiated in March 2019, with initial data expected in the second half of this year. -- A phase Ib multiple ascending dose trial in patients with systemic lupus erythematosus (SLE) and lupus nephritis, dubbed EQUALISE, initiated last September. Data from the SLE cohort of this trial is expected in the second half of 2020, with data from the lupus nephritis cohort expected in the first half of 2021. As of September 30, 2019, Equillium had total cash, cash equivalents and short-term investments of $62.2 million. EQ has traded in a range of $2.56 to $13.32 in the last 1 year. The stock closed Thursday's trading at $4.09, up 21.01%. In light of the important data readouts scheduled for this year, Equillium is a stock worth the watch. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
475
Zihan1004/FNSPID
2020 Should Be a Breakout Year for Square Stock Square (NYSE:) delivered a 2019 return of 10%, approximately one-third the performance of the entire U.S. market. Worse still, since it hit an all-time high of $101.15 in September 2018, Square stock is down 38%. Source: Piotr Swat / Shutterstock.com Over the past 15 months, while the company’s financial picture has gotten stronger, SQ stock has sputtered badly, trading in a range between $60 and $80, nowhere near its all-time high. To me, it’s inexplicable. Buy SQ Stock on the Dip In October 2018, I suggested that after it lost 25% of its value in just five days of trading. A buy on the dip bet and all that. The cause of the dip: Former CFO Sarah Friar announced she was leaving to become CFO of Nextdoor, a social network for local neighborhoods. I suggested CEO Jack Dorsey’s comments regarding Friar’s departure reflected those of someone in charge of a mature organization where its multiple revenue streams were in the hands of their own lead managers or CEOs. Dorsey felt neither he or Friar were expendable given the company’s organizational structure. In the meantime, since Friar’s departure, Square has grown revenues by 44%, gross payment volume (GPV) by 25%, and adjusted EBITDA by 85%. Those are hardly the numbers of a slow-growth business. Square Is Poised for Growth InvestorPlace’s Laura Hoy recently reminded investors that the company is , increasing its Cash App peer-to-peer payment revenue by 115% in the third quarter to $159 million, or 26% of its $602 million in adjusted revenue. No wonder she called Cash App “one of Square’s most promising future bets.” In October, I highlighted some of the reasons why I liked Cash App providing to its 59.8 million potential users. One of the big ones is that Cash App users tend to be younger and in need of easy ways to save up for retirement. By delivering an ecosystem that solves problems for its users, Cash App’s revenues will become stickier than its peers, including Venmo, PayPal’s (NASDAQ:PYPL) peer-to-peer payment app. On a different subject, Square’s Q3 2019 report showed that larger businesses are taking to Square’s payment processing products and services. Since Q3 2017, Square’s GPV from sellers with an annual GPV of more than $500,000 . Meanwhile, those sellers with a yearly GPV of less than $125,000 dropped 700 basis points to 45%. At the same time, sellers with between $125,000 and $500,000 in GPV increased by 100 basis points to 28%. Why is this important? It shows that the company’s revenue has become far more diversified; it now benefits from payment processing across businesses of all sizes. 2020 Will Be a Breakout Year for Square Stock Late in 2019, CEO Jack Dorsey tweeted that he would spend as much as six months in Africa in 2020 to explore the fintech opportunities on the continent. As InvestorPlace contributor Josh Enomoto the business and investment community are split on Dorsey’s decision to abandon his biggest market in search of the next great marketplace for Square products. However, Josh reminds readers that Africa has a very young population, most are unbanked, and two-thirds of Africans use mobile phones, a trifecta of growth for Square’s products and services. As they say in hockey, you don’t go where the puck is; you go where it’s going to be. Digital payments in North America are commonplace. Not so much in Africa. For this reason, I believe Dorsey’s African exploration should generate both positive PR for the company while also laying the groundwork for a significant future revenue stream. That should be enough to light a fire under SQ in 2020.   At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,138
Zihan1004/FNSPID
General Electric Stock Could Have Another Huge Year in 2020 2019 was bumpy for General Electric (NYSE:) stock, but it ended on a high note for its shareholders. The firm’s share price climbed almost 30% last year. Looking back over the past decade, though, tells a different story. General Electric fell off a cliff back in 2017 and still has a long way to go before returning to its former glory. Source: testing / Shutterstock.com With the gains of 2019 under its belt, though, many investors are wondering if General Electric is finally making a comeback. Of course, that’s impossible to answer with certainty. But the shares look poised to rally again this year as long as GE’s CEO, Larry Culp, and his team stay the course. Culp Is Making a Difference One of the biggest reasons investors have been returning to General Electric is the changes Culp has made. His efforts to make General Electric more transparent are a big reason that sentiment towards the stock has been improving. He has vowed to be as open as possible with investors about the challenges faced by General Electric, a promise he’s made good on so far. Culp has disclosed more information in the company’s quarterly reports and set up an “insurance teach-in” to update investors on the progress of the . All in all, Culp looks like the right man for the job and investors seem to trust him. That trust doesn’t appear to be unfounded, either. Culp’s promise to be transparent is one thing, but his actions so far have backed up that sentiment. What’s more, data from natural language processing firm Amenity Analytics shows that Culp’s has been less deceptive than that of his predecessors. He was also rated as less “deceptive” than the average S&P 500 CEO. Culp’s Compensation Is Tied to GE’s Success All of that is well and good, but I think the most important issue is Culp’s . Culp’s compensation is closely tied to General Electric’s share price. If he can increase GE’s share price by more than 50% by the third quarter of 2022, he will get a $47 million bonus. If he can increase the share price by 150%, that bonus will rise to a whopping $300 million. If nothing else, shareholders can be certain that Culp is going to do everything in his power to increase GE’s value. How GE’s Shares Can Rally Raising General Electric’s share price is no small feat. The firm is battling against a host of headwinds, including a struggling power business, hefty debt, and a worrying cash-burn rate as GE Capital continues to be a drag on its overall business. While Culp’s dedication to reworking the culture of General Electric and implementing cost-cutting measures are a good place to start, it’s worth noting that some circumstances beyond Culp’s control could prevent a General Electric rally. First of all, a sustainable rally by GE can’t take place without economic strength. While economic data has continually improved in the past year, 2020 is a different animal all together. Since this is an election year, we could see some big swings in important drivers like consumer confidence, business confidence and the stock market. Another factor that efforts is Boeing’s (NYSE:BA) ability to get its 737 MAX back in the skies. Boeing’s grounding of the MAX planes is reportedly costing General Electric of free cash flow every quarter. It’s unclear how much longer Boeing’s MAX issues will persist, though some say that the FAA could start performing test flights on the plane at the end of January. The Bottom Line on GE General Electric certainly isn’t risk-free, but the stock looks like a good pick for long-term investors who are comfortable taking on some uncertainty. Culp’s proven success as a leader, coupled with his strong incentives to lift the stock, make General Electric a good bet. Plus, though General Electric’s success is tied to the economy, that’s the case for most industrials. The Boeing issue is certainly something to consider, but that problem could start to be resolved over the next month. As of this writing Laura Hoy did not hold a position in any of the aforementioned securities. The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,185
Zihan1004/FNSPID
Noteworthy Friday Option Activity: EXPE, AJRD, CVX Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Expedia Group Inc (Symbol: EXPE), where a total of 18,045 contracts have traded so far, representing approximately 1.8 million underlying shares. That amounts to about 49% of EXPE's average daily trading volume over the past month of 3.7 million shares. Especially high volume was seen for the $105 strike call option expiring February 21, 2020, with 5,347 contracts trading so far today, representing approximately 534,700 underlying shares of EXPE. Below is a chart showing EXPE's trailing twelve month trading history, with the $105 strike highlighted in orange: Aerojet Rocketdyne Holdings Inc (Symbol: AJRD) saw options trading volume of 1,976 contracts, representing approximately 197,600 underlying shares or approximately 48.7% of AJRD's average daily trading volume over the past month, of 405,335 shares. Especially high volume was seen for the $50 strike call option expiring January 17, 2020, with 672 contracts trading so far today, representing approximately 67,200 underlying shares of AJRD. Below is a chart showing AJRD's trailing twelve month trading history, with the $50 strike highlighted in orange: And Chevron Corporation (Symbol: CVX) options are showing a volume of 27,457 contracts thus far today. That number of contracts represents approximately 2.7 million underlying shares, working out to a sizeable 48.4% of CVX's average daily trading volume over the past month, of 5.7 million shares. Particularly high volume was seen for the $125 strike call option expiring January 31, 2020, with 5,151 contracts trading so far today, representing approximately 515,100 underlying shares of CVX. Below is a chart showing CVX's trailing twelve month trading history, with the $125 strike highlighted in orange: For the various different available expirations for EXPE options, AJRD options, or CVX options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
557
Zihan1004/FNSPID
Noteworthy ETF Outflows: MDYG, ZBRA, STE, TYL Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— 400 Mid Cap Growth ETF (Symbol: MDYG) where we have detected an approximate $360.9 million dollar outflow -- that's a 17.4% decrease week over week (from 36,150,000 to 29,850,000). Among the largest underlying components of MDYG, in trading today Zebra Technologies Corp. (Symbol: ZBRA) is down about 0.9%, STERIS plc (Symbol: STE) is down about 0.3%, and Tyler Technologies, Inc. (Symbol: TYL) is lower by about 0.1%. For a complete list of holdings, visit the MDYG Holdings page » The chart below shows the one year price performance of MDYG, versus its 200 day moving average: Looking at the chart above, MDYG's low point in its 52 week range is $45.142 per share, with $57.38 as the 52 week high point — that compares with a last trade of $56.88. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ». Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs. Click here to find out which 9 other ETFs experienced notable outflows » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
499
Zihan1004/FNSPID
Stock Alert: Shares Of Tyler Technologies Inc. (TYL) Hit 52-Week High (RTTNews) - Shares of Tyler Technologies Inc. (TYL), integrated information management solutions and services provider, touched a 52-week high of $306.40 on Jan. 2, 2020, and closed Thursday's trading session at $306.24, up $6.22 or 2.07%. Q3 Results Tyler Technologies' Q3 net income was $40.4 million, or $1.00 per share, up 3.8% compared to $38.9 million, or $0.96 per share, for the third quarter of 2018. Non-GAAP net income was $54.3 million, or $1.35 per share, up 9.3% compared to $49.7 million, or $1.23 per share, last year. Total revenues were $275.4 million, up 16.7% from $236.1 million for the third quarter of 2018. Organic revenue growth was 8.9%. Non-GAAP total revenues were $277.2 million, up 16.7% from $237.6 million for the third quarter of 2018. Non-GAAP organic revenue growth was 8.3%. FY19 Outlook The company sees fiscal 2019 GAAP total revenues in the range of $1.082 billion - $1.095 billion, non-GAAP total revenues of $1.090 billion - $1.103 billion, GAAP earnings per share of $3.50 - $3.63 and non-GAAP earnings per share of $5.22 - $5.35. Wall Street analysts are looking for earnings of $5.30 per share on revenue of $1.09 billion for fiscal 2019. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
466
Zihan1004/FNSPID
5 Energy ETFs to Buy for Higher Oil Prices Energy stocks and exchange-traded funds (ETFs) were a miserable bet in 2019. Indeed, the energy sector was the worst-performing sector by a mile, gaining less than 5% - far below the S&P 500's 29% return, and significantly lagging even the second worst sector, health care (18%). However, despite tepid analyst outlooks for oil and gas prices in 2020, energy ETFs and individual stocks are suddenly being thrust in the spotlight once more. On Jan. 2, the Pentagon confirmed that the U.S. military killed Qasem Soleimani - a top Iranian general who headed the Islamic Revolutionary Guard Corps' elite Quds Force - with a drone airstrike in Iraq. While the Pentagon said the attack was meant to deter "future Iranian attack plans," Iran nonetheless has vowed "severe revenge." The clear, abrupt escalation in Middle East tensions immediately sent oil prices higher in response. Whether oil continues to climb is unclear. Tensions could de-escalate. Also, American fracking has changed the playing field. "The major potential risk - to oil markets - is mitigated by the fact that the U.S. is now the largest producer of oil and essentially approaching Energy independence," says Brad McMillan, Chief Investment Officer for Commonwealth Financial Network. "Our oil supplies are much less vulnerable than they were, and the availability of oil exports from the U.S. means that other countries have an alternative source." However, if the conflict worsens - especially if oil tankers and infrastructure are targeted in any violence - oil might continue to spike, regardless. Here, we explore five energy ETFs to buy to take advantage of higher oil prices. But approach them with caution. Just like increases in crude-oil prices should benefit each of these funds in one way or another, declines in oil have weighed on them in the past, and likely would again. SEE ALSO: The 20 Best ETFs to Buy for a Prosperous 2020 Invesco Dynamic Energy Exploration & Production ETF Market value: $25.6 million Dividend yield: 1.7% Expenses: 0.63%, or $63 annually on a $10,000 investment* Exploration and production (E&P) companies are among the energy stocks most heavily dependent on commodity prices. These firms seek out sources of oil and natural gas, then physically extract the hydrocarbons. They typically make their money by selling oil and gas to refiners, who turn them into products such as gasoline, diesel fuel and kerosene. While costs to extract those hydrocarbons vary from company to company, in general, the more they can sell those hydrocarbons for, the fatter their profits. The Invesco Dynamic Energy Exploration & Production ETF (PXE, $16.69) is a smaller energy ETF that allows you to buy the industry broadly, providing access to 30 U.S. stocks that are primarily engaged in E&P. These companies include the likes of Marathon Oil (MRO), Devon Energy (DVN) and ConocoPhillips (COP). While many sector funds will simply assign weights to each stock based on their relative size (e.g., the largest stocks account for the largest percentages of the fund's assets), PXE does things a little differently. For one, its underlying index evaluates companies based on various criteria, including value, quality, earnings momentum and price momentum. It also "tiers" market capitalization groups, ultimately giving mid- and small-cap stocks a chance to shine. Roughly half of PXE's assets are allocated to small companies, and another 36% are in midsize firms, leaving just 14% to larger corporations. These smaller companies sometimes react more aggressively to oil- and gas-price changes than their larger brethren - good news for PXE when commodity prices spike, but more painful when they slump. * Includes a one-basis-point fee waiver good through at least Aug. 31, 2021. Learn more about PXE at the Invesco provider site. SEE ALSO: The 11 Best ETFs to Buy for Portfolio Protection Energy Select Sector SPDR Fund Market value: $11.1 billion Dividend yield: 3.7% Expenses: 0.13% The Energy Select Sector SPDR Fund (XLE, $60.58) is the de facto king of energy ETFs, with more than $11 billion in assets under management - No. 2, Vanguard Energy ETF (VDE), has just $3.2 billion. But it's also a much different creature than the aforementioned PXE - and that affects how much it can benefit from oil-price spikes. For one, the Energy SPDR is a collection of the 28 energy stocks within the S&P 500, so most of the fund (83%) is large-cap stocks, with the rest invested in mid-caps. There are no small companies in the XLE. More importantly: While the XLE owns pure E&P plays, including some of PXE's holdings, it also invests in other businesses that have different relationships with oil prices. For instance, refiners - who take hydrocarbons and turn them into useful products - often improve when oil prices decline, as that lowers their input costs. Middle East flare-ups can negatively affect some refiners that rely on crude oil supplies from the region, too, while lifting those that don't. This fund also carries energy-infrastructure companies such as Kinder Morgan (KMI), whose "toll booth"-like business is more reliant on how much oil and gas is going through its pipelines and terminals than on the prices for those products. Then there's XLE's top two holdings: Exxon Mobil (XOM) and Chevron (CVX), which collectively command 45% of assets. Exxon and Chevron integrated oil majors, meaning they're involved in almost every aspect of the business, from E&P to refining to transportation to distribution (think: gas stations). As a result, they can benefit from higher oil prices ... but it's a complicated relationship. Still, XLE typically does improve when oil and gas prices do, and it holds large, well-funded companies that are better able to withstand price slumps than smaller energy firms. It also offers up a generous 3.7% dividend yield that will help you withstand small disruptions in energy prices. Learn more about XLE at the SPDR provider site. SEE ALSO: The 7 Best New ETFs of 2019 iShares North American Natural Resources ETF Market value: $496.0 million Dividend yield: 5.6%* Expenses: 0.46% The iShares North American Natural Resources ETF (IGE, $30.17) provides broad-based energy-sector exposure similar to the XLE, but with a number of twists. The first has to do with the name. Whereas the XLE is a collection of U.S. companies within the S&P 500, the IGE's holdings are within all of North America. U.S. companies still dominate the fund, at 77%, but the remaining assets are spread across numerous Canadian companies, including multinational Enbridge (ENB). IGE also invests more broadly, across 100 energy-sector companies. The fund is cap-weighted, so Chevron and Exxon are still tops, but they make up far smaller percentages at the fund - roughly 10% each, versus about 22% each in XLE. Another difference is found in the name: "natural resources." In addition to heavy investment in energy industries such as integrated oil and gas companies (26%), E&P (19%) and storage and transportation (17%), IGE also owns gold mining (7%) and even construction materials (3%) companies, among other non-energy firms. Thus, while IGE will move on changes in oil and gas prices, its movement can be affected by other commodities, too. * IGE's most recent distribution included a special one-time distribution from Occidental Petroleum (OXY) as part of its acquisition of Anadarko Petroleum. This has skewed the dividend yield data at providers such as Morningstar. While Morningstar lists a trailing 12-month yield of 5.6%, iShares' listed trailing 12-month yield of 2.8%, as of Nov. 29, 2019, is much closer to what investors can expect. XLE's stated yield of 3.7% excludes a separate special payout it made closer to the end of the year related to its exposure to Occidental. Learn more about IGE at the iShares provider site. SEE ALSO: 3 Preferred Stock ETFs for High, Stable Dividends iShares Global Energy ETF Market value: $852.2 million Dividend yield: 7.0%* Expenses: 0.46% The iShares Global Energy ETF (IXC, $31.08) takes geographical diversification another step farther, and unlike IGE, it focuses completely on energy. A reminder here that "global" and "international" mean different things. If a fund says it's international, chances are it holds no U.S. stocks. A global fund, however, can and will invest in American stocks as well as international ones ... and often, the U.S. is the largest slice of the pie. The IXC is no exception, holding a 52% slug of American companies. It also has another 12% of its assets invested in Canadian companies. However, the U.K. (16%) and France (6%) are significant weights in the fund, and it also allows investors to reach energy companies in Brazil, China and Australia, among a few other countries. International top holdings include France's Total (TOT) and Dutch-British oil giant Royal Dutch Shell (RDS.A). Like other energy ETFs, IXC's holdings are primarily driven by oil and gas prices. But other factors are at play, such as the fact that some of these companies have distribution businesses that are reliant on strong gasoline demand, which can be affected by a country's economic strength. Investing across several countries can help reduce such risks. * Like IGE, IXC's most recent distribution was affected by a special one-time distribution from Occidental Petroleum. While Morningstar lists a trailing 12-month yield of 7.0%, iShares' listed trailing 12-month yield of 4.0%, as of Nov. 29, 2019, is much closer to what investors can expect. Learn more about IXC at the iShares provider site. SEE ALSO: 7 ESG ETFs to Buy for Responsible Profits United States Oil Fund Market value: $1.2 billion Dividend yield: N/A Expenses: 0.73% But what if you want to invest closer to the source? That is, what if rather than buying oil companies, you wanted to invest in crude oil itself? The United States Oil Fund (USO, $12.81) is one of a few energy ETFs that let you do that ... but be warned that it's not as straightforward as it seems. The USO is an "exchange-traded security designed to track the daily price movements of West Texas Intermediate ("WTI") light, sweet crude oil" - what most refer to as "U.S. crude." However, unlike some commodity funds, such as the iShares Gold Trust (IAU), that actually hold the physical commodity, USO invests in crude oil futures, as well as other financial instruments to generate its returns. The problem? USO holds "front-month" futures, so every month it must sell any contracts that are about to expire and replace them with futures expiring in the next month. This can result in cases where USO is selling contracts for less than what it's buying up new ones from - or sometimes the opposite, buying for less than what it's selling for. In short, this means that sometimes USO will reliably track WTI, but sometimes it won't - it might go lower when West Texas crude goes higher, and vice versa. The fund's expenses further throw off performance. USO clearly is far from perfect. But it remains a more direct play on oil than publicly traded companies, and it generally will follow WTI's direction over time. Learn more about USO at the USCF provider site. SEE ALSO: The Kip ETF 20: The 20 Best Cheap ETFs You Can Buy The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
2,682
Zihan1004/FNSPID
Can Plug Power Really Hit $1 Billion in Sales by 2024? It's important to have goals, but is Plug Power's (NASDAQ: PLUG) plan to hit $1 billion in revenue by 2024 reasonable, or is it just pie-in-the-sky wishful thinking? Considering the hydrogen fuel cell manufacturer generated almost $185 million in gross billings in 2018, the five-year plan laid out at Plug Power's September symposium would seem to be a case of simple daydreaming. Even with revenue up 15% through the first nine months of 2019, the 10-fold leap in gross bookings necessary in five years is still a long way from the 40% compounded annual growth rate required to hit the target. The market, however, rewarded Plug Power for its optimism with a 150% stock gain last year, but that enthusiasm needs to be tempered with the reality of a decade of investor disappointment. So let's see whether the hydrogen fuel cell maker really has the power to reach its $1 billion goal. Image source: Plug Power. Industrial applications at its heart The impetus behind Plug Power's goal is fueling further growth in its primary material handling business, or making hydrogen fuel cells that power forklifts in warehouses and distribution centers. Plug Power has shipped over 28,000 fuel cells to dozens of customers to date, but Walmart (NYSE: WMT) and Amazon.com (NASDAQ: AMZN) are its two biggest, together representing over two-thirds of total revenue. At 44% of the total, Walmart is by far the biggest, and most of the growth Plug envisions over the next five years is forecast from expanding its relationship with the offline and online retailers. It also intends to add at least one additional multi-site customer, while expanding overseas so that it is shipping 25,000 annually by 2024. Automakers to drive expansion Plug Power sees it as a $30 billion global opportunity, with more than 6 million forklifts deployed that can be retrofitted with Plug's hydrogen fuel cells, which is why Plug says it's "comfortable" with its ability to deploy so many new systems each year. Doing so will allow it to hit $750 million in revenue in this segment. Bolstering its belief was Plug deploying 1,700 GenDrive fuel cell systems at Walmart, Kroger, and Sysco in the third quarter, while also touting a list of major automobile manufacturers it has lined up to begin testing its technology, including BMW, Daimler, General Motors, Honda, VW, and most recently Fiat Chrysler. It says growing such new and old customers would allow it to triple segment revenue. Can it do that, though? Although Plug reiterated its full year guidance of $235 million to $245 million in gross billings, and year to date it has recorded over $142 million, that means it will need to generate another $100 million in the fourth quarter to achieve that goal, a 60% increase over what it recorded in the year ago period. Not only does that seem like a tall order for the current quarter, but it will need to continue growing sales like that every year for the next four years. Moving on to street-legal vehicles Plug Power estimates it will generate another $200 million in revenue from a greater shift to on-road vehicle adoption of its fuel cell technology, which it sees expanding the total addressable market ten-fold. Plug already supplies hydrogen fuel cell-powered engines for global delivery giant DHL, securing in May a deal to supply 100 trucks for DHL with fuel cells. It quotes DHL's head of DHL Express operations in Germany as saying, "If everything works as we imagine it would, there could soon be 500 vehicles worldwide." Plug also started a pilot program last year outfitting FedEx delivery trucks in Albany, NY. Plug Power sees commercial fleet vehicles alone as exceeding $200 billion globally because hydrogen fuel cells double the vehicle range of battery electric vehicles (BEV), provide twice the fuel efficiency of diesel engines, and don't take up as much cargo space as BEVs do. The last $50 million in revenue will come from stationary applications, such as power stations or data centers. Plug Power is the biggest user of liquid hydrogen at over 22 tons per day, more than that used by NASA. Flooding the market with stock The biggest problem for Plug Power doesn't seems to be in its potential, but rather in its execution as it affects investors. The fuel cell maker has a long history of destroying shareholder value, and even today it continues to dilute investors by issuing more stock. In early December Plug Power raised another $100 million by issuing an additional 40 million shares priced at $2.75 each. With around 242 million shares outstanding at the time, the stock sale amounted to a better than 16% dilution of existing investors. Nor has it been able to grow its sales profitably. Even with the gains generated so far in 2019, losses have widened to almost $74 million and operating cash flows have been a $52 million use of cash compared to less than $42 million a year ago. Still a risky bet It seems that although Plug Power looks like it has the capability to potentially achieve its $1 billion sales forecast, it will require perfect execution. And even if it does hit its goal, that doesn't mean it will do so profitably. Moreover, over the next five years, Plug Power will likely have substantially diluted existing shareholders' stakes even further. With Plug Power's stock having come so far so fast in 2019, it would undoubtedly suffer a collapse if it does not make any of its lofty targets at any point along the way. It may be a less risky stock from a business perspective than it was a decade ago, but it seems to offer the same investment risks as it did back then. 10 stocks we like better than Plug Power When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Plug Power wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Rich Duprey has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Amazon and FedEx. The Motley Fool recommends BMW. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,487
Zihan1004/FNSPID
WESCO Further Improves Offer For Anixter - Quick Facts (RTTNews) - WESCO International Inc. (WCC) on Friday submitted a revised proposal to the board of directors of Anixter International (AXE) to acquire Anixter for $97.00 per share in cash and stock. This revised proposal materially improves upon WESCO's December 26, 2019 proposal, while retaining all of the prior proposal's attractive features. The consideration includes $63.00 cash, plus a fixed exchange ratio of 0.2397 shares of WESCO common stock, as in WESCO's prior proposal, plus $19.89 of a newly created class of WESCO perpetual preferred stock. Based on the closing price of WESCO's common stock on January 2, 2020, the total consideration translates to $97.00 per share. The transaction is not subject to a financing condition. WESCO has obtained fully committed debt financing from Barclays for the cash portion of the transaction. WESCO intends to fund the required cash consideration with a combination of long-term debt financing and additional equity or equity-content securities. The WESCO transaction is subject to Anixter's stockholder approval, receipt of regulatory approval in the U.S. and certain foreign jurisdictions, as well as other customary closing conditions. WESCO anticipates the transaction could be completed in the summer of 2020. WESCO had made an initial offer of $90 per Anixter share on December 24 and improved it to $93.50 per Anixter share in cash and stock three days later. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
372
Zihan1004/FNSPID
Daily Markets: Bull Market May Have Met Its Bear Today's Big Picture The seemingly unstoppable upward movement of equity markets may have met its match last night. Yesterday, the first day of trading in 2020, saw the Nasdaq 100 rise 1.6%, the Nasdaq Composite gain 1.3%, the Dow 1.2%, and the S&P 500 0.8% driven in large part by the news that China's central bank cut reserve requirements, unleashing a material level of liquidity. This morning things have changed. US equity futures are in the red on the news that General Qassim Soleimani, Iran's top commander who led a special forces unit of Iran's elite Revolutionary Guards and has been a key figure in Middle East politics, was killed by a US drone strike in Baghdad. As we warned in yesterday's piece, this comes after a New Year's Eve attack by Iran-backed militias on the US Embassy in Baghdad. The Defense Department's statement, issued last night at 10 pm ET, can be read here, and a response on Twitter from Iran's Foreign Minister Mohammad Javad Zarif is here. This could get very ugly. In response, crude oil rose over 4%, the CBOE Volatility Index rose over 25%, and safe-havens such as US Treasury bond futures, gold, and the Japanese yen spiked upwards as well. The majority of equity indices in Asia were mixed. The Kong Kong Hang Seng and China's Shanghai Composite closed lower while the Chinese Shenzhen Composite, Korean Kospi and Australia's S&P/ASX 200 rose slightly. Japan's Nikkei remained closed. European equity indices all moved lower with all sectors of the pan-European Stoxx 600 in the red except oil and gas. US futures are down over 1% across the board. The explosive situation in the Middle East is likely to put a damper on the excessive levels of enthusiasm we have been seeing. Just yesterday, the CNN Business Fear & Greed Index hit 97 out of 100 and flashed Extreme Greed. Investor sentiment was already shifting direction before today's news. The American Association of Individual Investors most recent sentiment survey findings for January 2, 2020, revealed that after peaking at 44.1% in late December, Bullish investor sentiment has fallen to 37.22%. That's below the 40.9% reading for Neutral sentiment that has climbed from 35.4% in late December. We interpret that shift as investors recognizing the velocity of the recent melt-up in the stock market may have it priced to perfection, leaving it vulnerable to the kind of shock we've had in the past 24 hours. There are few earnings reports expected today, however next week, more than 20 companies will issue their latest quarterly results. Inside those reports, investors will be on the hunt for clues as to what we'll hear in the soon to be upon us December quarter earnings season that kicks off in force on January 14, one day before President Trump is expected to sign the phase-one trade agreement with China. The good, the bad and the potentially ugly clues obtained in those earnings reports next week will also inform investors as to how realistic the consensus EPS view of +9.6% year over year growth for the S&P 500 is. That determination over the coming weeks will likely be one of the major catalysts for the market's March quarter move. Data Download Putting aside the profound spike in tensions in the Middle East, this morning, some interesting economic data from around the world was released. The unemployment rate in Germany was unchanged as expected in November, at 3.1% (seasonally adjusted harmonized rate), the 7th consecutive month the rate has been at a 39-year low. Neither the number of unemployed nor employed changed. The number of people in Spain registering as unemployed decreased by 34.6k to 3.2k in December, the lowest level for a December since 2008. Inflation is starting to appear to a small degree in Europe. Housing prices in the UK rose to 1.4% in December YoY as expected, up from 0.8% previously. The preliminary inflation rate in France rose to 1.4% YoY in December from 1.0% in November. That said, the M3 money supply in the EU rose less than expected in November, remaining at 5.6% YoY versus expectations for an increase to 5.7%. Loans to households in the European Union remained steady at 3.5% YoY in November as expected. Loan growth to non-financial corporations slowed to 3.4% YoY in November from 3.8% in October. Consumer credit in the UK rose just over half as much as expected in November, increasing by £0.563 billion versus expectations for £1.0 billion. As we get ready for US equity markets to open, we have several pieces of December quarter data coming at us today. These include November Construction Spending, December Auto & Truck Sales, and the weekly reports for EIA Natural Gas and Crude Oil inventories. We strongly suspect the US economic data that will take the spotlight will be the December ISM Manufacturing Index, a key input to GDP estimates, and one that we'll be digging into, particularly the new order component to determine the initial speed of the economy in the March 2020 quarter. We'd also like to point out as we work through the final data points for 2018 that the year-over-year change for the Conference Board's US Leading Economic Indicator ex S&P 500 recently dropped below zero for the first time since the Great Financial Crisis. This afternoon the Federal Reserve will release the minutes from its December meeting. We'll be looking for further insight into the Fed's thoughts on its support of the overnight repo market, which expanded the Fed's balance sheet from $3.8 trillion in September (when the repo situation was a one-off, idiosyncratic situation) to $4.17 trillion as of January 1st. And for those who thought it was just a 2019 event, yesterday the Fed added another $56.72 billion, nearly half of which was via a 14-day repo. Stocks to Watch WESCO International (WCC) has submitted a revised proposal to the board of directors of Anixter International (AXE) to acquire Anixter for $97.00 per share in cash and stock, up from its prior offer of $93.50 a share. Efforts are once again underway for a Eurozone-wide tax on plastic waste. While there remains ample road ahead for this endeavor, investors should look to comments during the upcoming earning season from Dow (DOW), LyondellBasell Industries (LYB), Exxon Mobil (XOM), Chevron (CVX) and other suppliers to the global plastic industry. We see this as another step in the global movement that is reflected in Tematica's Cleaner Living investment theme and index. Fiesta Restaurant Group's (FRGI) Pollo Tropical announced the launch of a Vegan Tropichop and Wrap featuring a "picadillo" made with Beyond Meat's (BYND) plant-based ground meat. The South China Morning Post reports luxury goods company LVMH Moet Hennessy Louis Vuitton (LVMHF), is preparing to shut one of its Louis Vuitton shops in Hong Kong where protests have hit demand and rental costs remain high. Investors will likely watch moves made by Moncler SpA (MONC:IM), Gucci owner Kering (KER:FP), and other luxury goods companies that are contending with falling sales in Hong Kong and in some cases a large footprint of shops. After securing government subsidies and just days before it rolls out cars manufactured at its plant in Shanghai, Tesla (TSLA) shaved almost $8,000 off the starting price of its Chinese-built Model 3s to 299,050 yuan ($42,900). Universal Forest Products (UFPI) has completed the reorganization of its operations and is now operating as UFP Industries, a change announced in August 2019. Apple (AAPL) signed a five-year contract with the production company of former HBO exec Richard Plepler to make television series, documentary, and feature film exclusive for Apple TV+. This is the latest sign of escalation in the streaming wars, which we continue to think will drive demand and prices for content, particularly quality content, higher. Sticking with streaming services, reports suggest Disney (DIS) may have hit the 25 million subscriber mark for its Disney+ service as it entered 2020. Yesterday shares of Advanced Micro Devices (AMD) rose 7.1%, leading the semiconductor sector higher. Its shares now trade at triple their peak during the dotcom insanity with revenue growth that is roughly half of what it was back then. Even though the chip sector has several growth drivers, including 5G, WiFi 6, and the continued data center build-out, as we shared above, past a certain point, investors are likely to question upside potential and valuations to stocks that are seemingly priced to perfection. After today's US equity markets close, there are no companies slated to report their quarterly results. For a look at upcoming earnings reports, we recommend checking in with Nasdaq's earnings calendar page. On the Horizon Upcoming IPOs: There are no IPOs scheduled for this week. For a complete list of upcoming IPOs by month, please visit the Nasdaq IPO Calendar. Dates to mark: January 7-10: 2020 International CES January 15: President Donald Trump is expected to sign the phase one trade deal with China. Thoughts for the Day As we get ready to close the final holiday season week, two thoughts to ponder from Greek Stoic philosopher Epictetus: "The key is to keep company only with people who uplift you, whose presence calls forth your best." "It's not what happens to you, but how you react to it that matters." The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
2,160
Zihan1004/FNSPID
PARR Stock Crowded With Sellers In trading on Friday, shares of Par Pacific Holdings Inc (Symbol: PARR) entered into oversold territory, changing hands as low as $22.345 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30. In the case of Par Pacific Holdings Inc, the RSI reading has hit 29.0 — by comparison, the universe of energy stocks covered by Energy Stock Channel currently has an average RSI of 57.8, the RSI of WTI Crude Oil is at 69.1, the RSI of Henry Hub Natural Gas is presently 35.7, and the 3-2-1 Crack Spread RSI is 47.4. A bullish investor could look at PARR's 29.0 reading as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. Looking at a chart of one year performance (below), PARR's low point in its 52 week range is $14.88 per share, with $25.69 as the 52 week high point — that compares with a last trade of $22.36. Par Pacific Holdings Inc shares are currently trading off about 3.3% on the day. Click here to find out which 9 other oversold energy stocks you need to know about » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
372
Zihan1004/FNSPID
Gold Price Forecast – The Christmas Breakout FXEmpire.com - In my article – Gold Prices Close to A Decisive Break, I described how gold was at a critical juncture. The trend broke higher a few days later and confirmed a cycle breakout. The next advance is underway, and I see significant potential in platinum as prices play catchup. Dollar Breakdown The US dollar has rolled over and broken vital support. This should continue to fuel the Q1 advance in precious metals. The next level of support arrives between 95.00 – 95.50. Note: The 50-day EMA is crossing bearishly below the 200-day. Gold’s Cycle Breakout Confirmed I’ve explained before how gold forms intermediate lows approximately every 6-months. The previous cycle peaked in September, and prices entered a prolonged cycle correction. The Christmas eve rally above $1492 confirmed a November 6-month low, and the next advance is underway. **The breakout above the cycle trendline in gold triggered a trade alert for NUGT released to Premium members before the open on Tuesday, December 24, 2019. Explosive Potential in Platinum In the 2019 Metals Market Recap, I mentioned the explosive potential in platinum heading into 2020. Prices are already testing the $1000 level, and the structure looks ready to explode higher. AG Thorson is a registered CMT and expert in technical analysis. He believes we are in the final stages of a global debt super-cycle. For more information, please visit https://goldpredict.com/ This article was originally posted on FX Empire More From FXEMPIRE: E-mini NASDAQ-100 Index (NQ) Futures Technical Analysis – Strengthens Over 9053.25, Weakens Under 8966.25 AUD/USD Price Forecast – Australian Dollar Continues To Grind Higher COT: Iran Tensions Lift Gold and Oil Longs The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
453
Zihan1004/FNSPID
4 Reasons Under Armour Will Head Lower in 2020 Under Armour (NYSE: UA) (NYSE: UAA) was once hailed as the "next Nike (NYSE: NKE)," but the footwear and athletic apparel maker's stock has tumbled nearly 40% over the past five years as its growth decelerated. That's a painful drop, and I think that decline could continue in 2020 for four simple reasons. 1. Competition from Nike and Adidas Under Armour is struggling to keep pace with Nike and Adidas (OTC: ADDYY) in three key areas: North America, overseas markets, and direct-to-consumer (DTC) sales. Under Armour's North American sales fell 4% annually last quarter, marking its fifth consecutive decline in a market that generated 71% of its revenue. Nike and Adidas reported 5% and 16% annual revenue growth in North America, respectively, in their latest quarters. Image source: Under Armour. UA's international sales grew 5% annually last quarter, but that barely offset the weak growth of its North American business. Nike posted double-digit sales growth across all its overseas markets last quarter, while Adidas posted double-digit sales growth across all its markets except Europe. UA's DTC sales -- which come from its website, apps, and first-party stores -- fell 1% last quarter. Meanwhile, Nike's DTC revenue rose 17% on a constant currency basis last quarter, led by its 38% growth in digital revenue. Adidas' DTC revenue also grew by the double digits last quarter. That competition caused Under Armour's double-digit revenue growth to drop to the low single digits in 2017 and 2018, and analysts expect just 2% revenue growth in 2019. 2. Two regulatory probes Last November, the Wall Street Journal reported that Under Armour faced probes from the Securities and Exchange Commission and the Department of Justice regarding inflated revenue figures. The report claims that UA dumped inventories intended for factory stores to off-price retailers in the final days of each quarter in 2016. That alleged move, which wasn't previously disclosed to investors, likely boosted UA's revenue and reduced its inventories at the expense of its gross margins. These probes could result in fines and force UA to restate its revenue over the past three years -- which would cause its multi-year slowdown to look even worse. 3. Management changes and unclear plans for the future Under Armour's accounting issues might have been caused by the leadership of three different CFOs between 2016 and 2017. But that's not the only major management change over the past three years. UA's chief designer Dave Dombrow resigned in early 2016 to work at Nike. UA rehired Dombrow later that year after its infamous "Chef Curry" disaster, but he failed to revive UA's flagship Curry shoes with new designs. UA then hired Kasey Jarvis, the former VP of Product and Design at Black Diamond Equipment, to replace Dombrow in early 2019. Founder and CEO Kevin Plank, who led the company for over two decades, also resigned on Jan. 1 and was succeeded by COO Patrik Frisk. Image source: Under Armour. All those management shifts raise troubling questions about UA's future. For now, UA's main strategy for 2020 is to cut costs and improve its gross margin, then invest any excess cash into fresh marketing campaigns. It isn't planning to enter the higher-growth athleisure market to challenge companies like Lululemon. Those listless plans indicate that UA will likely continue to struggle against Nike and Adidas, which are both executing multi-year expansions with marketing blitzes and aggressive brick-and-mortar expansions into urban and overseas markets. 4. The stock's valuation UA's revenue growth is sluggish, but analysts expect its cost-cutting efforts to boost its earnings 26% this year and 41% next year. At first glance, that growth rate seemingly justifies its forward P/E ratio of 45. Yet I think that those forecasts are too optimistic. UA's revenue growth is still decelerating as its core growth engines sputter out, it faces intense competition from two bigger rivals with deeper pockets and clearer marketing strategies, and the ongoing regulatory probes could exacerbate its current problems. I don't mind paying a premium for a growth stock with a promising business and irons in the fire. But UA doesn't deserve to trade at a high multiple -- it deserves to go lower until it can grow its core business again. 10 stocks we like better than Under Armour (A Shares) When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Under Armour (A Shares) wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 Leo Sun has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Lululemon Athletica, Nike, Under Armour (A Shares), and Under Armour (C Shares). The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,171
Zihan1004/FNSPID
First Week of H August 21st Options Trading Investors in Hyatt Hotels Corp (Symbol: H) saw new options become available this week, for the August 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 231 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the H options chain for the new August 21st contracts and identified one put and one call contract of particular interest. The put contract at the $85.00 strike price has a current bid of $4.10. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $85.00, but will also collect the premium, putting the cost basis of the shares at $80.90 (before broker commissions). To an investor already interested in purchasing shares of H, that could represent an attractive alternative to paying $88.83/share today. Because the $85.00 strike represents an approximate 4% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 65%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 4.82% return on the cash commitment, or 7.62% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Hyatt Hotels Corp, and highlighting in green where the $85.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $90.00 strike price has a current bid of $5.70. If an investor was to purchase shares of H stock at the current price level of $88.83/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $90.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 7.73% if the stock gets called away at the August 21st expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if H shares really soar, which is why looking at the trailing twelve month trading history for Hyatt Hotels Corp, as well as studying the business fundamentals becomes important. Below is a chart showing H's trailing twelve month trading history, with the $90.00 strike highlighted in red: Considering the fact that the $90.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 49%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 6.42% boost of extra return to the investor, or 10.14% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 25%, while the implied volatility in the call contract example is 23%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $88.83) to be 19%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
972
Zihan1004/FNSPID
Health Care Sector Update for 01/03/2020: EYEG,CEMI,BNTX,NOVN Top Health Care Stocks JNJ -0.86% PFE -0.14% ABT -0.92% MRK -0.20% AMGN -0.65% Health care stocks lost ground Friday but outperformed most other sectors. At last look, the NYSE Health Care Index was dropping almost 0.7% on Friday while the shares of health care companies in the S&P 500 also were down over 0.8% as a group. The Nasdaq Biotechnology index was falling nearly 1.3%. Among health care stocks moving on news: (+) Eyegate Pharmaceuticals (EYEG) was more than 1% lower on Friday, paring most of a 6% decline earlier in the session that followed the specialty drugmaker announcing a $5 million direct offering of 500,000 common shares priced at the market at $10 each. Net proceeds will be used to support Eyegate operations, including clinical studies along with working capital and other general corporate purposes. In other sector news: (+) Chembio Diagnostics (CEMI) climbed 15% after saying it expects the US Food and Drug Administration to approve its 15-minute diagnostic test to detect type 1 and 2 HIV antibodies along with syphilis-causing bacteria "within two months." The DPP HIV-Syphilis system now under agency review also includes the DPP Micro Reader, the company said. (+) BioNTech (BNTX) rose almost 2% after the German biopharmaceuticals company published data showing its second generation CLDN6-CAR-T therapy resulted in complete tumor regression of transplanted human tumors in mice within two weeks of starting treatment. CAR-T cell therapy uses a body's own immune system to fight cancer and has previously demonstrated significant clinical efficacy in blood cancers but not with solid tumors. (-) Novan (NOVN) plunged as much as 79% on Friday after saying it plans to begin a new late-stage trial of its SB206 drug candidate in April after the prospective treatment for molluscum contagiosum skin infections produced inconclusive top-line results during a pair of ongoing phase III trials. The company also warned it will need "substantial" funding to keep business operations going. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
539
Zihan1004/FNSPID
First Week of CNNE August 21st Options Trading Investors in Cannae Holdings Inc (Symbol: CNNE) saw new options become available this week, for the August 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 231 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CNNE options chain for the new August 21st contracts and identified the following call contract of particular interest. The call contract at the $40.00 strike price has a current bid of 65 cents. If an investor was to purchase shares of CNNE stock at the current price level of $37.98/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $40.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 7.03% if the stock gets called away at the August 21st expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if CNNE shares really soar, which is why looking at the trailing twelve month trading history for Cannae Holdings Inc, as well as studying the business fundamentals becomes important. Below is a chart showing CNNE's trailing twelve month trading history, with the $40.00 strike highlighted in red: Considering the fact that the $40.00 strike represents an approximate 5% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 52%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 1.71% boost of extra return to the investor, or 2.70% annualized, which we refer to as the YieldBoost. The implied volatility in the call contract example above is 42%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $37.98) to be 28%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
654
Zihan1004/FNSPID
MT Makes Notable Cross Below Critical Moving Average In trading on Friday, shares of ArcelorMittal SA (Symbol: MT) crossed below their 200 day moving average of $16.97, changing hands as low as $16.90 per share. ArcelorMittal SA shares are currently trading down about 4.5% on the day. The chart below shows the one year performance of MT shares, versus its 200 day moving average: Looking at the chart above, MT's low point in its 52 week range is $12.53 per share, with $24.24 as the 52 week high point — that compares with a last trade of $16.91. Click here to find out which 9 other metals stocks recently crossed below their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
208
Zihan1004/FNSPID
Why Boeing Stock Lost 11% in December What happened Shares of Boeing (NYSE: BA) were losing altitude last month, as the 737 MAX crisis continued to expand. Boeing's CEO was forced to resign, and the company said it will suspend production the popular jet, which has remained grounded since a second crash in March. As a result. the aerospace and defense stock fell 11% over the month. So what Boeing's problems picked up early in the month, as the company invited industry stakeholders to Seattle to help build up support for recertifying the 737 MAX. However, at the same time, news reports continued to come out showing how much control over the regulatory process the Federal Aviation Administration had given to Boeing. Also that day, new FAA chief Steve Dickson made plans to testify before Congress about the MAX on Dec. 11, putting the company back in a potentially negative spotlight. Image source: Getty Images. The stock lost 5.6% over the first four sessions of December on worries that approval of the MAX would continue to be delayed. The stock's worst day of the month then came on Dec. 16, with shares falling 4.3% as the company said it would suspend production of the 737 MAX planes, a reflection of the impact the plane's grounding has had. Later in the month, shares bounced back briefly after the company said CEO Dennis Muilenberg, who was seen as having mismanaged the crisis, would be stepping down. Chairman David Calhoun is set to become the next CEO on Jan. 13. Now what Calhoun will have a lot of work to do when he takes over later in the month. He must repair relationships with airlines, negotiate payments for planes being grounded, and find a way to gain the FAA's approval for the MAX so the company can get back to manufacturing and selling the planes. After an initial dive in March following the second crash, Boeing's shares have been surprisingly stable throughout the MAX crisis. The company will report fourth-quarter earnings on Jan. 29, which will give investors an opportunity to hear directly form Calhoun as well as a look at the company's guidance for 2020, showing the expected impact of the MAX crisis for the year. In other words, expect January to be another busy month for the stock. 10 stocks we like better than Boeing When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Boeing wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
680
Zihan1004/FNSPID
First Week of February 21st Options Trading For The Materials Select Sector SPDR Fund (XLU) Investors in The Materials Select Sector SPDR Fund (Symbol: XLU) saw new options begin trading this week, for the February 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XLU options chain for the new February 21st contracts and identified one put and one call contract of particular interest. The put contract at the $63.00 strike price has a current bid of 70 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $63.00, but will also collect the premium, putting the cost basis of the shares at $62.30 (before broker commissions). To an investor already interested in purchasing shares of XLU, that could represent an attractive alternative to paying $64.05/share today. Because the $63.00 strike represents an approximate 2% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 64%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 1.11% return on the cash commitment, or 8.28% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for The Materials Select Sector SPDR Fund, and highlighting in green where the $63.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $65.00 strike price has a current bid of 71 cents. If an investor was to purchase shares of XLU stock at the current price level of $64.05/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $65.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 2.59% if the stock gets called away at the February 21st expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if XLU shares really soar, which is why looking at the trailing twelve month trading history for The Materials Select Sector SPDR Fund, as well as studying the business fundamentals becomes important. Below is a chart showing XLU's trailing twelve month trading history, with the $65.00 strike highlighted in red: Considering the fact that the $65.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 66%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 1.11% boost of extra return to the investor, or 8.26% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 13%, while the implied volatility in the call contract example is 12%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $64.05) to be 11%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
930
Zihan1004/FNSPID
3 Big Stock Charts for Friday: P&G, Walgreens, and Harley-Davidson The key question facing U.S. stocks at the moment is: how much is left? The bull market almost certainly will enter its twelfth year in March (though by some measures, it ended, however briefly, in December 2018). The S&P 500 rose 29% in 2019 alone; the NASDAQ Composite performed even better. Equities are at all-time highs, and valuation multiples seem much the same. Source: Shutterstock Friday’s big stock charts focus on three stocks for which the key question is similar to that of the market as a whole. These aren’t necessarily stocks that have led, or in two cases even joined, the broader rally. But all three closed 2019 on a high note and in an uptrend. As a result, for these names investors can wonder how much of a rally remains. In all three cases, near-term trading could set the tone for the remainder of 2020. And in all three cases, these big stock charts suggest at least some reason for caution. Procter & Gamble (PG) Source: Provided by Finviz Procter & Gamble (NYSE:) was one of the most impressive stocks of 2019. The 36% rise in PG stock perhaps doesn’t seem that spectacular relative to the 29% increase in the S&P 500 or even the 22% gain for the Dow Jones Industrial Average, of which PG is a component. But in context, the move is close to extraordinary. After all, PG is a mega-cap and defensive name. Both characteristics suggest the stock should underperform in a bull market. CPG (consumer packaged goods) stocks as a whole posted smaller returns than the market, yet P&G stock outperformed pretty much every peer. At the same time, the stock managed to reverse a long-stagnant trend: shares gained less than 1% total in the previous four years. With all that backward-looking good news, however, the first of Friday’s stock charts suggests a more muted view looking forward: Fundamentally, there’s a case for a modest decline as well. After a decade marked by cost-cutting, reorganization, and divestitures, P&G found the recipe for growth in fiscal 2019 (ending June). But there’s simply not much left in the way of catalysts. This now is a company likely to post mid-single-digit net profit growth whose stock trades at 25x the FY20 consensus earnings per share estimate. That’s a potentially dicey combination, particularly given that historically PG received at most a P/E multiple in the low 20s. It’s possible the market, as it has in recent years, keeps bidding up names it views as quality. But there’s a strong case that at the least, the performance of PG stock this year will be much less impressive than it was in 2019. Walgreens Boots Alliance (WBA) Source: Provided by Finviz Walgreens Boots Alliance (NASDAQ:) seems to have found its footing. Shares have bounced about 20% since hitting a six-year low in late August. A cheap valuation, takeover speculation and better results across the sector have contributed. The question looking to 2020 is if the uptrend can hold. Both the second of our big stock charts and fundamental analysis suggest that it should: Fundamentally, WBA is one of the Dow Jones’ cheapest stocks, at less than 10x forward earnings. Rivals Rite Aid (NYSE:) and CVS Health (NYSE:) have shown signs of life after their recent earnings reports, with leveraged RAD stock in particular soaring. Walgreens earnings on Wednesday look like a potential catalyst. That earnings report, however, presents a risk on both fronts. A sell-off next week would breach the uptrend established since late August. Shares probably would need to rely on the 200DMA for support. And with rivals doing better, a weak report might suggest that Walgreens has execution issues in addition to the margin and sales problems that have pressured the industry in recent years. Harley-Davidson (HOG) Source: Provided by Finviz Harley-Davidson (NYSE:) managed to put in a bottom in late August. An eight-year low proved the nadir of an inverse head-and-shoulders pattern, and a gap up after third quarter earnings allowed the stock to re-test resistance above $40. Since that test failed, however, HOG stock has struggled. And the third of Friday’s big stock charts suggests more downside ahead: As of this writing, Vince Martin has no positions in any securities mentioned. The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,101
Zihan1004/FNSPID
SLYG, ARWR, NEOG, CBU: ETF Outflow Alert Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— 600 Small Cap Growth ETF (Symbol: SLYG) where we have detected an approximate $420.5 million dollar outflow -- that's a 17.6% decrease week over week (from 37,000,000 to 30,500,000). Among the largest underlying components of SLYG, in trading today Arrowhead Pharmaceuticals Inc (Symbol: ARWR) is down about 0.4%, Neogen Corp (Symbol: NEOG) is up about 0.5%, and Community Bank System Inc (Symbol: CBU) is lower by about 1%. For a complete list of holdings, visit the SLYG Holdings page » The chart below shows the one year price performance of SLYG, versus its 200 day moving average: Looking at the chart above, SLYG's low point in its 52 week range is $53.37 per share, with $65.08 as the 52 week high point — that compares with a last trade of $64.28. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ». Sponsored Links Help Pay Down Balances Instead Of Interest Credit Karma Learn More Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs. Click here to find out which 9 other ETFs experienced notable outflows » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
516
Zihan1004/FNSPID
Dogs of the Dow for 2020: Dividend Bargains, or Yield Traps? By Brett Owens The New Year is here, which means itaEURtms once again time to revisit a contrarian (and income) investing tradition: The aEURoeDogs of the Dow.aEUR This simple yet famous dividend strategy involves buying the 10 highest yielders in the 30-component Dow Jones Industrial Average at the beginning of each year. ItaEURtms an income play, sure, but this strategy also has to do with value. The idea: Truly strong blue-chip stocks rarely become aEURoeobsolete,aEUR so high yieldsaEUR"often driven by lower prices in the prior yearaEUR"are just a signal that the stocks are oversold and due to bounce back. ItaEURtms a win-win, in theory. Not only do you get higher-than-usual income on these blue chips, but you also get them at a good price. The combined income and value upside should make these total-return juggernauts. But theory didnaEURtmt play out practice last year, as dog-lovers left money on the table: Data source: Ycharts.com To be fair, it was a rare bit of underperformance for the Dogs. The Dogs have beaten the Dow on a total-return basis since 2001, and last year snapped a four-year winning streak for the ubiquitous dividend strategy. But as I look at the 2020 Dogs, itaEURtms clear we need to be more discerning: International Business Machines (IBM), for instance, hasnaEURtmt been able to escape the aEURoedoghouseaEUR for years, and for good reason: ItaEURtms a dividend dumpster fire. A couple of months ago, the tech company announced its fifth consecutive quarter of revenue declines. Maybe itaEURtms trying to aEURoereclaim the magicaEUR from its 22-quarter sales fail that ended back in 2018. This Is Not a Recipe for Success. (Note: The red bars above indicate lower sales year-over-year. We are dividend investors, but we still require sales growth to fund our payouts over the long-term!) Here are three better bets for Dow Dogs in 2020: 3M (MMM) Dividend Yield: 3.3% The pain continued for industrial conglomerate 3M (MMM) in 2019. Shares of 3MaEUR"the maker of Post-it Notes, Ace brand bandages, Scotch tape, Thinsulate insulation and numerous other commercial and consumer brandsaEUR"have lost almost a third of their value since early 2018, including a single-digit loss in 2019. A huge chunk of the issue has been a mix of global cyclicalityaEUR"weakening growth in China and other emerging markets has weighed heavily on demand for the multinational giantaEUR"and further Chinese pain thanks to the countryaEURtms trade war with the U.S. Thus, analyst predictions for a small recovery in global growth, paired with the expected Jan. 15 signing of a aEURoePhase OneaEUR trade deal, should bode well for 3M. Alas, this longtime Dividend Aristocrat has more problems on its plate. As I highlighted back in October, JPMorganaEURtms Stephen Tusa didnaEURtmt mince words when he called the companyaEURtms business model aEURoebroken.aEUR He called into question billions of dollars spent on restructuring, deeming 3MaEURtms problem a aEURoestructural issue, that there is generally a higher cost to serve than many appreciate, now seems clear.aEUR And on top of that, the company faces mounting legal issues (and costs) over its aEURoePFASaEUR chemicals. While it has set aside hundreds of millions to cover potential legal costs, some experts are estimating a price tag upward of $10 billion. 3M might have a few bricks taken off its shoulders in 2019, but thataEURtms not enough reason to enthusiastically buy this troubled Dog of the Dow. 3M Is Undergoing a Painful aEURoeNormalizingaEUR Walgreens Boots Alliance (WBA) Dividend Yield: 3.1% Walgreens Boots Alliance (WBA) was the worst performer in the Dow last year, at -11% including dividends, and in fact has been dead money since 2015. ItaEURtms Like YouaEURtmre Being Taxed Just to Hold Walgreens (WBA) Much of the pain came on a 12% single-day drop in April after the company reported what CEO Stefano Pessina called aEURoethe most difficult quarter we have had since the formation of Walgreens Boots Alliance.aEUR Second-quarter earnings fell short of expectations, and the company was forced to cut its full-year outlook amid weak performance on numerous fronts. WalgreensaEURtm situation is so tenuous that the company has been trying to entice KKR & Co. (KKR) into executing a leveraged buyout to take the drugstore private. But analysts called shenanigans on the logistics of the deal, and in December, The Wall Street Journal reported that it had run into financing issues. Dividend Aristocrats are notoriously low yielders, so WBAaEURtms 3%-plus payout looks attractive on that front. And Walgreens is trading at a dirt-cheap 9.6 times forward earnings estimates. But given that profits are expected to decline this year, and the company is otherwise rudderless, investorsaEURtm best hope of significant gains in 2020 would seem to be a buyout aEUR" one that looks less likely than it did a couple months ago. Verizon (VZ) Dividend Yield: 4.0% Verizon (VZ) is participating in one of the more exciting investing mega-trends of the new decade: the roll-out of 5G technology. 5G is the next generation of communications techaEUR"what many expect to usher in an explosion of the Internet of Things, and general connectivity with the world around us. And Verizon is widely considered to be leading U.S. telecomsaEURtm push to get that infrastructure up and running. It sounds good. And for infrastructure REITs such as American Tower (AMT) and Crown Castle (CCI), and communications chipmakers such as Qualcomm (QCOM) and Broadcom (AVGO), it is good, and should lead to tangible growth. But at least in 2020, the prosaEURtm expectations for Verizon look no different than recent years: low-single-digit gains on the top and bottom lines. ThataEURtms also problematic given issues with its core business. MoffettNathanson analyst Craig Moffett points out troubling signs including shrinking margins, slightly higher customer churn and even questions about whether Verizon indeed has the best network. Verizon is a de facto utility, and it at least pays out cash like one. Its 4% yield is one of the most respectable among the 30 Dow stocks. This IsnaEURtmt Normal. But note the chart above. I frequently discuss how stock prices aEURoecatch upaEUR to dividend growth over time, but we have a situation in Verizon where we might be due for the same process in reverseaEUR"where VZ the stock aEURoeslows downaEUR to its glacial dividend growth. Even worse is the fact that VerizonaEURtms payout is growing as slowly as many Dividend Aristocrats, but the telecom only has a 13-year streak under its belt. That bodes poorly for future hikes, which I expect to be nominal. We can do better than Verizon. In fact, we can triple or even quadruple the yields most investors bank from their lame blue-chips by following my aEURoeperfectaEUR income strategy. aEURoePerfectaEUR Retirement IncomeaEUR: Start 2020 By Quadrupling Your Yield The Dogs of the Dow feed into one of the most common mistakes that aEURoefirst-levelaEUR retirement investors: buying the overcrowded, overpriced blue chips that financial talking heads prop up as safe bets year-in and year-out. But theyaEURtmre not safe. ThereaEURtms nothing aEURoesafeaEUR about not making enough income to take care of your most basic needs. aEURoeSafeaEUR is being able to afford your home, your utilities and a high quality of life even if the stock market doesnaEURtmt cooperate. And you can lock up that level of safety from the dividend-rich stocks in my aEURoePerfect Income Portfolio.aEUR Nest eggs are being stretched paper-thin because medical innovations are helping us live longer than ever before, meaning retirement accounts have to last far longer than they were ever intended to. But this is 2020, not 2000. 10-year Treasuries donaEURtmt pay 6.6% anymore aEUR" they pay 2.6%. The 2%-3% yields on most Dow stocks just wonaEURtmt cut it, either. Instead, investors aEUR" especially those with more modest nest eggs aEUR" need roughly 3x to 4x the yield of the broader market. And those substantial income checks need to survive not just through 2021 or 2022, but literally decades down the road. My Perfect Income Portfolio offers exactly that. In fact, several of my readers have emailed me to tell me this portfolio has literally doubled, tripled, or in a few cases actually quadrupled their annual income. Also, this is a buy-and-hold portfolio. This isnaEURtmt a crazy options tactic or a set of short-term swing trades. ItaEURtms just a set of under-the-radar, contrarian income plays that can quickly build your wealth without piling on the extra risk of gambling on newspapers and dying retailers. Too good to be true? Look at this strategyaEURtms past 10 years of returns, and youaEURtmll see why I call it the aEURoePerfect Income PortfolioaEUR: What really makes this group of stocks stand out is that itaEURtms so much more than high headline yield. This portfolio checks off a bundle of vital retirement boxes: It gives you a safe, secure, and steady income of $10s of thousand per year in cashaEUR"not just aEUR~paper gains.aEURtm It pays out more than enough to live on from dividends without drawing down your savings or assets. You avoid overly complex, high-risk investments that can wipe out decades of hard-earned money in a matter of weeks or months! YouaEURtmre not involved in any risky options, spread-bets, or day-trading. ItaEURtms simple to set up and simple to manage. That way youaEURtmre not glued to your screen all day. Go out. Enjoy life. Your checkaEURtmll be in the mail. DonaEURtmt lie awake anymore worrying about your yo-yo-ing net worth. Instead, let me teach you more about this incredible strategy, including its dominant track record. In fact, IaEURtmll even let you hear it from the mouths of other investors that have reaped market-smashing gains from my research service. DonaEURtmt wait another minute. Learn how to get 2x-4x your current income with this simple, straightforward system. Click here to get a FREE copy of my Perfect Income Portfolio report, including tickers, buy-in prices, dividend yields, full analyses of each pick aEUR The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
2,497
Zihan1004/FNSPID
Broadridge Financial Solutions Breaks Below 200-Day Moving Average - Notable for BR In trading on Friday, shares of Broadridge Financial Solutions (Symbol: BR) crossed below their 200 day moving average of $122.95, changing hands as low as $121.90 per share. Broadridge Financial Solutions shares are currently trading off about 0.4% on the day. The chart below shows the one year performance of BR shares, versus its 200 day moving average: Looking at the chart above, BR's low point in its 52 week range is $93.77 per share, with $136.99 as the 52 week high point — that compares with a last trade of $123.23. The BR DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other dividend stocks recently crossed below their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
233
Zihan1004/FNSPID
RSI Alert: PriceSmart (PSMT) Now Oversold Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of PriceSmart Inc (Symbol: PSMT) entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $67.79 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 64.9. A bullish investor could look at PSMT's 29.6 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of PSMT shares: Looking at the chart above, PSMT's low point in its 52 week range is $48.06 per share, with $79.90 as the 52 week high point — that compares with a last trade of $68.08. Find out what 9 other oversold stocks you need to know about » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
336
Zihan1004/FNSPID
Friday's ETF Movers: XAR, MCHI In trading on Friday, the SPDR— S&P— Aerospace & Defense ETF (XAR) is outperforming other ETFs, up about 1.3% on the day. Components of that ETF showing particular strength include shares of Kratos Defense & Security Solutions (KTOS), up about 9.4% and shares of Northrop Grumman (NOC), up about 4.9% on the day. And underperforming other ETFs today is the iShares MSCI China ETF (MCHI), off about 1.6% in Friday afternoon trading. Among components of that ETF with the weakest showing on Friday were shares of Noah Holdings (NOAH), lower by about 3.9%, and shares of Qudian (QD), lower by about 3.6% on the day. Sponsored Links 브라우저에서 지금 플레이하세요 Hero Wars 플레이하기 VIDEO: Friday's ETF Movers: XAR, MCHI The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
248
Zihan1004/FNSPID
Health Care Sector Update for 01/03/2020: CEMI,BNTX,NOVN Top Health Care Stocks JNJ -0.45% PFE +0.38% ABT -0.43% MRK +0.19% AMGN +0.01% Health care stocks were lower with the NYSE Health Care Index was dropping 0.6% on Friday while the shares of health care companies in the S&P 500 also were down just over 0.4% as a group. The Nasdaq Biotechnology index was falling 1%. Among health care stocks moving on news: (+) Chembio Diagnostics (CEMI) climbed almost 14% after saying it expects the US Food and Drug Administration to approve its 15-minute diagnostic test to detect type 1 and 2 HIV antibodies along with syphilis-causing bacteria "within two months." The DPP HIV-Syphilis system now under agency review also includes the DPP Micro Reader, the company said. In other sector news: (+) BioNTech (BNTX) rose 4% after the German biopharmaceuticals company published data showing its second generation CLDN6-CAR-T therapy resulted in complete tumor regression of transplanted human tumors in mice within two weeks of starting treatment. CAR-T cell therapy uses a body's own immune system to fight cancer and has previously demonstrated significant clinical efficacy in blood cancers but not with solid tumors. (-) Novan (NOVN) plunged after saying it plans to begin a new late-stage trial of its SB206 drug candidate later this year after the prospective treatment for molluscum contagiosum skin infections produced inconclusive top-line results during a pair of ongoing phase III trials. The company also warned it will need "substantial" funding to keep business operations going. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
420
Zihan1004/FNSPID
Booking Holdings Reaches Analyst Target Price In recent trading, shares of Booking Holdings Inc (Symbol: BKNG) have crossed above the average analyst 12-month target price of $2072.89, changing hands for $2074.58/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. Analyst reaction may also depend on the fundamental business developments that may be responsible for driving the stock price higher — if things are looking up for the company, perhaps it is time for that target price to be raised. There are 19 different analyst targets contributing to that average for Booking Holdings Inc, but the average is just that — a mathematical average. There are analysts with lower targets than the average, including one looking for a price of $1800.00. And then on the other side of the spectrum one analyst has a target as high as $2350.00. The standard deviation is $141.375. But the whole reason to look at the average BKNG price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes. And so with BKNG crossing above that average target price of $2072.89/share, investors in BKNG have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $2072.89 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? Below is a table showing the current thinking of the analysts that cover Booking Holdings Inc: RECENT BKNG ANALYST RATINGS BREAKDOWN » Current 1 Month Ago 2 Month Ago 3 Month Ago Strong buy ratings: 7 7 7 8 Buy ratings: 2 2 2 3 Hold ratings: 15 15 15 14 Sell ratings: 0 0 0 0 Strong sell ratings: 0 0 0 0 Average rating: 2.33 2.33 2.33 2.24 The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. This article used data provided by Zacks Investment Research via Quandl.com. Get the latest Zacks research report on BKNG — FREE. The Top 25 Broker Analyst Picks of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
612
Zihan1004/FNSPID
Technology Sector Update for 01/03/2020: NOK, TSLA Top Tech Stocks: MSFT: -1.20% AAPL: -0.93% IBM: -0.89% CSCO: -1.49% GOOG: -1.04% Top tech stocks were trading lower during pre-market hours on Friday. Stocks moving on news include: (+) Tesla (TSLA), which was 2% higher pre-bell Friday after reporting record production and deliveries for Q4 2019, saying output came in at almost 105,000 vehicles and deliveries totaled about 112,000, and that in 2019 it delivered roughly 367,500 vehicles, 50% more than the previous year and in line with its guidance. (-) Nokia (NOK), down nearly 2% pre-market Friday. British telecommunication giant Vodafone Group's (VOD) joint venture in Australia with Hutchison said early on Monday that it partnered with Nokia (NOK) to begin the rollout of its 5G technology network in 2020. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
281
Zihan1004/FNSPID
Dow Movers: JPM, CVX In early trading on Friday, shares of Chevron Corporation (CVX) topped the list of the day's best performing Dow Jones Industrial Average components, trading up 0.4%. Year to date, Chevron Corporation registers a 1.1% gain. And the worst performing Dow component thus far on the day is JPMorgan Chase & Co (JPM), trading down 1.5%. JPMorgan Chase & Co is lower by about 0.9% looking at the year to date performance. Two other components making moves today are American Express (AXP), trading down 1.4%, and Boeing (BA), trading down 0.0% on the day. VIDEO: Dow Movers: JPM, CVX The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
188
Zihan1004/FNSPID
This Is the Biggest Risk for Amazon Stock For holders of Amazon (NASDAQ:) stock, it’s been a disappointing 2019. The return of AMZN stock was about 23%, which underperformed the 35.2% gain by the NASDAQ. And Amazon stock greatly lagged Apple (NASDAQ:) and Microsoft (NASDAQ:) in 2019. Source: Mike Mareen / Shutterstock.com That performance, though, is not necessarily something to panic over. AMZN stock has been a standout over the long-term. For the past 15 years, its average annual return was about 28%. Yet the performance of AMZN stock in 2019 should still be a warning sign, and it’s apparent that Wall Street is getting a bit antsy about the company. First of all, the company is stretched, with investments in a myriad of categories like streaming, healthcare, groceries, devices, apparel, and lending/payments. So far, Jeff Bezos has been able to somehow manage the complexities, but it won’t get any easier for him. History shows that AMZN’s management will ultimately get overwhelmed, as happened to conglomerates like GE (NYSE:). And with Amazon’s annual revenues over $230 billion, it is getting harder for the company to prevent its growth from slowing. Interestingly, as the company has become larger, it has become more vulnerable to potential antitrust actions. AWS So what is the biggest risk facing AMZN stock? Well, it could easily be the company’s cloud business, which it calls Amazon Web Services or AWS. Over the past ten years, AWS has been the biggest positive contributor to Amazon’s profits. In fact, if Amazon did not get into the cloud business, the company would be much smaller today. Note that AWS currently accounts for 70% of the company’s operating income. In other words, AWS has masked the low margins of the company’s core e-commerce business while enabling AMZN to invest in new categories. But there are some danger signs emerging for AWS. Just look at the competition. Nowadays AWS must take on numerous rivals like SAP (NYSE:), Oracle (NYSE:), IBM (NYSE:), MSFT and Alphabet (NASDAQ:, NASDAQ:GOOG). All of those companies have the resources to put up a tough fight against AWS, as they all have substantial capital, technical talent, global customer bases and extensive product lines. Because of all that, Amazon is starting to lose some of its advantages. AWS’ offerings now look comparable to those of Microsoft’s Azure, for example,. Consider that MSFT recently won a coveted $10 billion cloud contract with the US. Department of Defense. No doubt, this will likely lead to other major contracts for Azure. According to Wedbush analyst : “Microsoft remains in an enviable position heading into 2020 on the heels of its cloud success as it continues to fire on all cylinders around its Office 365 and Azure strategic vision.” Microsoft, along with other mega tech operators, also can be price competitive, since it has other high-margin businesses. And, in an ominous development for AMZN stock, AWS’ margins and growth are both slowing. In Q3, its growth came in at about 35%, versus the 40%+ rate that it was generating not long ago. Its margins fell from 31.1% in Q3 of 2018 to 25.1% in Q3 of 2019. On theearnings call there was little explanation for the weakening of AWS. But it does seem like a good bet that the competition is starting to take a toll. The Bottom Line on AMZN Stock Again, there’s probably no reason to panic. AWS still throws off substantial cash flows, and its growth is still fairly strong, given its large revenue base. But in the tech world, things can go sideways fast. And given the fact that AMZN stock fetches a high valuation and relies heavily on AWS, the unit’s unexpected deceleration could be a big-time problem for Amazon stock. Thus, it’s a good idea to be cautious on AMZN and keep an eye on how its business progresses. Tom Taulli is the author of the book, . Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,153
Zihan1004/FNSPID
U.S. Construction Spending Climbs More Than Expected In November (RTTNews) - Construction spending in the U.S. increased by more than expected in the month of November, according to a report released by the Commerce Department on Friday. The report said construction spending climbed by 0.6 percent to an annual rate of $1.324 trillion in November after inching up by 0.1 percent to an upwardly revised $1.317 trillion in October. Economists had expected construction spending to rise by 0.3 percent compared to the 0.8 percent slump originally reported for the previous month. The Commerce Department said spending on private construction rose by 0.4 percent to an annual rate of $985.5 billion in November. The increase in private construction spending came as spending on residential construction jumped by 1.9 percent to $536.1 billion, more than offsetting a 1.2 percent nosedive in spending on non-residential construction to $449.4 billion. Spending on public construction also climbed by 0.9 percent to an annual rate of $338.6 billion in November, partly reflecting a 2.2 percent spike in spending on highway construction. Compared to the same month a year ago, total construction spending in November was up by 4.1 percent, as spending on private construction increased by 1.6 percent and spending on public construction spiked by 12.4 percent. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
336
Zihan1004/FNSPID
S&P 500 Movers: INCY, LW In early trading on Friday, shares of Lamb Weston Holdings (LW) topped the list of the day's best performing components of the S&P 500 index, trading up 8.3%. Year to date, Lamb Weston Holdings registers a 5.8% gain. And the worst performing S&P 500 component thus far on the day is Incyte Corporation (INCY), trading down 10.1%. Incyte Corporation is lower by about 11.5% looking at the year to date performance. Two other components making moves today are American Airlines Group (AAL), trading down 5.3%, and Northrop Grumman Corp (NOC), trading up 5.1% on the day. VIDEO: S&P 500 Movers: INCY, LW The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
210
Zihan1004/FNSPID
Insiders Bullish on Certain Holdings of VLUE Ford Motor Co. (Symbol: F), which makes up 1.56% of the iShares Edge MSCI USA Value Factor ETF (VLUE), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $73,302,747 worth of F, making it the #13 largest holding. The table below details the recent insider buying activity observed at F: F — last trade: $9.42 — Recent Insider Buys: PURCHASED INSIDER TITLE SHARES PRICE/SHARE VALUE 07/29/2019 John C. Lechleiter Director 10,000 $9.60 $95,950 08/01/2019 William Clay Ford Jr. Exec. Chairman and Chairman 840,962 $9.51 $7,995,783 10/25/2019 John C. Lechleiter Director 25,000 $8.68 $216,998 And Prudential Financial Inc (Symbol: PRU), the #48 largest holding among components of the iShares Edge MSCI USA Value Factor ETF (VLUE), shows 3 directors and officers as recently filing Form 4's indicating purchases. The ETF holds $27,994,047 worth of PRU, which represents approximately 0.60% of the ETF's total assets at last check. The recent insider buying activity observed at PRU is detailed in the table below: PRU — last trade: $94.84 — Recent Insider Buys: PURCHASED INSIDER TITLE SHARES PRICE/SHARE VALUE 09/09/2019 Kenneth Tanji EVP and CFO 2,500 $83.84 $209,600 09/09/2019 Robert Falzon EVP and Vice Chairman 3,580 $83.98 $300,648 09/09/2019 Charles F. Lowrey Chief Executive Officer 7,500 $83.68 $627,600 10 ETFs With Stocks That Insiders Are Buying » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
548
Zihan1004/FNSPID
Franklin Covey Finds Itself at a Crossroads Ahead of First-Quarter Earnings Leadership training and organizational consulting dynamo Franklin Covey (NYSE: FC) will report its fiscal first-quarter 2020 earnings on Jan. 9 after the close of trading. The company completed a turnaround in its fiscal 2019 that helped its stock soar by 44% during the calendar year. However, with much of the heavy lifting of that transformation now complete, will investors maintain their enthusiasm? Below, we'll discuss the company's recent progress, and why its successes of the last 12 months may be hard to top during the next 12. Reaping the rewards of a strategy shift Franklin Covey reached a significant milestone in fiscal 2019 as it successfully finished a three-year shift of its revenue framework to a subscription model. The organization's subscription momentum was clear from the progress of its flagship "All Access Pass," which proved especially popular among larger enterprise customers. Total revenue in 2019 increased by 7% to $225.4 million, but more importantly, subscription revenue jumped by 23%. Other indicators commonly used to gauge the success of software-as-a-service (SaaS) companies also exhibited vibrancy. Franklin Covey finished fiscal 2019 with a deferred subscription revenue balance of $58.2 million (up 20%), and its unbilled deferred revenue balance advanced by 22% against the balance at fiscal year-end 2018, to $30 million. That rapid growth in subscription-based revenue helped investors view Franklin Covey as a viable SaaS business, and the market rewarded its brighter prospects. The company backed up its top-line performance with significantly higher margins and earnings: Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) climbed 73% to $20.6 million, and net loss dwindled to $1 million against nearly $6 million in fiscal 2018. Image source: Getty Images. Two important numbers for fiscal 2020 Franklin Covey is closely focused on one outlook item, and it's something that it is encouraging investors to monitor over the next 12 months. In its last quarterly report, management advised shareholders to expect fiscal 2020 adjusted EBITDA of between $27 million and $32 million. At the midpoint of that range, that would be a torrid 43% improvement over fiscal 2019. Adjusted EBITDA is also the barometer by which Franklin Covey wants the market to measure its progress for the foreseeable future. Management has forecast annual adjusted EBITDA increases all the way out to fiscal 2022, when it projects they will land between $45 million and $50 million, which (at the midpoint) would mark a 130% increase over fiscal 2019. On the Q4 2019 earnings conference call, management also projected net cash generation (i.e. the net increase in the company's cash balance during the fiscal year) of $25 million to $30 million, against $17.5 million in net cash generation during fiscal 2019. Net cash generation is somewhat related to adjusted EBITDA growth, since the latter metric adjusts net income for non-cash items and items of comparability between periods. In other words, if the company doesn't hit its adjusted EBITDA targets, it won't meet its cash generation goals either. An expensive valuation ... for now After its highly successful year, Franklin Covey's stock may find itself in a more vulnerable position during calendar 2020. Shares were actually up as much as 75% in November before they began a gradual descent that left them finishing the year with a gain (as mentioned above) of 44%. We can infer from this that investors may have already priced in the earnings benefits that will accrue from the company's turnaround, which leaves Franklin Covey stock at something of a crossroads. The company is still experiencing rapid adjusted EBITDA growth, so it's unlikely to see a major stock decline as long as it keeps within management's guidance ranges. On the other hand, there may be a bit of a cap on potential stock appreciation unless the organization begins to outpace its 2020 outlook. This is because, for the first time in years, Franklin Covey will generate net income according to generally accepted accounting principles, or GAAP, in fiscal 2020. This means investors can finally calculate a forward P/E ratio for the company -- and currently, it stands at a lofty 78. That valuation level may seem extremely high for this small-cap stock, but if Franklin Covey achieves its adjusted EBITDA growth projections over the next three years, the associated GAAP earnings will lower its forward P/E ratio to one that's more in line with those of its peers. Nonetheless, this temporary pricing phenomenon is providing investors with reason to feel skittish about the company's upcoming year. One or two quarters of outperformance in 2020 may be what it takes for Franklin Covey to successfully navigate through these waters. 10 stocks we like better than Franklin Covey When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Franklin Covey wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 Asit Sharma has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,286
Zihan1004/FNSPID
Nasdaq 100 Movers: INCY, TSLA In early trading on Friday, shares of Tesla (TSLA) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.7%. Year to date, Tesla registers a 6.7% gain. And the worst performing Nasdaq 100 component thus far on the day is Incyte Corporation (INCY), trading down 10.4%. Incyte Corporation is lower by about 11.8% looking at the year to date performance. Two other components making moves today are American Airlines Group (AAL), trading down 5.7%, and Xcel Energy (XEL), trading up 0.5% on the day. VIDEO: Nasdaq 100 Movers: INCY, TSLA The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
209
Zihan1004/FNSPID
Validea Joel Greenblatt Strategy Daily Upgrade Report - 1/3/2020 The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields. SEALED AIR CORP (SEE) is a mid-cap growth stock in the Containers & Packaging industry. The rating according to our strategy based on Joel Greenblatt changed from 70% to 80% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest. Company Description: Sealed Air Corporation is engaged in food safety and security, facility hygiene and product protection business. The Company's segments are Food Care (includes Corporate, Medical Applications and New Ventures businesses), Product Care and Corporate. The Food Care segment focuses on providing a range of integrated system solutions. The Food Care business serves primarily perishable food and beverage processors, predominately in fresh red meat, smoked and processed meats, beverages, poultry and dairy (solids and liquids) markets throughout the world. The Product Care segment provides customers with a range of Product Care solutions to meet cushioning, void fill, surface protection, retail display, containment and dunnage needs. The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria. EARNINGS YIELD: NEUTRAL RETURN ON TANGIBLE CAPITAL: NEUTRAL FINAL RANKING: FAIL For a full detailed analysis using NASDAQ's Guru Analysis tool, click here Since its inception, Validea's strategy based on Joel Greenblatt has returned 95.79% vs. 153.78% for the S&P 500. For more details on this strategy, click here About Joel Greenblatt: In his 2005 bestseller The Little Book That Beats The Market, hedge fund manager Joel Greenblatt laid out a stunningly simple way to beat the market using two -- and only two -- fundamental variables. The "Magic Formula," as he called it, produced back-tested returns of 30.8 percent per year from 1988 through 2004, more than doubling the S&P 500's 12.4 percent return during that time. Greenblatt also produced exceptional returns as managing partner at Gotham Capital, a New York City-based hedge fund he founded. The firm averaged a remarkable 40 percent annualized return over more than two decades. About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
682
Zihan1004/FNSPID
Esperion (ESPR) Almost Doubled In 2019, What Awaits The Stock In 2020? Energy stocks were gaining pre-bell Thursday as the Energy Select Sector SPDR Fund (XLE) was advancing by 0.9% recently. The United States Oil Fund (USO) was 2.5% higher and the United States Natural Gas Fund (UNG) was down 0.8%. Front-month US West Texas Intermediate crude oil was up 1.9% at $72.74 per barrel at the New York Mercantile Exchange. Global benchmark North Sea crude oil gained 1.9% to $78.22 per barrel, and natural gas futures were 1.7% lower at $2.99 per 1 million British Thermal Units. Chesapeake Energy (CHK) and Southwestern Energy (SWN) have signed an all-stock merger agreement for $7.4 billion, the companies said. Chesapeake Energy was up over 3% in recent premarket activity. Exxon Mobil (XOM) is discussing oil and gas exploration opportunities with Algeria's state-owned energy company Sonatrach, with a deal possible as soon as this week, media outlets reported. Exxon Mobil was marginally advancing pre-bell. TC Energy (TRP) plans to meet with representatives from Indigenous groups to discuss the sale of a stake in Nova Gas Transmission, a natural gas pipeline in western Canada, Bloomberg reported, quoting sources with knowledge of the matter. TC Energy was slightly lower pre-bell. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
351
Zihan1004/FNSPID
Notable Friday Option Activity: PANW, UVV, MA Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Palo Alto Networks, Inc (Symbol: PANW), where a total volume of 6,717 contracts has been traded thus far today, a contract volume which is representative of approximately 671,700 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 79% of PANW's average daily trading volume over the past month, of 850,050 shares. Particularly high volume was seen for the $240 strike call option expiring January 03, 2020, with 572 contracts trading so far today, representing approximately 57,200 underlying shares of PANW. Below is a chart showing PANW's trailing twelve month trading history, with the $240 strike highlighted in orange: Universal Corp (Symbol: UVV) saw options trading volume of 1,032 contracts, representing approximately 103,200 underlying shares or approximately 75.2% of UVV's average daily trading volume over the past month, of 137,210 shares. Especially high volume was seen for the $45 strike put option expiring August 21, 2020, with 1,000 contracts trading so far today, representing approximately 100,000 underlying shares of UVV. Below is a chart showing UVV's trailing twelve month trading history, with the $45 strike highlighted in orange: And Mastercard Inc (Symbol: MA) options are showing a volume of 20,581 contracts thus far today. That number of contracts represents approximately 2.1 million underlying shares, working out to a sizeable 74.9% of MA's average daily trading volume over the past month, of 2.7 million shares. Especially high volume was seen for the $300 strike put option expiring January 03, 2020, with 695 contracts trading so far today, representing approximately 69,500 underlying shares of MA. Below is a chart showing MA's trailing twelve month trading history, with the $300 strike highlighted in orange: For the various different available expirations for PANW options, UVV options, or MA options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
575
Zihan1004/FNSPID
June 2021 Options Now Available For MGM Resorts International (MGM) Investors in MGM Resorts International (Symbol: MGM) saw new options become available today, for the June 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 532 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MGM options chain for the new June 2021 contracts and identified one put and one call contract of particular interest. The put contract at the $32.00 strike price has a current bid of $3.65. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $32.00, but will also collect the premium, putting the cost basis of the shares at $28.35 (before broker commissions). To an investor already interested in purchasing shares of MGM, that could represent an attractive alternative to paying $33.12/share today. Because the $32.00 strike represents an approximate 3% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 61%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 11.41% return on the cash commitment, or 7.83% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for MGM Resorts International, and highlighting in green where the $32.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $35.00 strike price has a current bid of $3.40. If an investor was to purchase shares of MGM stock at the current price level of $33.12/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $35.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 15.94% if the stock gets called away at the June 2021 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if MGM shares really soar, which is why looking at the trailing twelve month trading history for MGM Resorts International, as well as studying the business fundamentals becomes important. Below is a chart showing MGM's trailing twelve month trading history, with the $35.00 strike highlighted in red: Considering the fact that the $35.00 strike represents an approximate 6% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 51%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 10.27% boost of extra return to the investor, or 7.04% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 33%, while the implied volatility in the call contract example is 29%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $33.12) to be 26%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of Stocks Conducting Buybacks » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
976
Zihan1004/FNSPID
After an Epic 2019 Rally, I've Got Nike Stock on Hold -- for the Moment Trade wars. Global economic slowdown. Recession. These are terms that don't bode well for any company, especially an international consumer goods powerhouse like Nike (NYSE: NKE). But when uncertainty abounds, it can sometimes lead to bargain purchases that pay off, and uncertainties in 2019 helped the world's largest shoe brand deliver with a 36% gain on the year. That tops off a nearly 100% return over the last three years (more than double what the S&P 500 has offered up over the same time frame). Sneakers are a hot commodity around the globe right now, and Nike's leadership in that department isn't going to fade anytime soon. However, as good as recent results have been, it's time for a pause. Don't bet against Nike, but I'm looking for a pullback before jumping back in. Image source: Nike. Recovering with the global economy Fiscal 2018 and 2019 (the years ended May 31, 2018, and 2019, respectively) were relatively sluggish ones for Nike. Revenues rose 6% in 2018 and 7% in 2019, with last year's results being dragged down due to negative foreign currency exchange rates. Excluding those effects, sales would have grown 11%. Halfway through fiscal 2020, Nike is faring much better. Sales are up 9% so far, including a 10% gain in the recently reported second quarter, which again got hit by currency exchange rates (growth would have been 13% otherwise). Earnings per share are up 31%, propped up by growing profit margins on products sold and Nike's generous share repurchase program. Sales in China are leading the way, up 21% in the first six months of the current fiscal year and bucking all the negative U.S.-China trade war doom and gloom during the period. METRIC SIX MONTHS ENDED NOV. 30, 2019 SIX MONTHS ENDED NOV. 30, 2018 CHANGE Revenue $21.0 billion $19.3 billion 9% Gross profit margin 44.9% 44% 0.9 pp Operating expenses $6.65 billion $6.21 billion 7% Earnings per share $1.56 $1.19 31% Data source: Nike. Pp = percentage point. It's possible that the world economy reaccelerates this year as well, adding further support to Nike's recent uptick in growth (since 56% of the company's sales have come from outside North America so far in fiscal 2020). The International Monetary Fund sees global GDP increasing to 3.4% from 3% in 2019 if trade tensions ease and manufacturing recovers. Added to a rosier outlook for the economy, Nike has also been a case study in going digital the right way. After announcing it was parting ways with Amazon, management credited its digital selling prowess for its reinvigorated profitable expansion -- besides its strong brand amid a general sports footwear craze around the globe. Optimism increasingly priced in However, Nike's stock run is showing signs it's losing a little steam. Q2 results were some of the best from the last few years, but they were greeted with a shrug from investors. Shares have actually been flat since the report card was released -- not surprising since the stock is priced at a premium. Share prices have been handily outpacing earnings growth, and the stock is now priced at 29 times one year forward expected earnings. The high price tag is certainly warranted (the S&P 500 currently trades for 19.8 times one year forward earnings on expectations for high-single-digit earnings growth), but the valuation prices in a fair amount of continued double-digit earnings gains. I'm certainly not saying to bet against Nike. Sneakers aren't just a hot fad, but rather the new norm in footwear, and Nike is in command of the industry. However, given the run-up in the stock in the last year, I say wait on a new purchase until shares notch a pullback. I for one am looking for a drop of about 10% before I buy in again. 10 stocks we like better than Nike When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Nike wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Nicholas Rossolillo and his clients have no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Amazon and Nike. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,179
Zihan1004/FNSPID
BAT: FDA Flavour Guidance A Welcome Step Towards Stable US Vapour Market (RTTNews) - British American Tobacco (BATS.L, BTI) on Friday announced that the U.S. FDA's Flavour Guidance is a welcome step towards returning the US vapour market to stability following a significant period of disruption and uncertainty. "Importantly, the guidance is clear that flavours can return to the market place once they have been cleared through the PMTA process," the company noted. The company noted the FDA's acknowledgment that a properly regulated vapour category continues to provide a credible alternative to smoking. The FDA also highlighted the important issue of preventing the access and appeal of vapour products to youth. BAT Chief Executive Officer Jack Bowles said, ".. focus must now shift to enforcement to ensure vapour market regulations are effective. We have long said it is not the marketing of these products per se that is the concern, it is the irresponsible marketing of them that should be robustly addressed." The company noted that the FDA guidance, together with the previously announced requirement to submit PMTAs by May 2020 for all products, would help ensure consumers have access to appropriately regulated, quality-assured products that do not appeal to or are accessible to youth. BAT's US subsidiary, RAI Group, has already submitted one brand PMTA for VUSE Solo and is well positioned to submit applications for the remaining VUSE portfolio ahead of the deadline of May 2020. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
326
Zihan1004/FNSPID
EEM June 2021 Options Begin Trading Investors in iShares Trust - iShares MSCI Emerging Markets ETF (Symbol: EEM) saw new options become available today, for the June 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 532 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EEM options chain for the new June 2021 contracts and identified one put and one call contract of particular interest. The put contract at the $33.00 strike price has a current bid of 18 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $33.00, but will also collect the premium, putting the cost basis of the shares at $32.82 (before broker commissions). To an investor already interested in purchasing shares of EEM, that could represent an attractive alternative to paying $45.12/share today. Because the $33.00 strike represents an approximate 27% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 96%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 0.55% return on the cash commitment, or 0.37% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for iShares Trust - iShares MSCI Emerging Markets ETF, and highlighting in green where the $33.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $53.00 strike price has a current bid of 67 cents. If an investor was to purchase shares of EEM stock at the current price level of $45.12/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $53.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 18.95% if the stock gets called away at the June 2021 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if EEM shares really soar, which is why looking at the trailing twelve month trading history for iShares Trust - iShares MSCI Emerging Markets ETF, as well as studying the business fundamentals becomes important. Below is a chart showing EEM's trailing twelve month trading history, with the $53.00 strike highlighted in red: Considering the fact that the $53.00 strike represents an approximate 17% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 80%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 1.48% boost of extra return to the investor, or 1.02% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 35%, while the implied volatility in the call contract example is 20%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $45.12) to be 15%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,000
Zihan1004/FNSPID
Apple Hospitality REIT Named Top Dividend Stock With Insider Buying and 7.50% Yield (APLE) In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So when stocks turn up that see insider buying, and are also top ranked, investors are wise to take notice. One such company is Apple Hospitality REIT Inc (Symbol: APLE), which saw buying by Director Redd Hugh. Back on November 15, Hugh invested $16,116.50 into 1,000 shares of APLE, for a cost per share of $16.12. In trading on Friday, bargain hunters could buy shares of Apple Hospitality REIT Inc (Symbol: APLE) and achieve a cost basis 1.5% cheaper than Hugh, with shares changing hands as low as $15.87 per share. It should be noted that Hugh has collected $0.20/share in dividends since the time of their purchase, so they are currently down 0.3% on their purchase from a total return basis. Apple Hospitality REIT Inc shares are currently trading +0.16% on the day. The chart below shows the one year performance of APLE shares, versus its 200 day moving average: Looking at the chart above, APLE's low point in its 52 week range is $14.40 per share, with $16.90 as the 52 week high point — that compares with a last trade of $16.04. By comparison, below is a table showing the prices at which insider buying was recorded over the last six months: PURCHASED INSIDER TITLE SHARES PRICE/SHARE VALUE 08/09/2019 Glade M. Knight Executive Chairman 5,000 $15.39 $76,945.50 08/12/2019 Redd Hugh Director 2,000 $15.55 $31,093.20 11/08/2019 Glade M. Knight Executive Chairman 5,000 $16.26 $81,296.50 11/13/2019 Redd Hugh Director 1,000 $16.05 $16,050.00 11/15/2019 Redd Hugh Director 1,000 $16.12 $16,116.50 The DividendRank report noted that among the coverage universe, APLE shares displayed both attractive valuation metrics and strong profitability metrics. For example, the recent APLE share price of $16.00 represents a price-to-book ratio of 1.1 and an annual dividend yield of 7.50% — by comparison, the average company in Dividend Channel's coverage universe yields 4.1% and trades at a price-to-book ratio of 2.2. The report also cited the strong monthly dividend history at Apple Hospitality REIT Inc, and favorable long-term multi-year growth rates in key fundamental data points. The report stated, ''Dividend investors approaching investing from a value standpoint are generally most interested in researching the strongest most profitable companies, that also happen to be trading at an attractive valuation. That's what we aim to find using our proprietary DividendRank formula, which ranks the coverage universe based upon our various criteria for both profitability and valuation, to generate a list of the top most 'interesting' stocks, meant for investors as a source of ideas that merit further research.'' The annualized dividend paid by Apple Hospitality REIT Inc is $1.2/share, currently paid in monthly installments, and its most recent dividend ex-date was on 01/02/2020. Below is a long-term dividend history chart for APLE, which the report stressed as being of key importance. Indeed, studying a company's past dividend history can be of good help in judging whether the most recent dividend is likely to continue. The Top DividendRank'ed Stocks With Insider Buying » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,007
Zihan1004/FNSPID
Ex-Dividend Reminder: Comcast, New York Times and Interdigital Looking at the universe of stocks we cover at Dividend Channel, on 1/7/20, Comcast Corp (Symbol: CMCSA), New York Times Co. (Symbol: NYT), and Interdigital Inc (Symbol: IDCC) will all trade ex-dividend for their respective upcoming dividends. Comcast Corp will pay its quarterly dividend of $0.21 on 1/29/20, New York Times Co. will pay its quarterly dividend of $0.05 on 1/23/20, and Interdigital Inc will pay its quarterly dividend of $0.35 on 1/22/20. As a percentage of CMCSA's recent stock price of $45.05, this dividend works out to approximately 0.47%, so look for shares of Comcast Corp to trade 0.47% lower — all else being equal — when CMCSA shares open for trading on 1/7/20. Similarly, investors should look for NYT to open 0.15% lower in price and for IDCC to open 0.64% lower, all else being equal. Below are dividend history charts for CMCSA, NYT, and IDCC, showing historical dividends prior to the most recent ones declared. Comcast Corp (Symbol: CMCSA): New York Times Co. (Symbol: NYT): Interdigital Inc (Symbol: IDCC): In general, dividends are not always predictable, following the ups and downs of company profits over time. Therefore, a good first due diligence step in forming an expectation of annual yield going forward, is looking at the history above, for a sense of stability over time. This can help in judging whether the most recent dividends from these companies are likely to continue. If they do continue, the current estimated yields on annualized basis would be 1.86% for Comcast Corp, 0.62% for New York Times Co., and 2.56% for Interdigital Inc . In Friday trading, Comcast Corp shares are currently down about 0.7%, New York Times Co. shares are down about 0.8%, and Interdigital Inc shares are down about 1.5% on the day. Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
531
Zihan1004/FNSPID
Notable ETF Inflow Detected - IWM, NVCR, MDCO, GNRC Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 2000 ETF (Symbol: IWM) where we have detected an approximate $182.4 million dollar inflow -- that's a 0.4% increase week over week in outstanding units (from 288,850,000 to 289,950,000). Among the largest underlying components of IWM, in trading today NovoCure Ltd (Symbol: NVCR) is down about 1.8%, Medicines Co (Symbol: MDCO) is trading flat, and Generac Holdings Inc (Symbol: GNRC) is lower by about 1.1%. For a complete list of holdings, visit the IWM Holdings page » The chart below shows the one year price performance of IWM, versus its 200 day moving average: Looking at the chart above, IWM's low point in its 52 week range is $133.71 per share, with $167.12 as the 52 week high point — that compares with a last trade of $164.64. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ». Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs. Click here to find out which 9 other ETFs had notable inflows » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
497
Zihan1004/FNSPID
Notable Two Hundred Day Moving Average Cross - IBTX In trading on Friday, shares of Independent Bank Group Inc. (Symbol: IBTX) crossed below their 200 day moving average of $54.11, changing hands as low as $53.75 per share. Independent Bank Group Inc. shares are currently trading down about 1.4% on the day. The chart below shows the one year performance of IBTX shares, versus its 200 day moving average: Looking at the chart above, IBTX's low point in its 52 week range is $46.245 per share, with $63.16 as the 52 week high point — that compares with a last trade of $54.04. Click here to find out which 9 other dividend stocks recently crossed below their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
214
Zihan1004/FNSPID
FBP Makes Notable Cross Below Critical Moving Average In trading on Friday, shares of First Bancorp (Symbol: FBP) crossed below their 200 day moving average of $10.47, changing hands as low as $10.36 per share. First Bancorp shares are currently trading off about 0.6% on the day. The chart below shows the one year performance of FBP shares, versus its 200 day moving average: Looking at the chart above, FBP's low point in its 52 week range is $8.48 per share, with $11.94 as the 52 week high point — that compares with a last trade of $10.49. Click here to find out which 9 other dividend stocks recently crossed below their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
207
Zihan1004/FNSPID
PRU June 2021 Options Begin Trading Investors in Prudential Financial Inc (Symbol: PRU) saw new options become available today, for the June 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 532 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PRU options chain for the new June 2021 contracts and identified one put and one call contract of particular interest. The put contract at the $85.00 strike price has a current bid of $6.65. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $85.00, but will also collect the premium, putting the cost basis of the shares at $78.35 (before broker commissions). To an investor already interested in purchasing shares of PRU, that could represent an attractive alternative to paying $92.88/share today. Because the $85.00 strike represents an approximate 8% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 65%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 7.82% return on the cash commitment, or 5.37% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Prudential Financial Inc, and highlighting in green where the $85.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $120.00 strike price has a current bid of 10 cents. If an investor was to purchase shares of PRU stock at the current price level of $92.88/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $120.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 29.31% if the stock gets called away at the June 2021 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if PRU shares really soar, which is why looking at the trailing twelve month trading history for Prudential Financial Inc, as well as studying the business fundamentals becomes important. Below is a chart showing PRU's trailing twelve month trading history, with the $120.00 strike highlighted in red: Considering the fact that the $120.00 strike represents an approximate 29% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 81%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 0.11% boost of extra return to the investor, or 0.07% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 36%, while the implied volatility in the call contract example is 27%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $92.88) to be 24%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of Stocks with Insider Buying » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
984
Zihan1004/FNSPID
Incyte is Now Oversold (INCY) Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Incyte Corporation (Symbol: INCY) entered into oversold territory, hitting an RSI reading of 20.1, after changing hands as low as $75.1573 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 64.9. A bullish investor could look at INCY's 20.1 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of INCY shares: Looking at the chart above, INCY's low point in its 52 week range is $69.12 per share, with $96.79 as the 52 week high point — that compares with a last trade of $76.66. Find out what 9 other oversold stocks you need to know about » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
335
Zihan1004/FNSPID
U.S. Manufacturing Index Unexpectedly Drops To Ten-Year Low (RTTNews) - Reflecting lingering concerns about global trade, the Institute for Supply Management released a report on Friday showing U.S. manufacturing activity unexpectedly contracted at a faster rate in the month of December. The ISM said its purchasing managers index slid to 47.2 in December from 48.1 in November, with a reading below 50 indicating a contraction in manufacturing activity. The modest decrease came as a surprise to economists, who had expected the manufacturing index to inch up to 49.0. With the unexpected drop, the index pointed to the fastest rate of contraction in manufacturing activity since June of 2009. "Global trade remains the most significant cross-industry issue, but there are signs that several industry sectors will improve as a result of the phase-one trade agreement between the U.S. and China," said Timothy Fiore, Chair of the ISM Manufacturing Business Survey Committee. The unexpected decrease by the headline index was partly due to a notable acceleration in the pace of contraction in production, as the production index plunged to 43.2 in December from 49.1 in November. The report also showed a slightly faster pace of contraction in new orders, with the new orders index dipping to 46.8 in December from 47.2 in November. The employment index also fell to 45.1 in December from 46.6 in November, suggesting the manufacturing sector lost jobs at faster rate. Meanwhile, the report said the prices index surged up to 51.7 in December from 46.7 in November, pointing to a turnaround in raw materials prices after six consecutive months of decreases. The ISM is scheduled to release a separate report next Tuesday on activity in the service sector in the month of December. The non-manufacturing index is expected to rise to 54.5 in December after dipping to 53.9 in November, with a reading above 50 indicating growth in service sector activity. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
448
Zihan1004/FNSPID
Fed Minutes Show Some Concern Low Rates Could Lead To Excessive Risk-Taking (RTTNews) - Members of the Federal Reserve generally agree that interest rates should remain unchanged for the foreseeable future unless there is a material shift in the economic outlook. However, the minutes of the Fed's December meeting showed a few participants raised concerns that keeping interest rates low over a long period might encourage excessive risk-taking. The participants suggested that policies that keep interest rates persistently low could exacerbate imbalances in the financial sector. Such policies could be inconsistent with sustaining maximum employment and could make the next recession more severe than otherwise, the Fed members warned. Nonetheless, economic projections provided by the Fed after the meeting show a majority of participants expect interest rates to remain unchanged throughout 2020. The meeting resulted in the Fed members voting to maintain the target range for the federal funds rate at 1-1/2 to 1-3/4 percent on the heels of three straight quarter-point reductions. The Fed judged that the current stance of monetary policy is appropriate to support a sustained economic expansion, strong labor market conditions, and inflation near its symmetric 2 percent objective. The central bank maintained its assessment of the economy, reiterating that recent data indicates the labor market remains strong and that economic activity has been rising at a moderate rate. The Fed also once again noted that while household spending has been rising at a strong pace, business fixed investment and exports remain weak. The accompanying statement noted the Fed will continue to monitor the implications of incoming information for the economic outlook, including global developments and muted inflation pressures, as it assesses the appropriate path for rates. The minutes revealed that members agreed retaining references to global developments and muted inflation pressures meant text referring to uncertainties about the economic outlook could be removed. The vote to leave interest rates was unanimous, as Kansas City Fed President Esther George and Boston Fed President Eric Rosengren joined in after voting against the past three rate cuts. The Fed is scheduled to hold its first monetary policy meeting of 2020 on January 28th and 29th, with rates widely expected to be kept unchanged. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
459
Zihan1004/FNSPID
Look for This Recovery in Cisco Stock to Carry Well into 2020 Cisco Systems (NASDAQ:) is best known as a giant in the networking hardware market. However, the company has been pursuing a strategy of diversification, which has provided some extra juice to Cisco stock. Source: Ken Wolter / Shutterstock.com In particular, a series of acquisitions has helped Cisco to expand into software and cybersecurity solutions. Last summer, growing revenue — helped in no small part by those acquisitions — was a key factor in driving Cisco stock to highs not seen since 2000, with CSCO topping $58 in July. A pair of quarters with weaker-than-expected guidance pulled the rug out from under CSCO stock, though. After dropping to $43.52 on Dec. 5, CSCO has rebounded, ending the year with a $47.96 close. That’s a modest 12% gain for 2019, but a drop of 17% from its highs in July. Will the current Cisco stock recovery continue into 2020? CSCO Stock Price Performance Cisco’s biggest competition in its core networking business is Juniper Networks (NYSE:). While Cisco stock posted a 12% gain for 2019, Juniper was in the red, losing nearly 8% of its value in 2019. Another key competitor is Arista Networks (NYSE:), which also slipped in 2019, closing the year down just over 1%. In that context, the performance of CSCO stock in 2019 seems much more solid. The investment Analysts polled by The Wall Street Journal have Cisco stock despite its poor performance in the second half of 2019. They also see upside for the stock, with a $52.70 average 12-month price target. Those analysts are not nearly so optimistic about Juniper or Arista Networks stock, both of which get a “hold” rating. Growth Strategy Compared to IBM On some level, Cisco has been a competitor with IBM (NYSE:), although the two were more into collaboration in 2019. The trajectories of the two companies are often compared. Both are old school technology giants that came to dominate their markets. That domination meant meaningful revenue growth required moving into promising new business areas. However, the success of their respective strategies shows markedly different results.  If you look at CSCO over the past five years, it has delivered nearly 80% growth — even after the slide in the second half of 2019. IBM, on the other hand, has struggled. Over the past five years, IBM stock is down 17%. “ — the acquiring and integrating of scores of other smaller technology companies,” Long Island University Economics professor Panos Mourdoukoutas wrote in Forbes. While IBM has been largely focused with trying to trying to change from within, Cisco has augmented its core networking business by buying into promising areas of growth. This has included a strong entry into workplace collaboration with the acquisition of Webex , and enterprise cybersecurity with Duo Security in 2018. Last year’s of Acacia Communications strengthens the company’s position in data center installations, through high-speed optical data transmission. In addition, Cisco has done a good job of integrating acquisitions into its portfolio and into the marketplace to make them even more enticing for customers. For example, last November, the company announced Cisco Webex Meetings with Microsoft’s (NASDAQ:MSFT) Teams. The China Factor There has been some thought that warming trade relations with China could provide a boost to CSCO stock in 2020. InvestorPlace’s Vince Martin points out that Cisco’s . However, China’s Huawei is a formidable global competitor for networking infrastructure. Any gains made by Cisco as a result of a thaw in the could well be offset by loosening of restrictions against Huawei.  Bottom Line on Cisco Stock At this point, the likelihood that the CSCO stock price will continue its recovery in 2020 seems good. Factors such as a weakness for demand in networking equipment that led to its slide in the second half of 2019 are expected to be offset by telecommunications companies investing heavily in 5G rollout. Meanwhile, CSCO’s acquisition and integration strategy has been successful and shows no sign of slowing. With their $52.70 average 12-month price target, investment analysts don’t see Cisco stock hitting the 19-year highs of last summer, but that’s still 10% upside. As of this writing, Brad Moon did not hold a position in any of the aforementioned securities. The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,166
Zihan1004/FNSPID
Facebook Had the 4 Top Mobile Apps of the Decade A decade is an eternity in the technology industry, and over the past 10 years Facebook has grown from a private start-up to one of the largest and most valuable publicly traded companies in the world. Most significantly, Facebook successfully pivoted from desktop to mobile shortly after it went public in 2012. Mobile platforms represented just 3% of ad revenue in mid-2012, but now represent 94% of that core business. Looking back over the past decade, Facebook had the top four most-downloaded apps, according to a recent report from mobile analytics specialist App Annie. Facebook CEO Mark Zuckerberg laid out a 10-year road map in 2016. Image source: Facebook. 4 of the top 10 Here are the top 10 apps by all-time downloads from 2010 through 2019, according to App Annie. These top four apps are what Facebook now refers to as its core "Family of services." RANK APP PARENT COMPANY 1 Facebook Facebook (NASDAQ: FB) 2 Facebook Messenger Facebook 3 WhatsApp Messenger Facebook 4 Instagram Facebook 5 Snapchat Snap (NYSE: SNAP) 6 Skype Microsoft 7 TikTok ByteDance 8 UC Browser Alibaba 9 YouTube Alphabet's Google 10 Twitter Twitter Data source: App Annie. Messenger used to be bundled into the core Facebook app, but CEO Mark Zuckerberg quickly realized that separate apps can deliver better experiences. "In mobile there's a big premium on creating single-purpose first-class experiences," Zuckerberg said shortly before unbundling Messenger in 2015. After acquiring Instagram in 2012, Facebook has done an incredible job in growing the service into the powerhouse photo- and video-sharing platform it is today. Instagram is now in the process of adding e-commerce functionalities like integrated checkouts, a natural extension since the visual nature of the platform lends itself effectively to ads. In comparison, WhatsApp was much larger when Facebook acquired it in 2014. The mobile messaging app had already accumulated 450 million monthly active users (MAUs) by then, many of whom were located in emerging markets. Nowadays, both Instagram and WhatsApp have over a billion MAUs each, and Facebook's Family of services collectively has 2.8 billion MAUs. Competitive threats remain App Annie's rankings also underscore the competition that Facebook is seeking to destroy. The social networking leader has replicated many of Snapchat's most popular features, most notably the Stories format that is now ubiquitous on social media. After a year of struggles in 2018, Snap has started to meaningfully grow its user base again thanks in large part to an overhauled Android version of Snapchat. The fact that China-based ByteDance's TikTok was able to rank No. 7 is a testament to that short-form video platform's astronomical growth since it's a relative newcomer to the scene. TikTok launched internationally in 2017, merged with Musical.ly in 2018, and emerged as one of the most popular social media apps in 2019. In that short time, TikTok has grown to an estimated 1.5 billion users, rivaling Facebook's own dominance. Zuckerberg is simultaneously dismissing TikTok's competitive threat while copying its features. 10 stocks we like better than Facebook When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Facebook wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool's board of directors. Evan Niu, CFA owns shares of Alibaba Group Holding Ltd. and Facebook. The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), Facebook, Microsoft, and Twitter and recommends the following options: long January 2021 $85 calls on Microsoft and short January 2021 $115 calls on Microsoft. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,038
Zihan1004/FNSPID
Does Instagram Have a User Growth Problem? It's been a while since Facebook (NASDAQ: FB) provided investors with an update on Instagram's user growth. Management said it had 1 billion monthly active users in June 2018, and it last updated its DAU count for Stories at 500 million nearly a year ago. Prior to its 1 billion user announcement a year and half ago, the tech company had been providing regular milestone updates about every six months. One reason for the lack of updates may be a slowdown in user growth; if Facebook doesn't have any good news to share, it's not going to say anything. Instagram's estimated user growth in the U.S. fell to just 6.7% last year, down from 10.1% growth in 2018, according to eMarketer. And while the U.S. is likely Instagram's most saturated market, the trend suggests Instagram is seeing a sharp decline in user growth rates. Combined with a disclosure from management that it has saturated ad load in the Instagram feed, a slowdown in user growth could produce lower-than-expected revenue from the app that accounted for a significant portion of Facebook's total revenue growth last year. Image source: Instagram. Why is growth slowing? There are a few reasons Instagram may be experiencing slower than anticipated user growth. First, older users are a particular area of weakness. Instagram appeals to the 13- to 35-year-old demographic much more than older users. Instagram has leaned into that demographic instead of trying to appeal to a broader audience, so it's not a big surprise that older consumers aren't as attracted to the platform. However, Instagram has seen increased competition for its target demographic. Snap (NYSE: SNAP) saw a return to user growth in 2019 thanks to its revamped Android app, and TikTok has emerged as a competitor for younger users' time on mobile devices. That said, there's still a wide gap between Instagram's user count and the competition. Snap said it had 210 million daily active users during the third quarter. That's still well behind the 500 million daily users Facebook reported for Instagram Stories last January. Still, with greater market penetration, further user growth will be more difficult going forward. Is it a problem for Facebook? The slowdown in user growth shouldn't concern investors too much. Facebook has been facing relatively slow user growth on its flagship platform for years, and it's seen saturation of ad load in its feed for even longer than Instagram. Facebook's user growth for its main app fell below 8% last quarter. But Facebook has managed to increase engagement on the platform, even in the highly saturated North American market. Meanwhile, ad product improvements have led to higher average prices for comparable ads, bolstering the metric despite the rapid increase in lower-priced Stories-based ads. Instagram should be able to follow a similar trajectory as its big sister. Facebook introduced several high-value ad formats for Instagram last year focused on e-commerce, which ought to produce strong growth in average ad price. Additionally, Instagram sees much greater engagement in its Stories product than Facebook's other apps. As Facebook grows the advertising products and demand for Stories-based ads, Instagram revenue growth should continue climbing at a relatively high growth rate. Indeed, eMarketer expects Instagram's revenue growth in the U.S. to come in at 46.6% this year, down only slightly from the 52.9% growth it saw last year. By comparison, it expects Snapchat's global revenue growth to total just 33% this year. Instagram benefits from its significantly larger audience and relationship with Facebook driving demand for its ad products over Snapchat and other competitors. That competitive advantage isn't going away anytime soon (or ever). Despite a slowdown in user growth, Instagram will remain a massive revenue growth driver for Facebook in 2020 and beyond. 10 stocks we like better than Facebook When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Facebook wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool's board of directors. Adam Levy owns shares of Facebook. The Motley Fool owns shares of and recommends Facebook. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,007
Zihan1004/FNSPID
Technology Sector Update for 01/03/2020: INPX,AXE,WCC,BKI Top Tech Stocks MSFT -0.55% AAPL -0.07% IBM -0.52% CSCO -1.45% GOOG +0.25% Technology stocks were lower with the shares of tech companies in the S&P 500 Friday falling 0.6% while the Philadelphia Semiconductor Index was sliding 1.3%. Among technology stocks moving on news: (+) Inpixon (INPX) surged more than 39% on Friday. A new regulatory filing showed hedge fund Sabby Management held more than 1.14 million shares, or about 1.73% of the big data analytics company's outstanding stock. In other sector news: (+) Anixter International (AXE) rose 1% after Wesco International (WCC) increased its buyout offer for the networking equipment company, one day after private-equity investors Clayton, Dubilier & Rice matched Wesco's most recent bid. The new Wesco offer values Anixter at $97 per share, up from its previous offer paying $93.50 per share in cash and stock. (+) Black Knight (BKI) still was fractionally higher after the software firm Friday said it has expanded its collaboration with privately held location technologies company Digital Map Products to also include risk and valuation analysis of commercial real estate transactions. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
339
Zihan1004/FNSPID
BeiGene is Now Oversold (BGNE) Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of BeiGene Ltd (Symbol: BGNE) entered into oversold territory, hitting an RSI reading of 29.98, after changing hands as low as $163.65 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 64.9. A bullish investor could look at BGNE's 29.98 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of BGNE shares: Looking at the chart above, BGNE's low point in its 52 week range is $113.01 per share, with $210.35 as the 52 week high point — that compares with a last trade of $164.89. Find out what 9 other oversold stocks you need to know about » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
338
Zihan1004/FNSPID
First Week of February 21st Options Trading For Mirati Therapeutics (MRTX) Investors in Mirati Therapeutics Inc (Symbol: MRTX) saw new options begin trading this week, for the February 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRTX options chain for the new February 21st contracts and identified one put and one call contract of particular interest. The put contract at the $110.00 strike price has a current bid of $9.70. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $110.00, but will also collect the premium, putting the cost basis of the shares at $100.30 (before broker commissions). To an investor already interested in purchasing shares of MRTX, that could represent an attractive alternative to paying $113.78/share today. Because the $110.00 strike represents an approximate 3% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 61%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 8.82% return on the cash commitment, or 65.69% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Mirati Therapeutics Inc, and highlighting in green where the $110.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $115.00 strike price has a current bid of $10.60. If an investor was to purchase shares of MRTX stock at the current price level of $113.78/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $115.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 10.39% if the stock gets called away at the February 21st expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if MRTX shares really soar, which is why looking at the trailing twelve month trading history for Mirati Therapeutics Inc, as well as studying the business fundamentals becomes important. Below is a chart showing MRTX's trailing twelve month trading history, with the $115.00 strike highlighted in red: Considering the fact that the $115.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 47%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 9.32% boost of extra return to the investor, or 69.40% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 80%, while the implied volatility in the call contract example is 83%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $113.78) to be 64%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
946
Zihan1004/FNSPID
INCY Makes Notable Cross Below Critical Moving Average In trading on Friday, shares of Incyte Corporation (Symbol: INCY) crossed below their 200 day moving average of $82.36, changing hands as low as $75.16 per share. Incyte Corporation shares are currently trading down about 11.5% on the day. The chart below shows the one year performance of INCY shares, versus its 200 day moving average: Looking at the chart above, INCY's low point in its 52 week range is $69.12 per share, with $96.79 as the 52 week high point — that compares with a last trade of $76.41. The INCY DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed below their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
222
Zihan1004/FNSPID
Insiders Buy the Holdings of VDE ETF A look at the weighted underlying holdings of the Vanguard Energy ETF (VDE) shows an impressive 11.0% of holdings on a weighted basis have experienced insider buying within the past six months. Range Resources Corp (Symbol: RRC), which makes up 0.09% of the Vanguard Energy ETF (VDE), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $3,396,016 worth of RRC, making it the #67 largest holding. The table below details the recent insider buying activity observed at RRC: RRC — last trade: $4.41 — Recent Insider Buys: PURCHASED INSIDER TITLE SHARES PRICE/SHARE VALUE 08/01/2019 Mark Scucchi SVP & CFO 9,483 $5.27 $49,976 08/01/2019 Mark Scucchi SVP & CFO 8,791 $5.69 $49,999 08/27/2019 Margaret K. Dorman Director 20,500 $3.40 $69,700 10 ETFs With Stocks That Insiders Are Buying » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
324
Zihan1004/FNSPID
What to Expect From UniFirst's Upcoming Earnings Uniform rental and business services provider UniFirst (NYSE: UNF) is on deck to report first-quarter fiscal 2020 results on Jan. 8 before the markets open for trading. The Wilmington, Massachusetts-headquartered garment and textiles giant enjoyed a 41% leap in its stock price in 2019. Can it maintain its drive over the coming 12 months? Below, let's briefly walk through key details that may influence UniFirst's shares when it releases its first scorecard of 2020 next week. Background: Vigorous growth in 2019 UniFirst improved revenue by 6.7% to $1.81 billion in fiscal 2019. This fast growth rate was anchored by the company's core laundry operations, which grew year-over-year revenue by 6.1%. Laundry operations make up 89% of total company sales; the smaller specialty garments and first aid divisions advanced annual revenue by 21.1% and 11.1%, respectively. UniFirst CEO Steve Sintros attributed the year's progress to a number of factors during the company's fourth-quarter 2019 earnings call; these included higher customer retention, record sales in new accounts, better sales rep productivity, and a favorable pricing environment. Sintros also noted that the 2019 fiscal year included 53 weeks. The extra week added roughly 2% to Unifirst's overall revenue total. Image source: Getty Images. The fiscal 2020 outlook UniFirst doesn't provide quarterly estimates; rather, it discloses an annual outlook that it updates as needed during the fiscal year. For 2020, the company expects revenue to fall between $1.86 billion and $1.88 billion. At the midpoint, this will equate to year-over-year expansion of 3.3%; however, shareholders should be aware that fiscal 2019 had the benefit of one extra week. On the earnings front, the company expects core laundry operating margin to land at 10.3%. Laundry margins are returning to a more normalized level after jumping to 13.2% in 2019 due to several one-time items that boosted reported profitability. In addition, management anticipates higher administrative expense in 2020 related to the company's CRM (customer relationship management) initiative. UniFirst projects that diluted earnings per share (EPS) will range between $7.47 and $7.97 this year. This compares to $9.33 in diluted EPS in 2019: Net earnings also benefited from the 53rd week, as well as a non-recurring gain from a vendor settlement related to the company's CRM initiative. Shareholders will also keep an eye on UniFirst's strong cash generation in fiscal 2020. Last year, the company achieved operating cash flow of $282.1 million. Even after adjusting for $13 million received in the company's CRM vendor settlement, operating cash flow jumped by 17% over the prior year. Finally, while this isn't part of the company's formal earnings guidance, management has signaled that UniFirst is actively seeking more of the smaller, bolt-on acquisitions it's undertaken in recent years. On the fourth-quarterearnings call CFO Shane O'Connor observed that UniFirst purchased a small uniform company in Kansas City, Missouri, in September 2019 after the fiscal year ended. This purchase is expected to add $12.5 million in additional revenue this year (the boost is included in annual guidance discussed above). O'Connor stated that the company continues "to look for and aggressively pursue additional targets as acquisitions remain an integral part of [UniFirst's] overall growth strategy." Market pricing of UniFirst stock As we head into four new quarters of reporting on UniFirst's operations, it's important for investors to understand that a disappointing quarter against the cadence of annual expectations could hurt its shares. Given last year's run-up and the fact that it now trades at nearly 25 times forward earnings, UniFirst is no value stock. However, the "UNF" symbol may have a slight bit of insulation as it trades at a discount to rival uniform rental bellwether Cintas Corporation, which currently trades at roughly 31 times forward earnings. UniFirst presents investors with similar characteristics to an investment at Cintas, but at a cheaper price, and thus, any post-earnings sell-off may be mitigated by bargain hunters. I've recently written in detail about UniFirst's valuation versus that of Cintas. 10 stocks we like better than UniFirst When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and UniFirst wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 Asit Sharma has no position in any of the stocks mentioned. The Motley Fool recommends Cintas. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,155
Zihan1004/FNSPID
Dow Jones Today: A Roaring Start to 2020 It’s too early to tell if the new decade will be this century’s equivalent of the “Roaring ’20s,” but stocks started the new year in much the same way they ended 2019: on an upbeat note. Source: Provided by Finviz We’re just one day into 2020, so it’s too early to tell what themes from last year will persist, what laggards will morph into leaders and which winners from last year will disappoint this year. But in late trading, 21 of 30 Dow Jones stocks were higher. On a related note, much of the ebullience to start the new year was attributable to familiar leadership fare as all of the Dow’s technology stocks were trading higher today. Speaking of familiar themes, on a day when news flow was light in the U.S., China helped global equities higher after the central bank there said it would increase access to cheap financing for the country’s financial institutions. On a related note, President Trump remains optimistic that the U.S. and China will sign Phase I of the this month and perhaps start discussions on the next phase. Apple Doing Apple Things There’s obviously a long way to go in 2020, but Apple (NASDAQ:), 2019’s best-performing Dow stock, is off to an excellent, gaining 2.2% on the first trading day of the new year. Conventional wisdom often dictates that a prior leader’s usually don’t retain that status in the following year, but that Apple may not be conventional in that regard. The stock gained 86.16% last year and asking for repeat performance in 2020 may be asking a lot, but Apple certainly has the ingredients and leadership to make . For today, Apple’s gains were largely attributable to the aforementioned liquidity injection in China and news that of the imminent trade deal signing. Speaking of Repeat Winners… Disney (NYSE:) gained a tidy 32% last year and was back at it today, jumping more than 2%. Last year’s familiar catalyst of Disney +, the company’s newly minted streaming service, greased the stock’s wheels today. Specifically, Rosenblatt Securities analyst Bernie McTernan said in a note out today that a recent survey indicates Disney+ has acquired a massive number of subscribers in a short amount of time. “McTernan estimated that Disney+ had 25 million subscribers as the first quarter of its 2020 fiscal year closed on Tuesday, up from his previous call of 21 million. Disney will likely report its results for the quarter in early February,” . Remember This Name? It has been awhile since industrial conglomerate United Technologies (NYSE:) was highlighted in this space, but the stock was one of the top performers in the Dow today. As has been widely noted, there are lot of moving parts with UTX stock, including previously announced spinoffs of its non-core segments, including Otis (elevators and escalators) and Carrier (HVAC) as well as the Raytheon (NYSE:) merger. It took investors a while to digest all those moves, but there a couple of important reasons why UTX could be a winner in 2020: earnings are expected to grow and the stock trades at a tempting 17x earnings, indicating it’s not richly valued despite strong EPS growth forecasts. Along For The Ride Advanced Micro Devices (NASDAQ:), one of last year’s best-performing names from the hot semiconductor space, hit a record high and dragged rival and Dow component Intel (NASDAQ:INTC) along for the ride. Waiting on the Dogs Several of the Dow’s 2019 disappointments, a.k.a. The Dogs of the Dow, such as Dow Inc. (NYSE:) and Verizon (NYSE:), were among the index’s losers today, indicating it could take awhile for the Dogs of the Dow theory to kick in this year. Bottom Line on the Dow Jones Today One thing to consider, and it’s relevant because we’ll soon be treated to the last major economic data points of 2019, is that economic growth in the U.S. is likely to cool this year, but that doesn’t dent the case for equities. “While the odds of a near-term recession appear to have diminished, growth is projected to slow in the coming quarters due to a weaker global outlook and reduced global trade flows,” . “U.S. economic growth is expected to continue to slow into 2020, with analysts surveyed by FactSet projecting 2.3% annual growth in 2019 followed by 1.8% in 2020.” As of this writing, Todd Shriber did not own any of the aforementioned securities. The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,108
Zihan1004/FNSPID
Financial Sector Update for 01/02/2020: JPM, BAC, WFC, C, USB, TCFC, APO, GLRE Top Financial Stocks: JPM: +0.43% BAC: +0.51% WFC: -0.09% C: +0.45% USB: flat The majority of top financial stocks were trading higher before markets open on Thursday. In other sector news: (=) Community Financial (TCFC) recently said that it completed a private placement of 312,747 common shares, raising $10.8 million. The company was flat during pre-bell trading hours. (=) Apollo Global Management (APO), along with Varde Partners, said they will no longer bid for Altico Capital India after refusing to meet creditor demands to inject 20 billion rupees ($280 million) of new equity into the Indian lender, sources told Bloomberg News. Apollo Global was also flat before markets open on Thursday. (=) Hedge fund Greenlight Capital (GLRE), which was also flat, recovered in 2019 from its worst year ever in 2018 and plans to focus on more concentrated investments going forward, Bloomberg News reported Wednesday. The company gained 14% for the year, compared to when it fell 34% in 2018, Bloomberg News said, citing Greenlight's client update. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
334
Zihan1004/FNSPID
February 14th Options Now Available For Yeti Holdings (YETI) Investors in Yeti Holdings Inc (Symbol: YETI) saw new options begin trading today, for the February 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the YETI options chain for the new February 14th contracts and identified one put and one call contract of particular interest. The put contract at the $28.50 strike price has a current bid of 25 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $28.50, but will also collect the premium, putting the cost basis of the shares at $28.25 (before broker commissions). To an investor already interested in purchasing shares of YETI, that could represent an attractive alternative to paying $34.76/share today. Because the $28.50 strike represents an approximate 18% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 100%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 0.88% return on the cash commitment, or 7.45% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Yeti Holdings Inc, and highlighting in green where the $28.50 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $36.50 strike price has a current bid of 70 cents. If an investor was to purchase shares of YETI stock at the current price level of $34.76/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $36.50. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 7.02% if the stock gets called away at the February 14th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if YETI shares really soar, which is why looking at the trailing twelve month trading history for Yeti Holdings Inc, as well as studying the business fundamentals becomes important. Below is a chart showing YETI's trailing twelve month trading history, with the $36.50 strike highlighted in red: Considering the fact that the $36.50 strike represents an approximate 5% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 2.01% boost of extra return to the investor, or 17.09% annualized, which we refer to as the YieldBoost. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $34.76) to be 56%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
896
Zihan1004/FNSPID
DRRX Plunges On Psoriasis Trial Data, INCY Fails GRAVITAS-301 Test, AGRX Abuzz (RTTNews) - Today's Daily Dose brings you news about Agile Therapeutics' strengthened commercial leadership team; DURECT's decision to discontinue the development of DUR-928 in mild to moderate plaque psoriasis; Novan's disappointing molluscum contagiosum trial results; Incyte's acute graft-versus-host disease trial results and Innate Pharma's regulatory catalyst that drove the stock to a new 52-week high. Read on… Agile Therapeutics Inc. (AGRX) has appointed Kimberly Whelan as Vice President of Market Access and filled two additional positions to further strengthen its finance and marketing capabilities. Charles Grass, CMA, has been named Senior Director, Finance and Matthew Riley has been named Product Manager. The Company's lead product candidate, Twirla, awaits the FDA decision on February 16, 2020. AGRX closed Thursday's trading at $2.97, up 18.80%. Shares of DURECT Corp. (DRRX) plunged more than 30% on Thursday, following disappointing results from its phase IIa clinical trial of DUR-928 in patients with mild to moderate plaque psoriasis. DUR-928 did not demonstrate a benefit over vehicle (placebo) based on Investigator's Global Assessment (IGA), which was the scoring system for the primary analysis, or in any of the secondary analyses, DURECT noted. The Company will no longer be pursuing the development of topical DUR-928 in psoriasis. James Brown, President and CEO of DURECT said, "With the recently announced positive results from our Phase 2a alcoholic hepatitis trial, our focus moving forward with DUR-928, will be on completing the NASH trial in the first half of this year and initiating the Phase 2b AH trial in the middle of the year." The Company successfully completed the phase IIa clinical trial of DUR-928 in patients with alcoholic hepatitis last August. Near-term Catalyst: On January 16, 2020, the Anesthetic and Analgesic Drug Products Advisory Committee is scheduled to review DURECT's resubmitted New Drug Application for POSIMIR, a post-operative pain relief depot. POSIMIR, a nonopioid, locally-acting analgesic, is designed to be administered directly into the surgical site to deliver the anesthetic bupivacaine for up to three days after surgery. The FDA had issued a Complete Response Letter for POSIMIR in February 2014. DRRX closed Thursday' trading at $2.61, down 31.18%. In after-hours, the stock was up 2.49% to $2.68. Incyte Corp.'s (INCY) phase III study evaluating Itacitinib in combination with corticosteroids in patients with treatment-naïve acute graft-versus-host disease did not meet the primary endpoint of improving overall response rate at Day 28. In the trial, dubbed GRAVITAS-301, Itacitinib in combination with corticosteroids was compared against placebo plus corticosteroids. Near-term Catalyst: The Company's New Drug Application for Pemigatinib as a treatment for patients with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements is under priority review by the FDA, with a decision expected on May 30, 2020. INCY closed Thursday's trading at $85.97, down 1.55%. In after-hours, the stock fell 10.08% to $77.30. Shares of Innate Pharma SA (IPHA) touched a new 52-week high of $8.24 in intraday trading on Thursday, following the European Medicines Agency's acceptance of the Marketing Authorization Application for Lumoxiti. In-licensed from AstraZeneca, Lumoxiti was approved by the FDA in September 2018. Lumoxiti is indicated for adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog. IPHA closed Thursday's trading at $7.30, up 13.53%. Novan Inc.'s (NOVN) phase III program with SB206 for the treatment of molluscum contagiosum has failed to achieve statistically significant results for the primary endpoint of efficacy. The phase III program, dubbed B-SIMPLE, consists of two trials namely, B-SIMPLE1 and B-SIMPLE2, evaluating SB206 for the treatment of molluscum in 707 patients aged 6 months and older, with a 2:1 (active: vehicle) randomization. However, the Company noted that multiple sensitivity analyses are supportive and consistent across both studies and support a potential path forward for SB206. The phase III B-SIMPLE program is ongoing, with full efficacy and safety data, including the prospectively planned safety evaluation ongoing through Week 24, targeted to be available by March 2020. NOVN closed Thursday's trading at $3.11, down 1.58%. In after-hours, the stock was down 72.67% to $0.85. Pulmatrix, Inc. (PULM) has entered into a licensing and development agreement with Johnson & Johnson's (JNJ) Lung Cancer Initiative. Through the agreement, the Lung Cancer Initiative gains an option to access Pulmatrix's portfolio of narrow spectrum kinase inhibitors intended for development in lung cancer interception. A phase Ib study of the Company's lead in-licensed inhibitor RV1162/PUR1800 in stable COPD patients is underway. Under the terms of the agreement, the Lung Cancer Initiative will pay a $7.2 million upfront payment and an additional $2 million milestone payment upon completion of the ongoing Phase 1b study of RV1162/PUR1800 in stable COPD patients, on-track for year-end 2020. If the Lung Cancer Initiative exercises the option on RV1162/PUR1800 and the portfolio of these kinase inhibitors, Pulmatrix is eligible for up to $91 million in additional development and commercial milestones, as well as royalty payments. PULM closed Thursday's trading at $1.62, up 88.37%. Trillium Therapeutics Inc. (TRIL) in an SEC filing dated December 31, 2019, reveals that Morgan Stanley has acquired a 5.9% stake in the Company. The Company's lead program is intravenous administration of TTI-621, which is in phase I clinical trial for advanced hematologic malignancies, and solid tumors and mycosis fungoides. TRIL closed Thursday's trading at $1.49, up 44.66%. In after-hours, the stock lost 2.68% to $1.45. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,562
Zihan1004/FNSPID
February 14th Options Now Available For Flex Investors in Flex Ltd (Symbol: FLEX) saw new options begin trading today, for the February 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the FLEX options chain for the new February 14th contracts and identified one put and one call contract of particular interest. The put contract at the $12.50 strike price has a current bid of 62 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $12.50, but will also collect the premium, putting the cost basis of the shares at $11.88 (before broker commissions). To an investor already interested in purchasing shares of FLEX, that could represent an attractive alternative to paying $12.66/share today. Because the $12.50 strike represents an approximate 1% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 100%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 4.96% return on the cash commitment, or 42.10% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Flex Ltd, and highlighting in green where the $12.50 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $13.00 strike price has a current bid of 55 cents. If an investor was to purchase shares of FLEX stock at the current price level of $12.66/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $13.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 7.03% if the stock gets called away at the February 14th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if FLEX shares really soar, which is why looking at the trailing twelve month trading history for Flex Ltd, as well as studying the business fundamentals becomes important. Below is a chart showing FLEX's trailing twelve month trading history, with the $13.00 strike highlighted in red: Considering the fact that the $13.00 strike represents an approximate 3% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 4.34% boost of extra return to the investor, or 36.88% annualized, which we refer to as the YieldBoost. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $12.66) to be 37%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
878
Zihan1004/FNSPID
Why Antares Pharma's Sliding 10% Today What happened After a big run-up in its share price following better-than-expected earnings and guidance in November, Antares Pharma (NASDAQ: ATRS) shares are down 10% at 3:30 p.m. EDT on Thursday. The company didnt reportany news, so today's drop could be a simple case of profit-taking following a nearly 40% gain since October 31. So what The company reported it's first quarterly operating profit in history in November, thanks to nearly triple-digit revenue growth following the launch of Xyosted -- a weekly testosterone product -- and Teva Pharmaceutical's (NYSE: TEVA) launch of a generic alternative to Mylan's EpiPen. IMAGE SOURCE: GETTY IMAGES. Overall, revenue was up 92% year over year, to $34.3 million in the third quarter of 2019, which resulted in net income of $1 million, or $0.01 per share. Wall Street's industry watchers were expecting sales and earnings per share (EPS) to clock in at $7 million and $0.03 lower, respectively. Xyosted sales accounted for much of the improvement in sales and profit. An alternative option to using messy gels daily, Xyosted is dosed through an auto-injector once per week. Sales of Xyosted totaled $7 million last quarter. Sales of Otrexup (a subcutaneous formulation of methotrexate) improved to $4.4 million in the quarter from $4.1 million in the same quarter one year ago. Revenue from Teva Pharmaceutical associated with its epinephrine product also contributed to sales significantly, lifting partnered-products revenue to $13.2 million from $7.5 million in the year-ago period. The epinephrine product also generated royalties that boosted Antares' companywide royalty revenue 126% year over year, to $8.4 million for the three months ended Sept. 30, 2019. Now what The sell-off may offer investors an opportunity to buy shares on sale. The company's third-quarter performance prompted management to boost its full year 2019 sales guidance to a range of between $115 million to $120 million, up from $100 million to $110 million previously. A tight lid on expenses, an ongoing ramp up in Xyosted, and the potential for Teva Pharmaceutical's generic EpiPen to win more market share could all help Antares Pharma deliver better-than-expected results in 2020. Additionally, Antares Pharma could benefit from a potential launch of Teva Pharmaceutical's generic version of the blockbuster drug Forteo later this year if regulators cooperate, providing yet another important revenue stream. 10 stocks we like better than Antares Pharma When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Antares Pharma wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 Todd Campbell owns shares of Mylan. His clients may have positions in the companies mentioned. The Motley Fool recommends Mylan. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
789
Zihan1004/FNSPID
Interesting KKR Put And Call Options For February 14th Investors in KKR & CO Inc Class A (Symbol: KKR) saw new options begin trading today, for the February 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the KKR options chain for the new February 14th contracts and identified one put and one call contract of particular interest. The put contract at the $29.00 strike price has a current bid of 70 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $29.00, but will also collect the premium, putting the cost basis of the shares at $28.30 (before broker commissions). To an investor already interested in purchasing shares of KKR, that could represent an attractive alternative to paying $29.25/share today. Because the $29.00 strike represents an approximate 1% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 100%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 2.41% return on the cash commitment, or 20.49% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for KKR & CO Inc Class A, and highlighting in green where the $29.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $29.50 strike price has a current bid of 65 cents. If an investor was to purchase shares of KKR stock at the current price level of $29.25/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $29.50. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 3.08% if the stock gets called away at the February 14th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if KKR shares really soar, which is why looking at the trailing twelve month trading history for KKR & CO Inc Class A, as well as studying the business fundamentals becomes important. Below is a chart showing KKR's trailing twelve month trading history, with the $29.50 strike highlighted in red: Considering the fact that the $29.50 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 2.22% boost of extra return to the investor, or 18.86% annualized, which we refer to as the YieldBoost. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $29.25) to be 28%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
896
Zihan1004/FNSPID
Why 5G – Not Memory Pricing – is Key Driver for Micron Stock For technology and semiconductor firms like Micron Technology (NASDAQ:), the recent thaw in U.S.-China relations couldn’t have come at a better time. Despite strong ideological differences, China has emerged as an unprecedented market for various industries. Therefore, the upside credibility of Micron stock depended in large part on geopolitical factors. Source: Charles Knowles / Shutterstock.com Better yet, optimistic signs have sprouted in the company’s core NAND and DRAM memory chip businesses. Notably, Susquehanna Financial Group analyst Mehdi Hosseini upgraded his outlook on MU stock to “positive” from “neutral.” Central to Hosseini’s thesis is a for 2020 and 2021. This view isn’t at all unreasonable. To quickly summarize, DRAM memory is typically found in personal computers and data servers. On the other hand, NAND chips are utilized by smartphone manufacturers, as well as solid-state drives. Both memory types have ample demand, particularly as computing moves into the cloud and the introduction of 5G technologies become more widespread. Therefore, the upside potential for Micron stock appears bright and viable. However, the NAND and DRAM markets are notoriously volatile. For instance, NAND flash memory prices for various capacities following a rebound in 2016 and 2017. While a rebound seems reasonable based on prior historical pricing trends, here’s the kicker: there’s no guarantee that history will repeat or resemble itself. And if pricing doesn’t improve, that puts MU stock in a quandary. During the heated portion of the Beijing-Washington trade war, the international semiconductor industry had no incentive to create a balanced supply-demand ecosystem. As such, a huge supply glut still exists, presenting a cloud over hot-running Micron stock. Can investors still trust this name, or should they move on to more credible opportunities? Catalysts for Micron Stock Stronger than the Pitfalls Although underlying events appear positive for MU stock, it’s hard not to think that the glass might be half-empty this time around. Since Christmas Eve, shares have dipped nearly 4%. Those are losses that you can’t ignore. They also suggest a return to the wildness that has characterized semiconductor stocks over the last few years. That said, I believe investors can take a more optimistic approach to Micron stock. For starters, memory chip prices will eventually fall because they are essentially designed to. Technology expert John C. McCallum created a very useful chart regarding the . Over a long enough time horizon, memory chips either fall to zero (because they’re irrelevant) or get pretty darn close. Thus, the pricing debate already has an inevitable victor. Arguably, though, computer chips are about as small as they’re ever going to be. Therefore, the real debate isn’t necessarily about size and capacity but rather, functionality. Here, the underlying fundamentals are unambiguously positive for MU stock (and to be fair, the competition). Thanks to the 5G rollout, many innovations, such as artificial intelligence and automated transportation, can now be actualized because of the 5G network’s incredible speed and data capacity. Appropriately, Micron laid out its to the 5G network, which involves mobile, automotive, the Internet of Things, networking, and cloud computing. And this is also where Micron stock has a distinction: the tech firm isn’t just about pumping out chips but rather, developing platforms that maximize various innovations’ full potential. Geopolitically, it doesn’t hurt MU stock that the Chinese tech industry has a . As Micron would know, trust is a valuable commodity in tech. They’re able to provide it far better than most Chinese counterparts. Expect Nearer-term Turbulence From a longer-term perspective, then, I’m not terribly worried about the memory pricing issues. As I mentioned, prices will eventually fall due to advancements in technology. What matters more is the opportunity for revenue growth that 5G provides. However, I’d be remiss not to mention the technical situation for Micron stock. Currently, shares are a bit overheated. Plus, in the near term, memory pricing matters quite a bit. As things stand, MU could possibly fall to at least its 50-day moving average (around $49). Once the turbulence fades, though, I believe MU stock offers a solid opportunity. In my view, Micron isn’t just participating in the 5G revolution; it’s actively leading it. So, don’t let the memory chip market be the ultimate deciding factor. As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,179
Zihan1004/FNSPID
Interesting NLY Call Options For February 14th Investors in Annaly Capital Management Inc (Symbol: NLY) saw new options begin trading today, for the February 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NLY options chain for the new February 14th contracts and identified the following call contract of particular interest. The call contract at the $9.50 strike price has a current bid of 16 cents. If an investor was to purchase shares of NLY stock at the current price level of $9.41/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $9.50. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 2.66% if the stock gets called away at the February 14th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if NLY shares really soar, which is why looking at the trailing twelve month trading history for Annaly Capital Management Inc, as well as studying the business fundamentals becomes important. Below is a chart showing NLY's trailing twelve month trading history, with the $9.50 strike highlighted in red: Considering the fact that the $9.50 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 62%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 1.70% boost of extra return to the investor, or 14.43% annualized, which we refer to as the YieldBoost. The implied volatility in the call contract example above is 37%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $9.41) to be 15%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the Mortgage REITs » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
583
Zihan1004/FNSPID
Caterpillar Stock Will Be Boosted by Multiple Macro Trends in 2020 Multiple, positive macro factors look poised to meaningfully improve Caterpillar’s (NYSE: financial results in the first half of 2020. As a result, Caterpillar stock should rise meaningfully during that time. Source: Shutterstock For several reasons, the U.S.-China trade deal will be a huge positive for Caterpillar. China’s economic recovery, which , will gather steam. As a result, the company’s construction business in China, which accounts for 5%-10% of the company’s total revenue, will accelerate. Moreover, Caterpillar’s mining equipment business (the company is ) will benefit as China’s revival leads to increased global demand for industrial metals like iron ore, copper, and silver. Already, iron ore prices have surged from about $80 in early November to around $92 recently. Similarly, copper prices have jumped from just over $2.50 . CAT also sells a significant amount of oil and gas exploration equipment. As China’s economy recovers, it will consume more oil, pushing oil prices higher and leading to increased demand for oil exploration equipment. CAT, which also sells farming equipment, should benefit as well from gigantic increases purchased by China. In order to grow all of the crops that the Asian country has promised to buy, American farmers will need to cultivate much more land and buy a great deal more agricultural equipment. Finally, that China could import natural gas from the U.S. as part of the trade deal If that scenario materializes, CAT’s natural gas equipment revenue would probably surge. Dollar Weakness and Caterpillar Stock The U.S. dollar is starting to weaken. That trend helps Caterpillar stock. because it makes oil, natural gas, minerals, and even food more expensive in dollar terms. As a result, mining, drilling and farming become more lucrative, increasing demand for Caterpillar’s equipment. In the last week, America’s currency currencies, and it has declined 2.6% over the last three months. According to CNBC, the dollar, “is widely expected to be weaker in the coming year, as other economies do better and catch up to the U.S.” The business news site added that the dollar “is expected to see at least a single digit (percentage) loss” in 2020. unlike a number of his predecessors, is actually very much in favor of a weaker dollar, so the Trump administration will not do anything to prevent the dollar from weakening and could even accelerate the process. Infrastructure, Nonresidential Construction and Caterpillar Stock Both Caterpillar and JPMorgan analyst Ann Dulgnan are upbeat on U.S. infrastructure spending trends, with Caterpillar CEO Jim Umpleby saying that he has seen “.” Barron’s reporting that Dulgnan “is…bullish on U.S. infrastructure spending.” Additionally, Chief Economist Anirban Basu is also upbeat on U.S. infrastructure spending. citing meaningful spending by states and municipalities to improve the country’s infrastructure. Meanwhile, the association’s Construction Backlog Indicator increased to nine months in August. Although the association reported that construction spending and employment — two lagging indicators — eased, I believe that the strength of the leading indicator indicates that spending on nonresidential construction will rise meaningfully in 2020. Of course, easing tariffs will definitely boost that trend as well. Valuation and Dividend Caterpillar’s valuation of less than 14 times analysts’ average 2020 earnings per share estimate is a real bargain in this market, where so many stocks are overvalued. And its 2.8% will pay investors to wait in case the market takes a while to realize that many macro trends are moving in Caterpillar’s favor. The Bottom Line on Caterpillar Stock Caterpillar’s stocks will rise, boosted by the China trade deal, China’s economic recovery, a weaker dollar, and favorable U.S. building and infrastructure trends. In 2020, Caterpillar’s shares should be able to reach at least $180, just $10 above its January 2108 high. Including dividends, that would give investors a total return of nearly 20%. Not bad for a stock that doesn’t pose very much risk. As of this writing, the author did not own any of the aforementioned securities. The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,158
Zihan1004/FNSPID
February 14th Options Now Available For WW International (WW) Investors in WW International Inc (Symbol: WW) saw new options become available today, for the February 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the WW options chain for the new February 14th contracts and identified one put and one call contract of particular interest. The put contract at the $33.00 strike price has a current bid of $1.20. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $33.00, but will also collect the premium, putting the cost basis of the shares at $31.80 (before broker commissions). To an investor already interested in purchasing shares of WW, that could represent an attractive alternative to paying $36.31/share today. Because the $33.00 strike represents an approximate 9% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 100%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 3.64% return on the cash commitment, or 30.87% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for WW International Inc, and highlighting in green where the $33.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $37.00 strike price has a current bid of $2.25. If an investor was to purchase shares of WW stock at the current price level of $36.31/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $37.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 8.10% if the stock gets called away at the February 14th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if WW shares really soar, which is why looking at the trailing twelve month trading history for WW International Inc, as well as studying the business fundamentals becomes important. Below is a chart showing WW's trailing twelve month trading history, with the $37.00 strike highlighted in red: Considering the fact that the $37.00 strike represents an approximate 2% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 6.20% boost of extra return to the investor, or 52.60% annualized, which we refer to as the YieldBoost. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $36.31) to be 78%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
880
Zihan1004/FNSPID
Better Buy: Abbott Laboratories vs. Pfizer Investors looking for large-cap, dividend-paying healthcare stocks have plenty of options. Whether it's large-scale drug manufacturers or medical technology providers, there's enough choice to suit whatever you're looking for. Abbott Laboratories (NYSE: ABT) and Pfizer (NYSE: PFE) both have large market valuations, solid dividends, and a strong track record of success. However, they operate in different areas of the healthcare market, with Abbott developing diagnostic equipment while Pfizer focuses on developing new pharmaceutical candidates. If you had to choose between the two, however, which is the better investment? Image source: Getty Images. Big changes for Pfizer on the horizon The upcoming year is going to bring quite a few changes for Pfizer, and that has many investors on edge. The company's new CEO, Albert Bourla, is implementing a major shift in corporate strategy, focusing on higher-margin products by spinning off well-known drug brands that have been dragging down revenue growth. Earlier in July, Pfizer announced that it was selling its non-patent drug unit, Upjohn, to Mylan, creating a new company called Viatris in the process. Viatris will be home to a number of well-known drug brands that have been decent revenue drivers, although their growth rates have slowed down. If shedding its Upjohn drug collection wasn't a big enough change, Pfizer also announced that it will combine its consumer healthcare unit with GlaxoSmithKline's own equivalent business to create a separate entity for over-the-counter products. While Pfizer's consumer healthcare division wasn't that large, and it still will retain a 32% stake in the new joint venture, it will mean the loss of some well-known products, most notably Advil. Pfizer will be going back to basics, so to speak, focusing on developing new drug candidates as well as marketing its existing lineup of rapidly growing blockbuster candidates. This includes a cancer drug called Inlyta, a rare heart disease treatment called Vyndaqel, and immunology drug Xeljanz. All three drugs have seen very strong growth rates, with Inlyta up 240%, Vyndaqel up 325%, and Xeljanz up 40% year over year in terms of sales. The company's best drug candidates, an anticoagulant called Eliquis and a breast cancer drug called lbrance, are also still staying with Pfizer. Both drugs are the primary revenue sources for their respective areas -- internal medicine and oncology -- and collectively account for 18% of Pfizer's total revenue. Overall, Pfizer's facing a big shift, but it's likely to emerge from it as a more focused and efficient drug developer than it's been in many years. Abbott's consistent growth from a diverse business In contrast to Pfizer, Abbott has stayed relatively the same for the past few years. Ever since splitting from AbbVie in 2013, the company has done quite well for itself. Doubling in stock price, delivering consecutive double-digit growth rates, and all the while maintaining a consistently increasing dividend is quite an impressive achievement, considering its large size. Unlike Pfizer, Abbott isn't a new drug developer. Instead, its main revenue source comes from the sale of medical diagnostics equipment and devices, primarily in the realm of cardiovascular disease but also other conditions, such as diabetes. Thanks to some major acquisitions, including a $25 billion buyout of rival medical device maker St. Jude Medical in 2016, Abbott's medical device sales have seen high single-digit growth in what's already the company's largest business segment. While medical device sales are Abbott's bread and butter, its total revenue is split among four main business areas. One of these is Abbott's nutritionals business, which primarily provides formulas for infants and small children. The company also has its own generic-drug business, which sells branded generic versions of drugs whose patents have expired. These two businesses accounted for 24% and 14% of Abbott's 2018 revenue. In comparison, Abbot's medical device segment accounts for 37% of the company's revenue, while its second largest-business, diagnostics, accounted for 25% of 2018 income. Comparing financials Both Pfizer and Abbott are large-cap stocks, with market caps around $216 billion and $154 billion, respectively. As it turns out, both companies have relatively similar financial metrics. Looking at their price-to-sales (P/S) ratios shows that Pfizer trades at 4.25, while Abbott comes in at 4.93. That's pretty much in line with most other large-cap healthcare stocks, with Johnson & Johnson trading at 4.8 times sales, while Amgen trades at a 6.39 P/S ratio. While Abbott ended up taking on a significant amount of debt to fund its acquisitions, the company has done a good job paying off its debt since then. Long-term liabilities have fallen from $27 billion in Q4 2017 to $17.6 billion in Q3 2019, a 35% decline in just two years. In comparison, Pfizer's debt has grown a little over that same period, from $31.8 billion to its current $36.0 billion. What's the verdict? Pfizer and Abbott have quite a few differences, despite their similarities. Pfizer is undergoing some major changes, spinning off many of its older, stagnating drug brands to focus on developing and marketing its portfolio of high-growth drug candidates. So far, the drug lineup that Pfizer's holding on to right now has seen very impressive growth rates, some even in the triple digits. On the other hand, Abbott embodies the philosophy of "slow and steady wins the race." The company has maintained a more than reasonable growth rate over a long period and is likely to continue doing what it's already doing. There's a strong case to be made for both companies, but if I had to choose, I'd lean a bit more toward Pfizer. While Abbott might be a better investment for a hands-off investor looking for a safe and secure stock, Pfizer's move to focus on its high-growth drug segment gives the stock major upside potential in the next year or two. Both companies, however, are good investments and should have a lot going for them in the future. 10 stocks we like better than Pfizer When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Pfizer wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 Mark Prvulovic has no position in any of the stocks mentioned. The Motley Fool recommends Amgen, Johnson & Johnson, and Mylan. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,515
Zihan1004/FNSPID
Technology Sector Update for 01/02/2020: PRSP,AMBA,AMZN,TSM,AMD Top Tech Stocks MSFT +1.59% AAPL +2.04% IBM +0.92% CSCO +1.56% GOOG +2.12% Technology stocks extended their market-leading gains on Thursday, with the shares of tech stocks in the S&P 500 advancing nearly 1.6% while the Philadelphia Semiconductor Index was rising about 1.8%. Among technology stocks moving on news: (-) Perspecta (PRSP) slipped 0.3% this afternoon. The information technology firm said its Perspecta Labs applied research arm successfully demonstrated long-distance, high-bandwidth data streaming between a test aircraft and a 4G LTE ground network. The test, part of a collaboration with the Pentagon's Test Resource Management Center, was conducted at Edwards Air Force Base in California. In other sector news: (+) Advanced Micro Devices (AMD) rose 7.3% to a new record high of $49.25 a share after Nomura Instinet raised its price target for the chipmaker by $18 to $58 and reiterated its buy recommendation. According to reports, Instinet analyst David Wong said Advanced Micro should continue to strengthen its competitive position during 2020 with new product launches, price increases and higher revenue as well as improved operating leverage. (+) Ambarella (AMBA) climbed 3.3% on Thursday after it will debut a new robotics platform using its artificial intelligence-powered CVflow software-on-a-chip technology at the Consumer Electronics Show 2020 starting next week in Las Vegas. Separately, Ambarella also said it was partnering with Amazon.com (AMZN) to allow Amazon SageMaker Neo users to produce new machine learning models and run them on any device equipped with Ambarella's CVflow computer vision chips. (+) Taiwan Semiconductor Manufacturing (TSM) was ahead more than 3% after Digitimes, citing a report by the Chinese-language Commercial Times, said the chipmaker will begin producing next-generation, five-nanometer chipsets for Apple's (AAPL) 2020 iPhone series by mid-year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
497
Zihan1004/FNSPID
Amgen Completes Purchase Of About $2.8 Bln Of BeiGene Shares (RTTNews) - Amgen (AMGN) has completed its purchase of an about 20.5% equity stake in BeiGene, Ltd. (BGNE). Amgen purchased about 15.90 million of BeiGene's American Depositary Shares for about $2.8 billion in cash, BeiGene said in a statement. As per the terms of the collaboration, BeiGene will assume responsibility for the commercialization and development in China of Amgen's three oncology medicines, XGEVA, KYPROLIS, and BLINCYTO (blinatumomab) that have been approved or filed in China. BeiGene and Amgen will collaborate to advance 20 investigational oncology assets in Amgen's pipeline, with BeiGene leading development and commercialization in China. BeiGene announced the election of Anthony Hooper, former Executive Vice President of Global Commercial Operations at Amgen, to its board of directors, effective today. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
241
Zihan1004/FNSPID
3 of the Best Healthcare Stocks to Buy in 2020 Stocks are ripping to ring in the New Year, and it is making it impossible not to be bullish. To speed along your profit-seeking quest, this piece will feature three of the best healthcare stocks to buy as we begin 2020. Two are sector leading giants, large caps boasting beefy gains throughout December. Their trends point higher across all time frames, and, best of all, they followed the broader sector’s lead and pulled back last week to create a clean, lower-risk entry point. In fact, that’s the reason we’re focusing on the healthcare space to begin with. It retreated to the rising 20-day moving average and offers the best-looking setup of all the sectors right now. The third stock is a small-cap lotto ticket that’s beginning to rise after a disastrous drop. Without further ado, here are three of the best healthcare stocks to buy. 3 Healthcare Stocks to Buy: Canopy Growth Corporation (CGC) Source: The thinkorswim® platform from TD Ameritrade We’ll begin with the most speculative play of the bunch — a pot stock. Canopy Growth Corporation (NYSE:) scored a massive gain on Tuesday, rising nearly 10% on 16.4 million shares. The jump ushered CGC stock to the cusp of a breakout that could change the trajectory of its trend. Because this is a trend reversal pattern, there’s a higher risk of failure — so risk management is imperative. But, if it works, significant profits could be in the offing. My advice? Buy CGC on a break over $22.50 with a stop loss below $18.50. Falling below it will invalidate the bottoming formation, and the $29 area is a logical target. Amgen Inc. (AMGN) Source: The thinkorswim® platform from TD Ameritrade Amgen Inc. (NASDAQ:) offers a more traditional, trend-following pattern. Since the beginning of October, AMGN stock has been carving out a healthy uptrend with multiple pullbacks and breakout setups along the way. Another such pause formed over the past two weeks, creating a high base pattern. Resistance has asserted itself at $245, providing a clear level that needs to be broken before the trend can continue. So, consider that your trigger. In case the breakout fails, you can stop out below $238.50. That’s the low of the base, as well as the 20-day moving average. This morning’s up-gap quickly filled, so AMGN may need some additional time before making a go at resistance. Regardless, it’s a great trade when and if it can reach and move past $245. Merck & Co. (MRK) Source: The thinkorswim® platform from TD Ameritrade Merck & Co. (NYSE:) rounds out today’s trio with a classic bull retracement pattern. Last year’s uptrend was topped off by a strong, high volume up-gap on Dec. 20. Since then, we’ve seen a garden variety pullback form — allowing AMGN stock to digest the gains while creating a lower-risk entry point. Like AMGN, Merck’s morning rally attempt was rejected. So, some additional backing-and-filling may be needed before a bonafide bounce emerges. Watch for support to form near $90, which is the rising 20-day moving average as well as the gap fill area. For now, MRK stock would need to take out this morning’s high of $91.30 before giving the green light to bullish trades. If you’re looking for an options trade idea, I like the February $90/$95 bull call spread — which currently trades for $2.14. As of this writing, Tyler Craig didn’t hold positions in any of the aforementioned securities. For a free trial to the best trading community on the planet and Tyler’s current home, ! More From InvestorPlace The post appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,033
Zihan1004/FNSPID
Will 5G Roll-Out Revive Ericsson's Fortunes In 2020? Ericsson (NASDAQ: ERIC) is undergoing a significant transformation to focus on its core Networks and Digital Services business to achieve sustainable growth. After a couple of years of turmoil, the telecom technology company is on track to revive its fortunes primarily due to the roll-out of commercial 5G operations in North America and Northeast Asia. Ericsson’s networks division, which delivers products and services that are needed for mobile and fixed communication, several generations of radio networks and transmission networks, is expected to contribute $16.1 billion to Ericsson’s 2019 revenues, making up 67% of the company’s $24.2 billion in revenues for the year. The Networks segment is nearly 4 times larger than the Digital Services segment, which provides solutions that primarily consist of software and services in the areas of monetization and management systems. The Digital Services business has been struggling of late and is expected to see revenues shrink $400 million over 2019-2020. Trefis highlights trends in Ericsson’s Revenues over the years along with our expectations for 2020 in an interactive dashboard, key elements of which are discussed below. How Has Ericsson’s Historical Revenue Trended? Ericsson has lost $1.7 billion in total revenue since 2016 at an average annual rate of 3.3% mainly due to losses across its core segments. Digital Services segment has been the worst-performing segment, losing more than $900 million over 2016-2018. Going forward, we expect Ericsson’s revenues to increase by 1.6% over 2019-2020 to reach $24.7 billion in 2020. A Detailed Look At Ericsson’s segment performance and revenue change over the years: (1) Networks Division Will Continue To Benefit From 5G Rollout Network division is the company’s largest segment with an average revenue share of 64% over the last three years. The division’s revenue has declined by 2% over 2016-2018, shedding $500 million in total revenues. Notably, this decline came in 2017 when the division’s revenues fell 9% due to lower operator investment in mobile broadband as well as lower demand for radio access network equipment. Going forward, we expect this division’s revenues to achieve steady growth and add over $800 million to total revenues over 2019-20 thanks to growing sales of 5G equipment in North America and South Korea. Moreover, as telecom operators continue to invest in network upgrades to cope with increased traffic volume, the demand for Ericsson’s network products and services is expected to increase. (2) Digital Services Business Will Continue To Tumble The company’s digital services business has been struggling of late, with the division’s shrinking by more than $900 million since 2016 at an average annual rate of 8.9%. This has led to the division’s contribution to Ericsson’s top line falling 18% points over this period. This decline can be attributed to lower sales in legacy products partially offset by growth in 5G and cloud products. We expect this declining trend to continue, with the division’s revenues declining at an average annual rate of 5%, losing nearly $425 million in total revenues over 2019-2020. This decline is likely to be driven by lower sales in legacy products across major geographic regions. (3) Revenue from Managed Services is expected to remain flat at $3.9 billion over 2019-2020, with its share of Total Revenue remaining stable at 16% Additional details about how revenues for Ericsson’s Managed Services and Other segment have changed over recent years are available in our interactive dashboard. What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams | Product, R&D, and Marketing Teams More Trefis Data Like our charts? Explore example interactive dashboards and create your own. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
914
Zihan1004/FNSPID
DGRO, WFC, PFE, CSCO: ETF Inflow Alert Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core Dividend Growth ETF (Symbol: DGRO) where we have detected an approximate $94.7 million dollar inflow -- that's a 0.9% increase week over week in outstanding units (from 243,050,000 to 245,300,000). Among the largest underlying components of DGRO, in trading today Wells Fargo & Co (Symbol: WFC) is off about 0.4%, Pfizer Inc (Symbol: PFE) is down about 0.4%, and Cisco Systems Inc (Symbol: CSCO) is higher by about 0.8%. For a complete list of holdings, visit the DGRO Holdings page » The chart below shows the one year price performance of DGRO, versus its 200 day moving average: Looking at the chart above, DGRO's low point in its 52 week range is $32.29 per share, with $42.2923 as the 52 week high point — that compares with a last trade of $42.13. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ». Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs. Click here to find out which 9 other ETFs had notable inflows » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
490
Zihan1004/FNSPID
Thursday Sector Laggards: Agriculture & Farm Products, Drugs In trading on Thursday, agriculture & farm products shares were relative laggards, down on the day by about 1.9%. Helping drag down the group were shares of Sundial Growers, down about 6.2% and shares of Cresud SA Comercial Industrial Financiera Y Agropecuaria down about 3.3% on the day. Also lagging the market Thursday are drugs shares, down on the day by about 1.9% as a group, led down by Durect, trading lower by about 33.5% and Clearside Biomedical, trading lower by about 23.8%. VIDEO: Thursday Sector Laggards: Agriculture & Farm Products, Drugs The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
189
Zihan1004/FNSPID
AMGN February 14th Options Begin Trading Investors in Amgen Inc (Symbol: AMGN) saw new options become available today, for the February 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMGN options chain for the new February 14th contracts and identified one put and one call contract of particular interest. The put contract at the $237.50 strike price has a current bid of $6.45. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $237.50, but will also collect the premium, putting the cost basis of the shares at $231.05 (before broker commissions). To an investor already interested in purchasing shares of AMGN, that could represent an attractive alternative to paying $239.28/share today. Because the $237.50 strike represents an approximate 1% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 100%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 2.72% return on the cash commitment, or 23.05% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Amgen Inc, and highlighting in green where the $237.50 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $242.50 strike price has a current bid of $5.40. If an investor was to purchase shares of AMGN stock at the current price level of $239.28/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $242.50. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 3.60% if the stock gets called away at the February 14th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if AMGN shares really soar, which is why looking at the trailing twelve month trading history for Amgen Inc, as well as studying the business fundamentals becomes important. Below is a chart showing AMGN's trailing twelve month trading history, with the $242.50 strike highlighted in red: Considering the fact that the $242.50 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 2.26% boost of extra return to the investor, or 19.16% annualized, which we refer to as the YieldBoost. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $239.28) to be 21%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the Nasdaq 100 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
895
Zihan1004/FNSPID
Energy Sector Update for 01/02/2020: XOM, CVX, COP, SLB, OXY, CLB, WMB, SDRL Correcting the price movement for CVX is the list of Top Energy Stocks. Top Energy Stocks: XOM: +0.43% CVX: +0.41% COP: Flat SLB: +0.87% OXY: +0.92% The West Texas Intermediate crude oil for February delivery was up 5 cents to $61.11 per barrel at the New York Mercantile Exchange, while the global benchmark Brent crude March contract gained 11 cents to $66.11 per barrel. February natural gas futures were 2 cents lower at $2.17 per 1 million BTU. Among energy-related ETFs, United States Oil (USO) retreated 0.2%, while United States Natural Gas (UNG) was dropping more than 3%. In other sector news: (+) Seadrill Ltd (SDRL) gained almost 6% after the marine oilfield-services company announced three-year contract extensions worth almost $200 million for its AOD II and AOD III drill rigs in the Middle East. (+) Core Laboratories N.V. (CLB) was up more than 1% after lowering its quarterly dividend by 54.5% from current levels to $0.25 per share and also reducing its outlook for the three months ending Tuesday. Furthermore, it lowered the forecast range for Q4 net income and revenue by $0.07 per share and $7 million, respectively, now expecting to earn between $0.37 to $0.38 per share. (=) Energy Fuels (UUUU) was flat pre-bell Thursday. The Colorado-based uranium mining company said it will renew its "at-the-market" stock sales program, under which the company may sell up to an additional $30 million of common shares on the NYSE American or any other US market. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
459
Zihan1004/FNSPID
Dow Jones News: Microsoft, Intel Hit the Ground Running in 2020 The Dow Jones Industrial Average (DJINDICES: ^DJI) soared on the first trading day of 2020, up 0.6% at 11:30 a.m. EST. The Dow was up around 22% in 2019. Helping to drive Thursday's gains were two tech giants, Microsoft (NASDAQ: MSFT) and Intel (NASDAQ: INTC). Both stocks performed well in 2019, but each company will face some challenges in 2020 that could jeopardize an encore performance. Microsoft starts 2020 on a strong note Microsoft had a great 2019. Revenue and earnings soared, thanks to the resilience of Office and the incredible growth of the company's cloud business. Microsoft secured the JEDI cloud contract from the U.S. Department of Defense, worth potentially $10 billion over 10 years. And the stock gained 55%, pushing the company's market capitalization well above $1 trillion. Image source: Getty Images. Shares of Microsoft were up another 1.1% Thursday morning, a solid start to 2020. While there's every reason to believe Microsoft will continue to thrive in the cloud this year, Alphabet's (NASDAQ: GOOG) (NASDAQ: GOOGL) Google is doubling down on its efforts to relieve Microsoft of its No. 2 position in the cloud infrastructure market. While Google has reportedly toyed with abandoning the market entirely, the company now has eyes on being a top 2 cloud infrastructure provider by 2023. If Google is serious about winning in the cloud, the company will likely need to dramatically expand its sales and marketing headcount while getting aggressive on price to close deals. This could trigger a price war, cutting into Microsoft's profits as it's forced to reduce prices. After an epic rally in 2019, Microsoft stock is far from cheap. Based on the average analyst estimate for fiscal 2020, shares of the software giant trade for just shy of 30 times earnings. That premium might be justified by the company's growth prospects, but any sign of trouble could send the stock tumbling. Intel rises despite AMD optimism For many years, chip giant Intel faced little competition in its core PC and server chip businesses. But rival Advanced Micro Devices (NASDAQ: AMD) started an assault on Intel's empire when it launched chips based on its Zen architecture in 2017. AMD's Ryzen PC chips and EPYC server chips are now whittling away at Intel's market share, forcing Intel to slash prices on some of its chips to remain competitive. Optimism for AMD continues to build. On Thursday, Nomura reiterated a buy rating on the stock and boosted its price target to $58. Nomura expects AMD's competitive position to continue to strengthen in 2020. While Intel is facing intense competitive pressure, the stock hasn't missed a beat. Shares surged 27.5% in 2019, and they were up another 1.5% Thursday morning. This performance is despite Intel's years-long delay getting its 10nm manufacturing process up and running for volume production. This delay has allowed AMD to erase its manufacturing disadvantage -- AMD's latest Ryzen and EPYC chips are built using TSMC's 7nm process. Intel will be aiming to protect its market share in 2020, which likely means more aggressive pricing, which could cut into margins. But Intel will also be opening a new front in its battle with AMD. Intel is working on its own discrete graphics cards, with a planned launch in 2020. The graphics card market is currently a duopoly, with NVIDIA the leader and AMD in the No. 2 position. Intel could shake things up if its graphics cards are competitive, creating a new revenue stream for the company. While Intel stock has largely shaken off the AMD threat so far, that could change in 2020 if Intel can't blunt AMD's momentum. 10 stocks we like better than Microsoft When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Microsoft wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool's board of directors. Timothy Green has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), Microsoft, and NVIDIA. The Motley Fool recommends Intel and Taiwan Semiconductor Manufacturing and recommends the following options: long January 2021 $85 calls on Microsoft, short January 2020 $50 calls on Intel, and short January 2021 $115 calls on Microsoft. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,160
Zihan1004/FNSPID
NOBL, TGT, ABBV, ADM: Large Inflows Detected at ETF Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares ProShares S&P 500 Dividend Aristocrats ETF (Symbol: NOBL) where we have detected an approximate $79.4 million dollar inflow -- that's a 1.2% increase week over week in outstanding units (from 85,400,000 to 86,450,000). Among the largest underlying components of NOBL, in trading today Target Corp (Symbol: TGT) is off about 0.9%, AbbVie Inc (Symbol: ABBV) is up about 0.6%, and Archer Daniels Midland Co. (Symbol: ADM) is lower by about 0.5%. For a complete list of holdings, visit the NOBL Holdings page » The chart below shows the one year price performance of NOBL, versus its 200 day moving average: Looking at the chart above, NOBL's low point in its 52 week range is $58.96 per share, with $76.17 as the 52 week high point — that compares with a last trade of $75.49. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ». Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs. Click here to find out which 9 other ETFs had notable inflows » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
499
Zihan1004/FNSPID
5 High-Yield Dividend Stocks to Make You Richer in 2020 New year, new you, new sources of potential income to pore over! The changing of the calendar offers an opportunity for income-seeking investors to find attractive or overlooked dividend stocks to add to their portfolios. If you need any reminder, a J.P. Morgan Asset Management report from 2013 reminds us that dividend stocks have run circles around their non-dividend-paying peers for decades. Companies that initiated and grew their payouts between 1972 and 2012 had an average annualized return of 9.5%, compared to just 1.6% for non-dividend payers over the same time frame. Dividend stocks are usually also time tested and profitable businesses that can easily contend with stock market corrections and short-term recessions. Of course, the biggest challenge income investors face is finding the highest yield possible with the least amount of risk. The problem is that as yield rises, risk increases, too. That's why I've handpicked the following five high-yield stocks as those likeliest to make investors richer in 2020. Image source: Getty Images. Innovative Industrial Properties No joke: There really is a safe, high-yielding cannabis stock, and it is Innovative Industrial Properties (NYSE: IIPR). Innovative Industrial Properties (IIP) is a cannabis-focused real estate investment trust (REIT) that began 2019 with 11 properties and ended it with 46 in 14 states. The beauty of this business model is that it leads to long-term, predictable cash flow. Providing updates following every acquisition, Innovative Industrial's weighted-average remaining lease length is 15.3 years, with an average return on its $489.3 million in invested capital of 13.6%. Translation: IIP will receive a complete payback on its invested capital in just over five years. Furthermore, the company also benefits from marijuana remaining a Schedule I drug in the United States. This reduces access to traditional forms of lending from banks for multistate operators, making it more likely that they seek out a sale-leaseback agreement with the likes of IIP. It's no wonder the company's payout has grown 567% in the past nine quarters, leading to its current 5.3% yield. Image source: Getty Images. Mobile TeleSystems Finding great high-yield stocks is all about predictability, and that's what you'll get with Russia's premier telecom company, Mobile TeleSystems (NYSE: MBT). MTS, as the company is known, is yielding a healthy 8.8% at the moment. The source of this company's consistency is its wireless operations throughout Russia and, to a lesser extent, Armenia, Ukraine, and Belarus. Although wireless saturation is high in Russia, MTS is presented with an incredible opportunity, because infrastructure upgrades to 4G LTE and 5G networks in major cities and to 4G in rural parts of the country should spark a smartphone upgrade cycle and lead to even greater data consumption. Data is the high-margin hamster that makes Mobile TeleSystems' wheels spin. Beyond just wireless growth, this is a company that's branched off into other industries. The incorporation of MTS Bank has led to year-over-year growth in its retail loan portfolio of 85% as of the third quarter, with cloud service revenue growth also particularly strong. Despite being a less-followed international stock, Mobile TeleSystems should make patient income seekers richer in 2020. Image source: Getty Images. Kinder Morgan Many on Wall Street have referred to the past 10 years as a "lost decade" for the energy sector, but that's not going to put a damper on midstream giant Kinder Morgan (NYSE: KMI) or its 4.7% yield in 2020. Once again, the focus here is all about predictability. Although oil and gas prices tend to ebb and flow, which can adversely impact production and profit projections for drillers and, to a lesser extent, refiners, it tends to have minimal impact on pipeline and storage companies like Kinder Morgan. That's because the bulk of Kinder Morgan's revenue is derived from fee-based contracts. This allows the company to forecast its cash flow and expenses well in advance, which, in turn, helps Kinder Morgan plan its capital spending and projects without compromising its operating profits. As my Foolish colleague Matt DiLallo recently pointed out, Kinder Morgan has also done a bang-up job of reducing its leverage through noncore asset sales. It'll end the year below its target of 4.5 times debt-to-EBITDA and looks to have the cash flow to significantly lift its payout in 2020. Image source: Getty Images. Annaly Capital Management Though this is bound to be an unpopular choice given how poorly mortgage REITs have performed in recent years, agency-based mortgage REIT Annaly Capital Management (NYSE: NLY) and its 10.2% yield could help make income investors richer this year. While Annaly's asset portfolio of mortgage-backed securities might sound complex, the business model itself is pretty easy to understand. Annaly borrows at short-term rates and buys assets with higher long-term yields then pockets the difference. When interest rates are rising, the yield curve is flattening, or the rate environment is uncertain, the gap between short-term and long-term yields shrinks, thereby squeezing Annaly's profits and top-tier dividend. But if rates stay low or remain steady for an extended period of time, Annaly's bottom line usually benefits. Right now, we've pushed toward the latter scenario, with the Fed funds rate falling 75 basis points in 2019 and the nation's central bank hitting the pause button on future rate moves. What's more, Annaly sticks to agency-only assets, meaning they're backed by the federal government in the event of default. That makes Annaly far less of a risk for income investors if and when the next recession strikes the U.S. Image source: Getty Images. AT&T Lastly, I see no reason not to own one of the safest dividend stocks on the planet, AT&T (NYSE: T), which also happens to offer a 5.3% yield. Like Mobile TeleSystems, AT&T is set to benefit from a major infrastructure and smartphone upgrade cycle. AT&T has already begun rolling out 5G in more than a dozen cities and should see a significant uptick in data usage from consumers once tech kingpin Apple introduces a 5G-capable iPhone later this year. With data providing a significant portion of AT&T's wireless profits, the 5G revolution could lead to a very real and sustainable uptick in growth. AT&T is also focusing its efforts on streaming. The acquisition of Time Warner in 2018 gives AT&T access to the CNN, TNT, and TBS networks, while the launch of HBO Max in the first half of the year provides exclusivity that could help bring in new streaming users. If there's a company on this list that wouldn't bat an eye if a recession hit, it's AT&T. 10 stocks we like better than AT&T When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and AT&T wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 1, 2019 Sean Williams owns shares of AT&T. The Motley Fool owns shares of and recommends Apple and Kinder Morgan. The Motley Fool recommends Innovative Industrial Properties. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,685
Zihan1004/FNSPID
Why Will Expedia's Total Expenses See Single-Digit Growth In 2019? Expedia‘s (NASDAQ: EXPE) total expenses have trended higher from $8 billion in 2016 to $10 billion in 2018. Operating expenses are the biggest driver of Expedia’s expenses, accounting for 83% of Revenue in 2015 and 84% of Revenues in 2018. We estimate that this increase in Operating Expenses as % of Revenue has impacted Expedia’s Operating Income by about $250 million. However, with Revenue expected to pick up in the near term driven by higher gross bookings from HomeAway and Egencia, Operating Expense as % of revenue is likely to decline to 82% in 2020, leading to improved operating profits. In 2019, we expect Expedia’s total expenses to grow at a slower rate as compared to the last 2 years. This is because the company expects a bigger impact on the cost rationalization efforts at Trivago. We have created an interactive dashboard on Expedia’s Expenses: How Does Expedia Spend Its Money?, where we take a look at Expedia’s expenses and net margins. We also discuss how the company’s key expense components have trended and the key reasons for the change. Expedia’s total expenses have increased from $8.1 billion in 2016 to $10 billion in 2018. The company’s total expenses are projected to stand at $11 billion for 2019. 1. Cost of Sales : Cost of Sales have increased from $1.6 billion in 2016 to $2 billion in 2018, driven by higher customer operations, data center, and cloud expenses. As Cost of Sales has grown at a slower rate than Revenues, the Gross Profit Margin has grown from 81.8% to 82.5% over the same period. 2. Operating Expenses Have Increased From $6.7 billion in 2016 to $8.5 billion in 2018, Driven By (A) $1.4 Billion Increase In S&M Expenses, (B) $380 Million Increase In T&C, and (C) $130 Million Increase in G&C Expenses (A) SG&M expenses have increased from $4.4 billion in 2016 to $5.8 billion in 2018. As a % of Revenues, SG&A has increased from 49.8% in 2016 to 51.4% in 2018 In 2019, we expect the company’s selling and marketing expense to grow at a slower rate and add nearly $150 million to total operating expenses. The company expects a bigger impact on the cost rationalization efforts at Trivago in 2019. (B) T&C Expenses increased from $1.2 billion in 2016 to about $1.6 billion in 2018, due to higher cloud costs. As a % of Revenue, T&C expenses have grown from 14.1% in 2016 to 14.4% in 2018 We expect T&C expense to add nearly $350 million to operating expenses in 2019. This is due to higher cloud cost as well as continued investments in product enhancements and platform initiatives across the company in 2019. Expedia expects cloud expenses to increase from $141 million in 2018 to around $250 million in 2019. (C) G&A Expenses increased from $678 million in 2016 to about $808 million in 2018. As a % of Revenue, R&D expenses have declined from 7.7% in 2016 to 7.2% in 2018 3. Non-Operating Income : Expedia’s Non-Operating Income Has Decreased From -$185 million in 2016 to -$230 million in 2018 driven by higher interest expenses relating to more long-term debt, partially offset by higher Interest and dividend income from its investments. 4. Tax Expense: Expedia’s Income Tax Expense has declined from -$15 million in 2016 to about -$87 million in 2018, driven by U.S. Federal Income Tax Reforms, with Effective Tax rate declining from -6% to -18%. What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams | Product, R&D, and Marketing Teams More Trefis Data Like our charts? Explore example interactive dashboards and create your own. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
뉴스
1,061